
<html lang="en"     class="pb-page"  data-request-id="7e142440-8eb4-4ffd-8a7c-6abf666da4f1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c00419;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis" /></meta><meta name="dc.Creator" content="James W.  Janetka" /></meta><meta name="dc.Creator" content="Allen T.  Hopper" /></meta><meta name="dc.Creator" content="Ziping  Yang" /></meta><meta name="dc.Creator" content="Jennifer  Barks" /></meta><meta name="dc.Creator" content="Mary Savari  Dhason" /></meta><meta name="dc.Creator" content="Qiuling  Wang" /></meta><meta name="dc.Creator" content="L. David  Sibley" /></meta><meta name="dc.Description" content="Calcium dependent protein kinase 1 (CDPK1) is an essential Ser/Thr kinase that controls invasion and egress by the protozoan parasite Toxoplasma gondii. The Gly gatekeeper of CDPK1 makes it exquisi..." /></meta><meta name="Description" content="Calcium dependent protein kinase 1 (CDPK1) is an essential Ser/Thr kinase that controls invasion and egress by the protozoan parasite Toxoplasma gondii. The Gly gatekeeper of CDPK1 makes it exquisi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 18, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00419" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00419" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00419" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00419" /></link>
        
    
    

<title>Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00419" /></meta><meta property="og:title" content="Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0016.jpeg" /></meta><meta property="og:description" content="Calcium dependent protein kinase 1 (CDPK1) is an essential Ser/Thr kinase that controls invasion and egress by the protozoan parasite Toxoplasma gondii. The Gly gatekeeper of CDPK1 makes it exquisitely sensitive to inhibition by small molecule 1H-pyrazolo[3,4-d]pyrimidine-4-amine (PP) compounds that are bulky ATP mimetics. Here we rationally designed, synthesized, and tested a series of novel PP analogs that were evaluated for inhibition of CDPK1 enzyme activity in vitro and parasite growth in cell culture. Optimal substitution on the PP scaffold included 2-pyridyl ethers directed into the hydrophobic pocket and small carbocyclic rings accessing the ribose-binding pocket. Further optimization of the series led to identification of the lead compound 3a that displayed excellent potency, selectivity, safety profile, and efficacy in vivo. The results of these studies provide a foundation for further work to optimize CDPK1 inhibitors for the treatment of acute and chronic toxoplasmosis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00419"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00419">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00419&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00419&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00419&amp;href=/doi/10.1021/acs.jmedchem.0c00419" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 6144-6163</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00266" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00435" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">James W. Janetka</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James W. Janetka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis. Missouri 63110, United States</div></div><span class="conrtib-corresp"><strong>*</strong>J.W.J.: <a href="/cdn-cgi/l/email-protection#dcb6bdb2b9a8b7bdb69caba9afa8b0f2b9b8a9"><span class="__cf_email__" data-cfemail="2248434c475649434862555751564e0c474657">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+W.++Janetka">James W. Janetka</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9888-5411" title="Orcid link">http://orcid.org/0000-0002-9888-5411</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Allen T. Hopper</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Allen T. Hopper</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vyera Pharmaceuticals, 600 Third Avenue, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Allen+T.++Hopper">Allen T. Hopper</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ziping Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ziping Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vyera Pharmaceuticals, 600 Third Avenue, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ziping++Yang">Ziping Yang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jennifer Barks</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennifer Barks</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Barks">Jennifer Barks</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mary Savari Dhason</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mary Savari Dhason</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Savari++Dhason">Mary Savari Dhason</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qiuling Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qiuling Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qiuling++Wang">Qiuling Wang</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">L. David Sibley</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">L. David Sibley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States</div></div><span class="conrtib-corresp"><strong>*</strong>L.D.S.: <a href="/cdn-cgi/l/email-protection#ed9e848f818894ad9a989e9981c3888998"><span class="__cf_email__" data-cfemail="94e7fdf6f8f1edd4e3e1e7e0f8baf1f0e1">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=L.+David++Sibley">L. David Sibley</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7110-0285" title="Orcid link">http://orcid.org/0000-0001-7110-0285</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00419&amp;href=/doi/10.1021%2Facs.jmedchem.0c00419" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 6144–6163</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 18, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 March 2020</li><li><span class="item_label"><b>Published</b> online</span>18 May 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 June 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00419" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00419</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6144%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJames%2BW.%2BJanetka%252C%2BAllen%2BT.%2BHopper%252C%2BZiping%2BYang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D11%26contentID%3Dacs.jmedchem.0c00419%26title%3DOptimizing%2BPyrazolopyrimidine%2BInhibitors%2Bof%2BCalcium%2BDependent%2BProtein%2BKinase%2B1%2Bfor%2BTreatment%2Bof%2BAcute%2Band%2BChronic%2BToxoplasmosis%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6163%26publicationDate%3DJune%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00419"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1096</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00419" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;W. Janetka&quot;},{&quot;first_name&quot;:&quot;Allen&quot;,&quot;last_name&quot;:&quot;T. Hopper&quot;},{&quot;first_name&quot;:&quot;Ziping&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Barks&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Savari Dhason&quot;},{&quot;first_name&quot;:&quot;Qiuling&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;L.&quot;,&quot;last_name&quot;:&quot;David Sibley&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;6144-6163&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00419&quot;},&quot;abstract&quot;:&quot;Calcium dependent protein kinase 1 (CDPK1) is an essential Ser/Thr kinase that controls invasion and egress by the protozoan parasite Toxoplasma gondii. The Gly gatekeeper of CDPK1 makes it exquisitely sensitive to inhibition by small molecule 1H-pyrazolo[3,4-d]pyrimidine-4-amine (PP) compounds that are bulky ATP mimetics. Here we rationally designed, synthesized, and tested a series of novel PP analogs that were evaluated for inhibition of CDPK1 enzyme activity in vitro and parasite growth in cell culture. Optimal substitution on the PP scaffold included 2-pyridyl ethers directed into the hydrophobic pocket and small carbocyclic rings accessing the ribose-binding pocket. Further optimization of the series led to identification of the lead compound 3a that displayed excellent potency, selectivity, safety profile, and efficacy in vivo. The results of these studies provide a foundation for further work to optimize CDPK1 inhibitors for the treatment of acute and chronic toxoplasmosis.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00419&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00419" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00419&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00419" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00419&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00419" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00419&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00419&amp;href=/doi/10.1021/acs.jmedchem.0c00419" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00419" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00419" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (10 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00419%26sid%3Dliteratum%253Aachs%26pmid%3D32420739%26genre%3Darticle%26aulast%3DJanetka%26date%3D2020%26atitle%3DOptimizing%2BPyrazolopyrimidine%2BInhibitors%2Bof%2BCalcium%2BDependent%2BProtein%2BKinase%2B1%2Bfor%2BTreatment%2Bof%2BAcute%2Band%2BChronic%2BToxoplasmosis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D11%26spage%3D6144%26epage%3D6163%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/jmcmar.2020.63.issue-11/20200611/jmcmar.2020.63.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Calcium dependent protein kinase 1 (CDPK1) is an essential Ser/Thr kinase that controls invasion and egress by the protozoan parasite <i>Toxoplasma gondii</i>. The Gly gatekeeper of CDPK1 makes it exquisitely sensitive to inhibition by small molecule 1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine-4-amine (PP) compounds that are bulky ATP mimetics. Here we rationally designed, synthesized, and tested a series of novel PP analogs that were evaluated for inhibition of CDPK1 enzyme activity <i>in vitro</i> and parasite growth in cell culture. Optimal substitution on the PP scaffold included 2-pyridyl ethers directed into the hydrophobic pocket and small carbocyclic rings accessing the ribose-binding pocket. Further optimization of the series led to identification of the lead compound <b>3a</b> that displayed excellent potency, selectivity, safety profile, and efficacy <i>in vivo</i>. The results of these studies provide a foundation for further work to optimize CDPK1 inhibitors for the treatment of acute and chronic toxoplasmosis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14123" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14123" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><i>Toxoplasma gondii</i> is a widespread parasite of domestic, companion, and wild animals that also frequently causes infections in humans.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The organism’s life cycle involves an acute phase dominated by rapidly growing tachyzoite stages that proliferate and disseminate widely within the body.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Following a vigorous immune response, the parasite differentiates into a semidormant state characterized by tissue cysts that contain bradyzoites, which replicate slowly and asynchronously.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Although the turnover of the chronic tissue stages is not precisely understood, available evidence suggests that there are successive waves of cysts that are formed, expand slowly, and rupture to release bradyzoites.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The majority of these released stages are destroyed by the adaptive immune response, and yet they give rise to daughter cysts such that the chronic infection is perpetuated. When ingested by members of the cat family, bradyzoites can initiate development of the sexual phase within enterocytes of the gut resulting in shedding of oocysts in the feces.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Oocysts are highly persistent in the environment and serve as a source of infection for many species of intermediate hosts including rodents and domestic animals.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Because <i>T. gondii</i> infection occurs commonly in food animals, it poses a risk to food safety and animal well being.</div><div class="NLM_p">Humans become infected with <i>T. gondii</i> by ingestion of tissue cysts in undercooked meat or oocyst contaminated food or water.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Most human infections give rise to mild illness that is effectively controlled by the immune response; however, toxoplasmosis poses a serious risk to the immunocompromised and due to congenital infection.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The severity of toxoplasmosis is related to the fact that tachyzoites disseminate to all organs and readily form tissue cysts within neurons in the brain and endothelial cells in the retina.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> When these chronic infections reactivate due to decreased immunity, the tachyzoite forms re-emerge and proliferate rapidly to cause encephalitis and retinitis, respectively.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Hence, drugs must readily cross the blood–brain barrier in order to be effective in control of toxoplasmosis. Current therapy for toxoplasmosis relies on inhibition of the folate pathway with pyrimethamine and sulfadiazine.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Complications from this treatment include intolerance to sulfa drugs, intolerance of pyrimethamine due to gastrointestinal distress, and the potential for bone marrow suppression that requires coadministration of leucovorin (i.e., folic acid).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Although the current standard of care can suppress active infection due to proliferation of tachyzoites, it has no effect on the semidormant bradyzoite forms.<a onclick="showRef(event, 'cit10a'); return false;" href="javascript:void(0);" class="ref cit10a">(10a)</a> Although there are backup treatments that can be used in the event of toxicity (i.e., clindamycin, atovaquone, azithromycin), they are also unable to cure chronic infection.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Consequently, those at risk of toxoplasmosis need to be treated for long-term, which is particularly problematic for the immunocompromised or newborns. As such, there is a need to develop new treatments with an improved safety profile and that would target the bradyzoites stages that are responsible for infection.</div><div class="NLM_p">The intracellular phases of <i>T. gondii</i> infection rely on active motility to power cell invasion and egress.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Among the components that are essential for this process is the calcium dependent protein kinase 1 (CDPK1), which controls microneme secretion and thus is essential for parasite motility, cell invasion, and egress.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The recognition that CDPK1 contains a glycine (Gly) gatekeeper residue<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> allowed repurposing of bulky small molecule ATP mimetics previously used to probe kinase function based on engineering of mammalian kinases to render them selectively susceptible.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> On the basis of this discovery, we and others have explored the existing 1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine-4-amine or “pyrazolopryimidine” (PP) kinase inhibitor scaffold (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) identifying compounds with good enzyme activity against CDPK1.<a onclick="showRef(event, 'cit13a ref15 ref16'); return false;" href="javascript:void(0);" class="ref cit13a ref15 ref16">(13a,15,16)</a> Other scaffolds based on the PP framework have also been shown to exploit this feature of the small gatekeeper residue,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and the shared nature of this enlarged ATP binding pocket has been used to demonstrate the general utility of CDPK1 inhibitors for inhibiting a variety of related parasites.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Comparison of PP CDPK1 Inhibitors with Phenyl (<b>1</b>) vs 2-Pyridyl (<b>2</b>) Ether R1 Groups</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0011.gif" alt="" id="GRAPHIC-d7e335-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">“R<sub>1</sub>”</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">CDPK1 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">cell EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">MLM <i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center">HLM <i>t</i><sub>1/2</sub> (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GXJ178 (<b>1a</b>)</td><td class="colsep0 rowsep0" rowspan="3" align="left">O-Ph</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">537</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GXJ184 (<b>1b</b>)</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">311</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GXJ176 (<b>1c</b>)</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">163</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3033 (<b>2a</b>)</td><td class="colsep0 rowsep0" rowspan="3" align="left">O-2-Pyr</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2091 (<b>2b</b>)</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2076 (<b>2c</b>)</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">112</td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">>145</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2885 (<b>3a</b>)</td><td class="colsep0 rowsep0" rowspan="3" align="left">O-2-Pyr</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">172</td><td class="colsep0 rowsep0" align="left">>145</td><td class="colsep0 rowsep0" align="left">>145</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2831 (<b>3b</b>)</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">8.4</td><td class="colsep0 rowsep0" align="left">141</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2886 (<b>3c</b>)</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">696</td><td class="colsep0 rowsep0" align="left">>145</td><td class="colsep0 rowsep0" align="left">>145</td></tr></tbody></table></div></div><div class="NLM_p">Previous studies have shown that within the core PP scaffold, the 4-position NH<sub>2</sub> and adjacent N5 of the pyrimidine ring interact with the hinge region of the kinase; the R1 substituent at the C3 position protrudes into the large hydrophobic pocket defined by the Gly gatekeeper residue; and the pyrazolo N1 substituent at the R2 position extends into the ribose sugar binding region of the ATP pocket.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Analogs from the PP series were shown to control acute infection in the murine model<a onclick="showRef(event, 'cit15c ref19'); return false;" href="javascript:void(0);" class="ref cit15c ref19">(15c,19)</a> and to either decrease the burden of chronic infection<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a> or cure immunocompromised mice with chronic infection.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The ability of PP-based inhibitors to reduce or prevent chronic infection may be related to the reliance of bradyzoites on CDPK1 for invasion, as suggested by <i>ex vivo</i> treatment of tissue cysts from chronically infected mice.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The effectiveness of PP inhibitors against bradyzoites is especially noteworthy as current therapies have little effect on these stages.</div><div class="NLM_p last">Although CDPK1 shows promise as a target for developing new inhibitors of parasite infection, existing analogs have been limited by serval undesirable features. Some of the previously described compounds exhibited problems such as lack of kinase selectivity (e.g., inhibition of Src or other human kinases)<a onclick="showRef(event, 'cit15a cit15b cit16c ref20'); return false;" href="javascript:void(0);" class="ref cit15a cit15b cit16c ref20">(15a,b,16c,20)</a> or undesired inhibition of the hERG channel,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> while others displayed adverse neurological symptoms when used to treat large animals.<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a> Other potent analogs <i>in vitro</i> showed low metabolic stability in liver microsomes (mouse and human) and high <i>in vivo</i> clearance in mice limiting their potential for advancement.<a onclick="showRef(event, 'cit15c ref20'); return false;" href="javascript:void(0);" class="ref cit15c ref20">(15c,20)</a> Herein we sought to rationally design and optimize new potent diverse PP CDPK1 inhibitors with improved drug-like properties, metabolic stability, and pharmacokinetic and safety profiles for advancement to the clinic.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We previously reported on a unique series of PP CDPK1 inhibitors<a onclick="showRef(event, 'cit15c ref20'); return false;" href="javascript:void(0);" class="ref cit15c ref20">(15c,20)</a> having a <i>tert</i>-butyl at the pyrazolo R<sub>2</sub> position and a phenyl ether at the R1 position (<b>1a</b>–<b>c</b>; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). We discovered the meta R<sub>3</sub> position on the phenyl ether was preferred for potency, further identifying trifluoromethyl, chloro, and methyl substituents as optimal substituents. While these analogs showed excellent potency and moderate cell activity, their stability in mouse liver microsomes was extremely low (half-life of ∼10 min). Thus, we initiated studies directed at evaluating new CDPK1 inhibitors using the PP scaffold with significant modification of R1 and R2 groups.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Inhibition of CDPK1</h3><div class="NLM_p last">To evaluate potential inhibitors of CDPK1, we expressed recombinant parasite enzymes in <i>E. coli</i> and used an ELISA assay to detect phosphorylation of a conserved peptide, as described previously.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> CDPK1 activity was tested across an 11-point dilution series ranging from 20 μM to 0.17 nM. We also tested compounds for inhibition of parasite growth using a previously described type 1 RH transgenic parasite that expresses β-galactosidase.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Growth of <i>T. gondii</i> tachyzoites in monolayers of human foreskin fibroblasts was tested across an 11-point dilution series ranging from 10 μM to 0.13 nM compound.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Rational Design of Novel PP-Based CDPK1 Inhibitors</h3><div class="NLM_p">Using the X-ray structure of compound <b>1b</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) bound to CDPK1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IHP">4IHP</a>) and our previous structural studies of other analogs,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> it was hypothesized that addition of a nitrogen in the ortho ring position (2-pyridyl; <b>2b</b>) would lock the 4-Cl-2-pyridyl ring in the bound confirmation through an internal H-bond to the 4 amino NH<sub>2</sub> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A) while at the same time significantly changing the physical properties and metabolic profile of the compound. Therefore, we synthesized analogs <b>2a</b> and <b>2b</b> and found that they retained similar values for enzyme inhibition, but were ∼10-fold more potent in inhibition of parasite growth. Additionally, the stability in human liver microsomes of <b>2b</b> improved 5-fold over matched pair <b>1b</b> with a decent half-life of 60 min. Further exploration of R<sub>3</sub> substituents in the 4-position produced cyano compound <b>2c</b> that displayed excellent metabolic stability in human liver microsomes (half-life of >145 min) and increased stability in mouse microsomes as well (half-life of 46 min). Next, we evaluated if the <i>tert</i>-butyl R2 group could be replaced with a smaller, less lipophilic, and often more metabolically stable cyclopropyl group. Compounds <b>3a</b>, <b>3b</b>, and <b>3c</b> had improved metabolic stability and similar CDPK1 potency as their <i>tert</i>-butyl matched pairs (<b>2a</b>–<b>c</b>), but cellular potency dropped-off by 2- to 5-fold (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Models of (A) 2-pyridyl-5-chloro PP <b>2b</b> and (B) 2-pyridyl-5-hydroxy PP <b>4l</b> (tBu R2) based on X-ray structure of <b>1b</b> bound to CDPK1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IHP">4IHP</a>). Residues that are thought to make contacts are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Structure–Activity Relationships (SAR) of R<sub>1</sub></h4><div class="NLM_p">On the basis of this preliminary work identifying the new O-linked pyridyl R<sub>1</sub>, we pursued a library of PP analogs with varied R1 substituents where the R<sub>2</sub> group was held constant as cyclopropyl (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Interestingly, the analog where R<sub>3</sub> is a hydroxy group and R<sub>2</sub> is cyclopropyl showed good enzyme and growth inhibition (<b>4l</b>; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). This outcome was unexpected as polar functional groups in this position are typically less active (e.g., <b>4x</b> and <b>4m</b>). We further explored these findings by modeling this compound bound to CDPK1 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). We hypothesize that the ring is twisted 180°deg relative to <b>2b</b> where the hydroxy group is making two H-bonds to backbone amide carbonyls of CDPK1. The model also places the pyridyl nitrogen within proximity for beneficial electronic interactions with a salt bridge Lys-Asp (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of PP CDPK1 Inhibitors (<b>4</b>) with a Cyclopropyl R2 Group and Varied Heteroaryl Ether R2 Groups</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0012.gif" alt="" id="GRAPHIC-d7e849-autogenerated" /></img><div></div></div><div class="NLM_p last">It became clear that a pyridin-2-yl ring was preferred over other pyridine and dinitrogen heteroaryl ring systems. Further analysis of SAR indicated that the position of the substituent off the 2-pyridyl ring was also important to achieve high enzyme inhibition, with the 4 position being optimal as in previous compounds <b>2a</b>–<b>c</b>. For example, compare 6-chloropyridin-2-yl <b>4b</b> with 4-chloropyridin-2-yl <b>3b</b> with CDPK-1 IC<sub>50</sub> values of 988 and 8.4 nM, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). This result was not surprising and is consistent with the location on the best non-pyridyl analogs reported previously. A compound worth mentioning is 2-pyrazine <b>4r</b> that had good enzyme inhibition (IC<sub>50</sub> = 66 nM) comparable to that of the unsubstituted 2-pyridyl <b>4a</b> (IC<sub>50</sub> = 38 nM). Subsequently, we constructed derivatives with varied R3 groups at the 4-position of the pyridine-2-yl ring where we found, as before with <b>2a</b>–<b>c</b>, that the CF<sub>3</sub> (<b>3a</b>), Cl (<b>3b</b>), and Me (<b>4u</b>) groups had the best potency in both the enzyme and growth inhibition assays.</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Evaluation of 4-(Trifluoromethyl)pyridin-2-yl PP R<sub>2</sub> Substituents</h4><div class="NLM_p">Having identified the CF<sub>3</sub> group as preferred in the 4-position based on the combination of potency and stability, we next explored analogs with a diverse range of R<sub>2</sub> substitutions on the pyrazolo nitrogen (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). We focused on carbocycles and nonaromatic heterocycles (<b>5</b> and <b>6</b>) and found that cyclopropyl (<b>3a</b>), cyclobutyl (<b>7a</b>, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), cyclopentyl (<b>5a</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), and cyclohexyl (<b>5b</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) rings were mostly similar in enzyme and cell activity, with CDPK1 IC<sub>50</sub> values of 16, 9.8, 23, and 15 nM, respectively. However, cyclopropyl (<b>3a</b>) was clearly differentiated from the others with superior metabolic stability in both mouse and human liver microsomes. The comparable oxygen containing heterocyclic analogs 3-oxetain, 3-tetrahydrofuran, 4-tetrahydropyran, and 3-tetrahydropyran (<b>5c</b>, <b>5d</b>, <b>5e</b>, <b>5f</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) had reduced and variable CDPK-1 potencies of 440, 48, 29, and 116 nM, respectively. The nitrogen containing heterocyclic analogs 4-piperidine and 3-piperidine (<b>5g</b>, <b>5i</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) showed similar decreased activity against the CDPK1 enzyme with IC<sub>50</sub> values of 68 and 57 nM. One important piece of SAR was determined by comparing 4-piperidine <b>5g</b> to 3,3-gem-difluoro-4-piperidine analog <b>5h</b>. The difluoro analog was predicted to reduce the p<i>K</i><sub>a</sub> of the piperidine ring nitrogen from a calculated value of 9.2 to 7.1 and thus hypothesized to improve cell penetration and potency. As predicted, <b>5h</b> showed a 10-fold increase in growth inhibition, although some of this improvement is likely due to its 3-fold increase in enzyme inhibition potency. Unfortunately, this strategy was not successful for 3-piperidine <b>5i</b> when compared to 3,3-gem-difluoro-5-piperidine <b>5j</b>, which was >3-fold less potent in growth inhibition. In contrast to the heterocycles, those rings appended externally with an oxygen or nitrogen largely retained enzyme inhibition with varied effects on growth inhibition and metabolic stability. The most promising results were obtained with either the four-membered or six-membered rings. Some representative examples include the 4-position cis and trans cyclohexyl alcohols <b>6c</b> and <b>6b</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), respectively. Both of these analogs had good enzyme and growth inhibition plus excellent half-life in human microsomes but only moderate stability in the mouse microsomes. Appending a methylene spacer between the ring and alcohol (<b>6d</b>, <b>6e</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) had a negative effect on the stability, while methylation of the alcohols (<b>6f</b>, <b>6g</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) decreased potency 2- to 3-fold without improvement in mouse microsome stability. However, 2-hydroxycyclohexanes (<b>6j</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) fared better, maintaining potency with increased mouse microsome half-life, which was largely dependent upon the stereochemistry with optimal substitution being trans and with the <i>R</i>,<i>R</i> stereochemistry as with <b>6j</b>. 2-Hydroxycyclohexane stereoisomers <b>6k</b> and <b>6i</b> were of substantially weaker activity. The absolute stereochemistry was determined by small molecule X-ray crystallography (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Compound <b>6j</b> had an EC<sub>50</sub> of 77 nM in the growth inhibition assay in addition to >145 min half-life in human and 66 min half-life in mouse microsomes. Likewise, amino substituted cycloalkyls largely showed good inhibition of enzyme and growth but interestingly were somewhat dependent on relative and absolute stereochemistry. For example, comparison of cis-3-aminocyclopentane (<b>6m</b>) to the trans isomer (<b>6l</b>) shows that the cis form was more potent in enzyme inhibition and also had excellent stability in human microsomes and a moderate 84 min half-life in mouse liver microsomes. A similar trend is noted for the 4-methylaminocyclohexyl versions as seen with <b>6n</b> and <b>6o</b> where the cis isomer <b>6n</b> is also 3× more potent in growth inhibition (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The dimethyl analog <b>6q</b> and the desmethyl analog <b>6p</b> both had similar enzyme and growth inhibition plus >145 min half-life in human microsomes but only 17 and 55 min half-life in the mouse liver microscome assay, respectively. Other issues were identified with these promising amino carbocycles including cellular efflux as indicated from the MDCK permeability assay and thus potentially poor CNS permeability and low oral bioavailability. Thus, from this study, 4-CF<sub>3</sub>-2-pyridylcyclopropyl <b>3a</b> and 2-hydroxycyclohexyl <b>6j</b> pyrazolopyrimidines both emerged as new lead compounds for inhibition of CDPK1.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Stereochemistry of <b>6j</b>: (A) structure of compound showing stereochemistry of <b>6j</b>; (B) small molecule X-ray structure of <b>6j</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of PP CDPK1 Inhibitors with 4-Trifluoromethyl(pyridine-2-yl) Ether at R1 with Unsubstituted Cycloalkyl and Heterocyclic Groups (<b>5</b>) or Substituted Cycloalkyl (<b>6</b>) at R2</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0013.gif" alt="" id="GRAPHIC-d7e1140-autogenerated" /></img><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Comparison of 2-Pyridyl 5-CF<sub>3</sub>, CN, Cl (<b>7</b>–<b>13</b>), and OH (<b>14</b>) Ether R1 PP Compounds with Preferred R2 Groups</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0014.gif" alt="" id="GRAPHIC-d7e1159-autogenerated" /></img><div></div></div></div><div id="secx" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Multivariate Analysis of 2-Pyridyl-4-CF<sub>3</sub>, Cl, CN, and OH Analogs with Optimal R<sub>2</sub> Groups</h4><div class="NLM_p">Shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> are several analogs with other optimized R2 groups that were synthesized in all three 4-CF<sub>3</sub>, Cl, and CN series of 2-pyridyl PP CDPK1 inhibitors (<b>7</b>–<b>13</b>). Many of these optimal R2 groups are substituted cyclobutyl derivatives bearing either a hydroxy or fluoro substitution. As with previous SAR, we found that the trend for inhibition of CDPK1 activity and parasite growth inhibition was Cl > CF<sub>3</sub> > CN. Consistent with this pattern, the analogs of <b>7b</b>, <b>7a</b>, and <b>7c</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) showed IC<sub>50</sub> values for enzyme inhibition of 6.2, 9.8, and 10 nM and EC<sub>50</sub> values for growth inhibition of 27, 95, and 272 nM. The trend was reversed for stability in microsomes where CN analog <b>7c</b> had a half-life in human microsomes of 141 min while <b>7b</b> and <b>7a</b> had 20 and 61 min half-lives, respectively. In an attempt to improve upon <b>3a</b>, the cyclopropyl was exchanged with a cyclopropylmethyl in compounds <b>12a</b>–<b>c</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), but this led to decreased metabolic stability. A similar result was found from adding a methylene spacer as in <b>13a</b>–<b>c</b> in comparison to <b>5j</b>. On the other hand, addition of a gem-difluoro group to cyclohexyl <b>5b</b> with <b>11a</b> and <b>11b</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) resulted in a >145 min half-life in human microsomes but only ∼25 min half-life in mouse microsomes. Better results were obtained with both the hydroxy and fluorocyclobutyl R<sub>2</sub> groups. In this case, cis versus trans stereochemistry was not as important as seen with earlier analogs of different R<sub>2</sub> ring sizes. For example, cis hydroxy analogs <b>8a</b>, <b>8b</b>, and <b>8c</b> have similar enzyme inhibition to trans hydroxy analogs <b>9a</b>, <b>9b</b>, and <b>9c</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) but the latter analogs did have a slight increase in growth inhibition relative to the cis variants. The most promising result was discovered with trans-3-fluorocyclobutyl analog <b>10c</b>. Although the 4-Cl 2-pyridyl analog <b>10b</b> clearly had the best potency in parasite growth inhibition, the 4-CF<sub>3</sub> analog <b>10a</b> was not far behind, and the 4-CN version <b>10c</b> had only a slightly diminished activity (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Excitingly, we elucidated that <b>10c</b> also had good stability in both human and mouse microsomes with a half-life of >145 min in both assays. In another study we looked at different R<sub>2</sub> groups where R was a 4-hydroxy-2-pyridine (<b>14</b>; <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) due to the promising results from initial cyclopropyl R<sub>2</sub> analog <b>4l</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). We surmised that the hydroxy group could potentially decrease metabolism; however, the best compound with a 4,4-difluorocyclohexyl R<sub>2</sub><b>14d</b> had a half-life of only 68 min in mouse microsomes.</div><div class="NLM_p">On the basis of compound <b>10c</b>, we decided to evaluate one more set of compounds shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> that had either the preferred trans-3-hydroxy (<b>16a</b>, <b>16b</b>, <b>16c</b>) or 3-fluoro (<b>15a</b>, <b>15b</b>, <b>15c</b>) cyclobutyl R<sub>2</sub> group. In this case, we switched the R<sub>1</sub> group back to a phenyl ether as opposed to pyridyl ether. Our combined results clearly demonstrate that the 2-pyridyl group in the new series of PP CDPK1 inhibitors is not only responsible for gains in cellular activity but also the enhancements attained in metabolic stability.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR of Phenyl-5-CF<sub>3</sub>, CN, Cl R1 Ether PP tCDPK1 Inhibitors (<b>15</b>, <b>16</b>) with Preferred Cyclobutyl R2 Groups</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0015.gif" alt="" id="GRAPHIC-d7e1387-autogenerated" /></img><div></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Synthesis</h3><div class="NLM_p">Analogs of the PP scaffold were synthesized utilizing both existing and new synthetic transformations/methodologies which are outlined in this section. <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> outlines the synthesis of compounds shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> specifically bearing a cyclopropyl R<sub>2</sub> group. Starting from cyclopropylboronic acid (<b>17</b>), the hydrazine (<b>18</b>) was obtained from reaction with di-<i>tert</i>-butyl (<i>E</i>)-diazene-1,2-dicarboxylate and copper acetate<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> followed by Boc deprotection. A novel condensation of <b>18</b> with ketene ethylene acetal <b>19</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> provided cyclopropylpyrazole intermediate <b>20</b>. Cyclization to the ring fused 5–6 pyrazolopyrimidine <b>21</b> was performed by reaction with formamide. Subsequent hydrolysis of the ethylene glycol ether with potassium hydroxide in diphenyl ether at high temperature yielded key intermediate alcohol <b>22</b>. The final target compounds such as <b>3a</b> were all obtained by substitution reactions of the appropriate chloropyridine (2-chloro-4-(trifluoromethyl)pyridine for <b>3a</b>) or bromoheterocyclo derivative with <b>22</b> using potassium carbonate and DMSO at 120 °C.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Cyclopropyl R2 Library with Varied Aryl R1 Ethers (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) Exemplified by <b>3a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) di-<i>tert</i>-butyl (<i>E</i>)-diazene-1,2-dicarboxylate, Cu(OAc)<sub>2,</sub> DMF, 4 days; (b) HCI, EtOAc, 25 °C, 3 h; (c) 2-chloroethyl carbonochloridate, NaOH, MeCN, 0–90 °C, 18 h; (d) TEA, EtOH, 90 °C, 3 h; (e) formamide, 180 °C, 4 h; (f) KOH/Ph<sub>2</sub>O, 180 °C, 3 h; (g) 2-chloro-4- (trifluoromethyl)pyridine, K<sub>2</sub>CO<sub>3</sub>, DMSO, 120 °C.</p></p></figure><div class="NLM_p">The 2-pyridyl-4-CF<sub>3</sub> pyridine PP analogs shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were constructed through a similar approach as in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> but with a slight variation to install the variable R<sub>2</sub> groups using a common intermediate shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>A. Starting with <i>tert</i>-butylpyrazolopyrimidine alcohol <b>23</b> (made in an analogous fashion to <b>22</b>),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> reaction with the 2-chloro-4-(trifluoromethyl)pyridine as before gave compound <b>2a</b>. Removal of the <i>tert</i>-butyl group was effected with concentrated sulfuric acid at 0 °C which gave advanced intermediate <b>24</b>. As an example of a final target synthesis, lead compound <b>6j</b> is highlighted. Cyclohexyl mesylate intermediate <b>27</b> was synthesized via a two-step procedure first by reaction of cyclohexane-cis-1,2-diol <b>25</b> with 0.5 equiv of benzyl bromide and NaH to provide monoprotected intermediate <b>26</b> and then further reaction with mesyl chloride. Displacement of the mesylate by <b>24</b> resulted in protected compound <b>27</b> which was debenzylated using boron trichloride. The final compound <b>6j</b> was isolated as the pure (<i>R</i>,<i>R</i>) enantiomer following SFC chiral chromatography. A modified route was developed shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>B where intermediate <b>24</b> was di-Boc protected as <b>28</b>, alkylated on the pyrazole nitrogen with 2-chlorocyclohexan-1-one to give <b>29</b>. After a systematic study of different chiral reducing agents, the final compound <b>6j</b> was obtained by utilization of the chiral reducing agent (<i>S</i>)-CBS (Corey–Bakshi–Shibata) oxazaborolidine catalyst which gave excellent enantioselectivity for the desired (R,R) isomer.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2-Pyridyl-4-CF<sub>3</sub> R1 Library with Varied R2 Groups (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) Exemplified by <b>2a</b> and <b>6j</b><sup><i>a</i></sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Outlined in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> is the general synthetic route applied in the synthesis of the 2-pyridyl-4-CN PP analogs shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Once again starting from intermediate <b>23</b>, reaction with 2-bromoisonicotinonitrile yields <i>tert</i>-butyl target compound <b>2c</b>. Unfortunately, removal of the <i>tert</i>-butyl group with sulfuric acid also hydrolyzed the nitrile to the carboxamide <b>30</b>. Conversion back to the nitrile using TFAA followed by reaction with pyridine in methanol gave <b>31</b>. Transformation of <b>31</b> to target compound <b>10c</b> was completed via alkylation with cis-3-fluorocyclobutyl mesylate <b>33</b> (from alcohol <b>32</b>) using cesium carbonate and potassium iodide.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2-Pyridyl-4-CN Ether R1 PP Compounds with Varied R2 Groups (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) Exemplified by <b>2c</b> and <b>10c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-bromoisonicotinonitrile, DMSO, K<sub>2</sub>CO<sub>3</sub>, 120 °C, 12 h; (b) H<sub>2</sub>SO<sub>4</sub>, 0 °C, 0.5 h; (c) TFAA, pyridine; (d) pyridine, MeOH; (e) MsCI, TEA, DCM,; (f) Cs<sub>2</sub>CO<sub>3</sub>, Kl, DMA, 66 °C, 40 h.</p></p></figure><div class="NLM_p">The R1 phenyl PP matched pairs of the pyridyl PP compounds shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> were produced following the route in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> and exemplified with compound <b>15a</b>. In this case we started with bromo PP intermediate <b>34</b>, reported in our previous publication of CDPKI inhibitors.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> S<sub>N</sub>2 displacement of trans-3-(benzyloxy)cyclobutyl mesylate <b>36</b> (from alcohol <b>35</b> in two steps) with <b>34</b> followed by debenzylation produced the cis-3-(benzyloxy)cyclobutyl-<i>N</i>-pyrazolopyrimidine bromide intermediate <b>37</b> which was subjected to addition of 3-(trifluoromethyl)phenol using cesium carbonate and copper chloride to yield PP alcohol <b>38</b>. Boc-protection of the 4-amino group gave <b>39</b> followed by fluorination with DAST with inversion of stereochemistry at the alcohol center then Boc-deprotection gave trans-3-(fluoro)cyclobutyl PP target compound <b>15a</b> as the direct matched pair of the pyridyl derivative <b>10a</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Phenyl Ether R1 PP Compounds with Varied R2 Groups (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) Exemplified by <b>15a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF 70 °C, 16 h; (b) BCI<sub>3</sub>, DCM, −60 to 0 °C, 3 h; (c) Boc<sub>2</sub>O, LiHMDS, THF, −60 to 20 °C, 1.5 h; (d) DAST, DCM, −60 to 20 °C, 2 h; (e) HCl, MeOH, 20 °C, 3 h; (f) 3-(trifluoromethyl)phenol, Cs<sub>2</sub>CO<sub>3</sub>, CuCI, TMHD, NMP, 200 °C, 3 h, microwave; (g) (i) 4-nitrobenzoic acid, DIAD, PPh<sub>3</sub>, toluene, 0–25 °C, 12 h, (ii) NaOH (2 M), dioxane, 25 °C, 2 h; (h) MsCI, TEA, DCM, 0–25 °C, 3 h.</p></p></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Evaluation of Top Leads</h3><div class="NLM_p">On the basis of the activity profiles of the compounds described above, we chose the top three analogs <b>3a</b>, <b>10c</b>, and <b>6j</b> for further <i>in vitro</i> and <i>in vivo</i> testing. These compounds demonstrated very similar IC<sub>50</sub> values for inhibition of enzyme activity and EC<sub>50</sub> values for inhibition of parasite growth (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). To confirm the specificity of leads <b>3a</b>, <b>6j</b>, and <b>10c</b> for the Gly gatekeeper feature, we compared the activity against wild-type CDPK1 to a mutant enzyme that altered at Gly128 to Met (G128M), as described previously.<a onclick="showRef(event, 'cit15c'); return false;" href="javascript:void(0);" class="ref cit15c">(15c)</a> This mutation resulted in loss of inhibition with all top three PP analogs even when tested at 20 μM (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). These results confirm that the inhibitors are selective for Gly gatekeeper kinases and indicate that the inhibition of parasite growth in cell culture is quite likely due to targeting CDPK1. At the doses used <i>in vitro</i> here, it is likely that the main effect of PP inhibitors is to block parasite invasion and egress, as described previously.<a onclick="showRef(event, 'ref12 cit15c'); return false;" href="javascript:void(0);" class="ref ref12 cit15c">(12,15c)</a> In contrast, studies using much higher doses (i.e., several μM) of some PP compounds can disrupt parasite cell division,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> an effect that may be attributable to inhibition of MAPK, which occurs at high concentrations using early PP inhibitors that lacked specificity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of CDPK1 enzyme activity and parasite growth by lead compounds: (A) structures of three top leads; (B) inhibition of CDPK1 enzyme <i>in vitro</i>; (C) inhibition of parasite growth in HFF cells. Each data point in the dilution series is the average of two technical replicates. Control refers to no compound. Curves were fit using nonlinear regression analysis based on sigmoidal dose–response curves with variable slope.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. <i>In Vitro</i> Activities of Lead Compounds against Select Kinases</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">wild type CDPK1</th><th class="colsep0 rowsep0" align="center" char=".">Gly-Met CDPK1</th><th class="colsep0 rowsep0" align="center" char=".">human Src</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2885 (<b>3a</b>)</td><td class="colsep0 rowsep0" align="char" char=".">16.5</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2996 (<b>10c</b>)</td><td class="colsep0 rowsep0" align="char" char=".">14.9</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-3217 (<b>6j</b>)</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Mean, <i>N</i> = 3 independent experiments each with two technical replicates.</p></div></div></div><div class="NLM_p">Additionally, we tested the specificity of these PP inhibitors against human c-Src, a kinase that contains Thr at the gatekeeper and that shows intermediate sensitivity to PP inhibitors.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The IC<sub>50</sub> for inhibition of c-Src was >20 μM (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), demonstrating that these PP inhibitors are extremely selective and show >1000-fold increased potency against the parasite enzyme. To further explore the selectivity of <b>3a</b> and <b>10c</b>, we screened an extensive panel of 485 human kinases (Thermo-Fisher) with compounds at a single fixed concentration of 1 μM. Compound <b>3a</b> inhibited five targets (i.e., CKε, BRK (PTK6), HGK (MAP4K4), TGFβ (ALK5), and PKACγ), while <b>10c</b> only inhibited two host kinases (i.e., CKε, BRK (PTK6)) by ∼50% (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf" class="ext-link">Table S1</a>). These findings indicate that these PP analogs are potent inhibitors of CDPK1 with relatively low off target activity against human kinases.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of human kinase targets by <b>3a</b> based on a human kinome-wide screen (ThermoFischer). Compounds were tested in duplicate at 1 μM using ATP levels that matched the kinase <i>K</i><sub>m</sub> or using Lantha-Screen binding assays in the absence of ATP. Targets shown in red were inhibited by ∼50%. See <a href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf" class="ext-link">Table S1</a> for further details. The kinome tree was generated using KinMap,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and the image was reproduced courtesy of Cell Signaling Technology, Inc. (<a href="http://www.cellsignaling.com" class="extLink">www.cellsignaling.com</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We also tested the <b>3a</b>, <b>6j</b>, and <b>10c</b> against type strains from the three major lineages of <i>T. gondii</i> that are found in North America and Europe.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> All three compounds exhibited similar EC<sub>50</sub> values when tested against this panel of strains (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). No adverse effect on the host cell monolayer was observed across this dilution series. We also tested the potential for these inhibitors to affect the growth or viability of a variety of human cell types including lines isolated from kidney, liver, brain, and gut. There was no observed inhibition of cell growth by these PP compounds, although they enhanced growth slightly for human brain endothelial cells (hCMEC) (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). As expected, the positive control mitomycin C showed significant inhibition of all the cell types.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Inhibition of Parasite Growth <i>in Vitro</i> by Lead Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">type I RH</th><th class="colsep0 rowsep0" align="center" char=".">type II ME49</th><th class="colsep0 rowsep0" align="center" char=".">type III CTG</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2885 (<b>3a</b>)</td><td class="colsep0 rowsep0" align="char" char=".">172.0</td><td class="colsep0 rowsep0" align="char" char=".">259.5</td><td class="colsep0 rowsep0" align="char" char=".">167.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2996 (<b>10c</b>)</td><td class="colsep0 rowsep0" align="char" char=".">200.6</td><td class="colsep0 rowsep0" align="char" char=".">177.7</td><td class="colsep0 rowsep0" align="char" char=".">273.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-3217 (<b>6j</b>)</td><td class="colsep0 rowsep0" align="char" char=".">77.5</td><td class="colsep0 rowsep0" align="char" char=".">89.6</td><td class="colsep0 rowsep0" align="char" char=".">227.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Mean, <i>N</i> = 3 independent experiments, each with technical replicates.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Effect of Lead Compounds on Replication of Human Cell Lines<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">% of control growth</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">HFF</th><th class="colsep0 rowsep0" align="center">MDCK</th><th class="colsep0 rowsep0" align="center">SH-SY5Y</th><th class="colsep0 rowsep0" align="center">Caco-2</th><th class="colsep0 rowsep0" align="center">hCMEC</th><th class="colsep0 rowsep0" align="center">HepG2</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">skin, fibroblast</th><th class="colsep0 rowsep0" align="center">kidney, endothelium</th><th class="colsep0 rowsep0" align="center">brain, neuronal</th><th class="colsep0 rowsep0" align="center">gut, epithelial</th><th class="colsep0 rowsep0" align="center">brain BBB, endothelial</th><th class="colsep0 rowsep0" align="center">liver, endothelial</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2885 (<b>3a</b>)</td><td class="colsep0 rowsep0" align="left">106.4 ± 6.8</td><td class="colsep0 rowsep0" align="left">97.8 ± 7.9</td><td class="colsep0 rowsep0" align="left">102.8 ± 7.9</td><td class="colsep0 rowsep0" align="left">93.3 ± 12.4</td><td class="colsep0 rowsep0" align="left">132.4 ± 11.7</td><td class="colsep0 rowsep0" align="left">104.1 ± 9.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2996 (<b>10c</b>)</td><td class="colsep0 rowsep0" align="left">111.8 ± 10.1</td><td class="colsep0 rowsep0" align="left">79.41 ± 19.54</td><td class="colsep0 rowsep0" align="left">102.8 ± 10.6</td><td class="colsep0 rowsep0" align="left">95.5 ± 6.1</td><td class="colsep0 rowsep0" align="left">135.1 ± 16.1</td><td class="colsep0 rowsep0" align="left">100.6 ± 9.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-3217 (<b>6j</b>)</td><td class="colsep0 rowsep0" align="left">107.1 ± 14.1</td><td class="colsep0 rowsep0" align="left">77.32 ± 32.3</td><td class="colsep0 rowsep0" align="left">105.2 ± 26.8</td><td class="colsep0 rowsep0" align="left">100.2 ± 8.1</td><td class="colsep0 rowsep0" align="left">126.4 ± 11.7</td><td class="colsep0 rowsep0" align="left">99.0 ± 14.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mitomycin C</td><td class="colsep0 rowsep0" align="left">25.8 ± 3.4</td><td class="colsep0 rowsep0" align="left">7.0 ± 2.9</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">33.4 ± 4.8</td><td class="colsep0 rowsep0" align="left">5.0 ± 2.6</td><td class="colsep0 rowsep0" align="left">0.7 ± 1.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Mean ± SD, <i>N</i> ≥ 3 independent experiments, each with technical replicates.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>In Vitro</i> ADME Properties</h3><div class="NLM_p">To examine the <i>in vitro</i> properties of the lead compounds, we profiled them using a standard set of assays designed to estimate solubility, permeability, and metabolic stability (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). First, all three leads showed good kinetic solubility at pH 7.4. They were also highly stable in the presence of human liver microsomes and human hepatocytes, showing low clearance in both assays. All three lead compounds showed minimal susceptibility to aldehyde oxidase, an enzyme involved in hepatic and extra-hepatic phase I metabolism of xenobiotics.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Finally, all three lead compounds showed good uptake by polarized epithelial MDCK cells and little capacity for efflux in a cell line overexpressing the MDR1 transporter. These properties predict the lead compounds should not be subject to efflux or rapid catabolism <i>in vivo</i> and therefore might have good pharmacokinetic properties.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. <i>In Vitro</i> Metabolism of Lead Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">kinetic solubility (μM)</th><th class="colsep0 rowsep0" align="center" char=".">human microsomes Cl<sub>int</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">human hepatocytes ((mL/min)/10<sup>6</sup> cells)</th><th class="colsep0 rowsep0" align="center" char=".">aldehyde oxidase (mL min<sup>–1</sup> mg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">MDCK-MDR1 <i>P</i><sub>app</sub> (A–B) (10<sup>6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">MDCK-MDR1 <i>P</i><sub>app</sub> (B–A)/(A–B)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2885 (<b>3a</b>)</td><td class="colsep0 rowsep0" align="char" char=".">191.00</td><td class="colsep0 rowsep0" align="char" char="."><8.60</td><td class="colsep0 rowsep0" align="char" char="."><6.4</td><td class="colsep0 rowsep0" align="char" char="."><3.2</td><td class="colsep0 rowsep0" align="char" char=".">33.0</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2996 (<b>10c</b>)</td><td class="colsep0 rowsep0" align="char" char=".">102.00</td><td class="colsep0 rowsep0" align="char" char="."><8.60</td><td class="colsep0 rowsep0" align="char" char=".">10.00</td><td class="colsep0 rowsep0" align="char" char="."><3.2</td><td class="colsep0 rowsep0" align="char" char=".">26.87</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-3217 (<b>6j</b>)</td><td class="colsep0 rowsep0" align="char" char=".">92.73</td><td class="colsep0 rowsep0" align="char" char="."><8.60</td><td class="colsep0 rowsep0" align="char" char="."><6.4</td><td class="colsep0 rowsep0" align="char" char="."><3.2</td><td class="colsep0 rowsep0" align="char" char=".">21.43</td><td class="colsep0 rowsep0" align="char" char=".">1.23</td></tr></tbody></table></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Off Target Activity and Potential for Genotoxicity</h3><div class="NLM_p">Although the lead compounds exhibited minimal activity against host kinases, we also wanted to profile them for other potential off-target activity against other host enzymes and receptors. We tested the three leads at a 10 μM concentration against the Safety panel 47 (Eurofins, DiscoverX) that includes human kinases, channels, GPCRs, cyclic nucleotide and calcium signaling pathways, and neurotransmitter activities. All three compounds partially inhibited the kinase Lck (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>), although this activity was not seen in the kinome-wide screen. This difference likely reflects the higher concentration of compounds used (10 μM for Discover X vs 1 μM for the kinome wide screen) and differences in ATP (Discover X assays lack ATP while the kinome wide screen was conducted at <i>K</i><sub>m</sub> for ATP). Additionally, <b>3a</b> showed modest activity against an antagonist of α 2A-adrenergic receptor (ADRA2A) (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>), an adrenergic receptor that is broadly distributed in the body.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Antagonists of ADRA2A have been studied for their ability to enhance motor function in rodent and non-human primate models of Parkinson disease.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Inhibition by <b>3a</b> would only be expected to be an issue in patients also receiving antagonists of this receptor. None of the three compounds showed appreciable inhibition of hERG, a K+ channel important in cardiac function.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The lack of activity against hERG channels is notable as other PP analogs that inhibit CDPK1 have previously been found to exhibit this liability.<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a> All three compounds were negative in a mini-Ames test and for micronucleus formation (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>), indicating that they have a low capacity for genotoxicity.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. <i>In Vitro</i> Toxicity and Genotoxicity Analysis of Lead Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Safety 47 DiscoverX, % inhib at 10 μM</th><th class="colsep0 rowsep0" align="center">hERG IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">Ames</th><th class="colsep0 rowsep0" align="center">micronucleus (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">TRC-2885 (<b>3a</b>)</td><td class="colsep0 rowsep0" align="left">ADRA2A (51%)</td><td class="colsep0 rowsep0" rowspan="2" align="left">>30</td><td class="colsep0 rowsep0" rowspan="2" align="left">negative</td><td class="colsep0 rowsep0" rowspan="2" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Lck (55%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2996 (<b>10c</b>)</td><td class="colsep0 rowsep0" align="left">Lck (74%)</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">negative</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-3217 (<b>6j</b>)</td><td class="colsep0 rowsep0" align="left">Lck (45%)</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div></div><div class="NLM_p">Finally, we tested the potential for the lead compounds to inhibit several cytochrome P450 enzymes or CYPs, which are involved in detoxification of xenobiotics and metabolism of drugs.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Compound <b>3a</b> showed inhibition of CYP1A2 at <1 μM and CYP2C19 at <10 μM, but otherwise there was minimal effect on these enzymes including on CYP3A4 and CYP2D6 (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>), which are responsible for metabolizing most drugs.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Collectively, these findings indicate that all three lead compounds encompass minimal potential for genotoxicity and a low likelihood for complications related to drug–drug interactions.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Inhibition of Cytochrome P450 Enzymes by Lead Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">EC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">CYP1A2</th><th class="colsep0 rowsep0" align="center" char=".">CYP2C9</th><th class="colsep0 rowsep0" align="center" char=".">CYP2C19</th><th class="colsep0 rowsep0" align="center" char=".">CYP2D6</th><th class="colsep0 rowsep0" align="center" char=".">CYP3A4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2885 (<b>3a</b>)</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">50.00</td><td class="colsep0 rowsep0" align="char" char=".">5.78</td><td class="colsep0 rowsep0" align="char" char=".">50.00</td><td class="colsep0 rowsep0" align="char" char=".">50.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2996 (<b>10c</b>)</td><td class="colsep0 rowsep0" align="char" char=".">20.80</td><td class="colsep0 rowsep0" align="char" char=".">50.00</td><td class="colsep0 rowsep0" align="char" char=".">50.00</td><td class="colsep0 rowsep0" align="char" char=".">50.00</td><td class="colsep0 rowsep0" align="char" char=".">50.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-3217 (<b>6j</b>)</td><td class="colsep0 rowsep0" align="char" char=".">50.00</td><td class="colsep0 rowsep0" align="char" char=".">50.00</td><td class="colsep0 rowsep0" align="char" char=".">50.00</td><td class="colsep0 rowsep0" align="char" char=".">50.00</td><td class="colsep0 rowsep0" align="char" char=".">50.00</td></tr></tbody></table></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>In Vivo</i> Pharmacokinetics</h3><div class="NLM_p">In order to estimate the potential metabolic stability of the top leads in different species, we compared the metabolism in liver microsomes from mouse, rat, rabbit, minipig, and dog. Compound <b>3a</b> showed low metabolism in mouse, rat, and minipig, with higher levels in dog and rabbit, relative to the normal single pass rate of clearance due to hepatic circulation (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf" class="ext-link">Table S2</a>). Compound <b>10c</b> showed low metabolic clearance in microsomes for all species (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf" class="ext-link">Table S2</a>). Compound <b>6j</b> showed high metabolism in mouse but was stable in the other species (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf" class="ext-link">Table S2</a>). Because these <i>in vitro</i> assays only estimate the potential for clearance <i>in vivo</i>, we also performed pharmacokinetic (PK) analysis over an 8 h time course following a single 10 mg/kg oral dose vs 3 mg/kg iv dose. We chose mouse for these studies since this species is the most versatile model for showing efficacy against toxoplasmosis. Compounds <b>3a</b> and <b>10c</b> showed similar maximum concentration in plasma (<i>C</i><sub>max</sub>) and area under the curve (AUC) values, although <b>3a</b> had a slightly longer half-life (<a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a></a>). By comparison, <b>6j</b> showed high clearance and corresponding lower <i>C</i><sub>max</sub> and plasma AUC. All three compounds showed moderate to high bioavailability (% <i>F</i>) and high unbound fractions in plasma and in brain and importantly exhibited favorable CNS/plasma ratios indicating they are brain penetrant (<a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a></a>). Finally, compounds <b>3a</b> and <b>10c</b> showed no adverse effects when dosed at 600 mg/kg for 7 consecutive days in mouse (data not shown). Although we have not performed any studies on the safety of PP compounds during pregnancy, prevention of congenital infection is an important unmet medical need. Hence, future studies warrant evaluation of these compounds for safety and efficacy in congenital transmission models of toxoplasmosis.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. <i>In Vivo</i> Pharmacokinetic (PK) Properties of Lead Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">mouse plasma protein binding UPB (%)</th><th class="colsep0 rowsep0" align="center" char=".">mouse brain tissue binding UBBr (%)</th><th class="colsep0 rowsep0" align="center" char=".">mouse CNS/plasma ratio<a class="ref internalNav" href="#t12fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">mouse <i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t12fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">mouse <i>C</i><sub>max</sub> (ng/mL)<a class="ref internalNav" href="#t12fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">mouse AUC ((ng/mL)·h)<a class="ref internalNav" href="#t12fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">mouse<a class="ref internalNav" href="#t12fn1" aria-label="a">a</a><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2885 (<b>3a</b>)</td><td class="colsep0 rowsep0" align="char" char=".">15.6</td><td class="colsep0 rowsep0" align="char" char=".">10.1</td><td class="colsep0 rowsep0" align="char" char=".">0.96</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">2067</td><td class="colsep0 rowsep0" align="char" char=".">2677</td><td class="colsep0 rowsep0" align="char" char=".">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-2996 (<b>10c</b>)</td><td class="colsep0 rowsep0" align="char" char=".">29.3</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">0.81</td><td class="colsep0 rowsep0" align="char" char=".">1.43</td><td class="colsep0 rowsep0" align="char" char=".">1503</td><td class="colsep0 rowsep0" align="char" char=".">3140</td><td class="colsep0 rowsep0" align="char" char=".">43.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRC-3217 (<b>6j</b>)</td><td class="colsep0 rowsep0" align="char" char=".">24.3</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">0.47</td><td class="colsep0 rowsep0" align="char" char=".">2.17</td><td class="colsep0 rowsep0" align="char" char=".">620</td><td class="colsep0 rowsep0" align="char" char=".">1100</td><td class="colsep0 rowsep0" align="char" char=".">48.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t12fn1"><div class="footnote" id="t12fn1"><sup><sup>a</sup></sup><p class="last">Dosing at 10 mg/kg po and at 3 mg/mL iv.</p></div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Efficacy against Acute Infection</h3><div class="NLM_p">Due to its better performance in PK and relatively low potential for toxicity, we chose compound <b>3a</b> for further PK and efficacy studies. We compared the clearance of <b>3a</b> in groups of mice that were dosed at 3, 10, and 30 mg/kg given once by oral gavage. The subsequent free plasma levels were plotted relative to the free EC<sub>50</sub> and multiples of this value (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). From these studies, it was evident that only a dose of 30 mg/kg was sufficient to maintain the plasma levels above the EC<sub>50</sub> for ∼8 h (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B), and in all dosing schemes <b>3a</b> dropped to undetectable levels by 24 h (data not shown). On the basis of these PK results, we reasoned that it would likely be necessary to provide either a higher total dose or repeated dosing at a level of at least 30 mg/kg to protect against toxoplasmosis.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <i>In vivo</i> pharmacokinetics and efficacy of compound <b>3a</b> in protecting against acute toxoplasmosis. (A) Model of experimental design. (B) PK analysis of escalating doses of <b>3a</b> delivered by oral gavage to adult female mice. Values plotted are free plasma levels based on estimation of % nonbound to serum proteins (<i>n</i> = 3 animals per group). For comparison the nonbound fractions equivalent to the EC<sub>50</sub>, 3 × EC<sub>50</sub>, and EC<sub>90</sub>, based on <i>in vitro</i> growth inhibition in HFF cells, are shown. (C) Groups of outbred female CD1 mice were infected with 3000 tachyzoites of the type 1 RH strain by ip inoculation, and compound <b>3a</b> was administered as shown by oral gavage for seven successive days beginning 24 h after infection (day 0). The control group had 9 animals and the treatment groups each had 12 animals. Expansion of parasite numbers and dissemination was monitored by bioluminescence imaging. Image shown is from 5 days postinfection. (D) Survival curves for animals inoculated and treated as described in (C). Control animals in (C) and (D) received vehicle only (0.5% CMC). (E) Surviving animals in (D) were sacrificed at day 15, and homogenates of lung and brain were injected into naïve recipient mice (1 recipient for each surviving animal) that were not further treated with compound. Survival curves of recipient mice are shown. Negative control animals were inoculated only with vehicle control (0.5% CMC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">On the basis of the anticipated PK profile, we designed a trial to evaluate <b>3a</b> for its ability to control acute toxoplasmosis in the laboratory mouse. Mice are a natural host for <i>T. gondii</i>, and they recapitulate the acute and chronic phases of infection that are seen in humans and other species.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Laboratory mice are somewhat more susceptible than other animals, and in particular, they are highly susceptible to type I strains, which are lethal at a very low inoculum in immunocompetent outbred and inbred mice.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Hence, challenge with type I strains offers a stringent test of the ability of compounds to prevent infection. We inoculated mice ip with 3000 tachyzoites of the RH strain, which is the equivalent of >1000 times the lethal dose<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). Infection was tracked using bioluminescence from a firefly luciferase expressing strain of the parasite.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Following infection, the parasites amplified rapidly and spread to all of the major organs, leading to a strong luciferase signal in the peritoneum (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). Treatments of mice with a total daily dose of 60 mg/kg, po, of <b>3a</b> using different dosing paradigms of 60 mg/kg once a day (QD), 30 mg/kg twice a day (BID), or 15 mg/kg four times per day (QID) for a total of 7 days were all effective at reducing parasite expansion and dissemination, as shown by bioluminescence measurements (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C) and prevention of death in the majority of animals (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D). To determine if animals were cured by treatment, the brain and lungs of surviving animals were homogenized and inoculated into recipient naïve animals that were subsequently followed without additional drug treatment. Because this strain is highly virulent in mice, inoculation of even a single parasite of the type I RH strain is expected to lead to death in the recipient.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Bioluminescence imaging and survival assays revealed that all of the animals inoculated with tissues from mice treated 60 mg/kg QD succumbed to infection, whereas 20% of those inoculated with tissues from mice treated with 30 mg/kg BID and 15 mg/kg QID survived (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D). For these results, we conclude that more frequent dosing at lower concentration provides equal protection from survival and greater frequency of cure.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Efficacy in the Immunocompromised Mouse Model</h3><div class="NLM_p">One of the key target populations for treatment of toxoplasmosis is immunocompromised patients such as those with HIV infection that have developed AIDS.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> To simulate this defect in the murine model, we used a previously described immunocompromised mouse that lacks IFN-γ receptors and hence is unable to control infection with a type II strain of the parasite, which is less virulent and prone to developing chronic infection in wild type mice.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> On the basis of the PK studies and efficacy in immune competent mice described above, we reasoned that higher doses would likely be required for control in the absence of a functional immune system. As such, we tested the PK in mice following an oral dose of 60, 90, or 120 mg/kg twice daily over a 24 h period. Analysis of plasma levels indicate that the compound reached a peak that exceeded the EC<sub>90</sub> (free concentration) but that the concentration dropped below the EC<sub>50</sub> by 8 or 12 h (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). To compare the efficacy of these doses in preventing reactivation of toxoplasmosis, we treated immunocompromised mice using the model described in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A. Ifngr1<sup>–/–</sup> mice were orally infected with tissue cysts of the type 2 strain ME49 expressing firefly luciferase and maintained by treatment with sulfadiazine, which suppresses tachyzoite growth but does not affect the development of tissue cysts.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> All inoculated animals became infected as shown by visible signs of illness and verified by positive ELISA titer at 3 weeks postinfection (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf" class="ext-link">Figure S1A</a>). At 22 days postinfection, treatment with sulfadiazine was discontinued, and 48 h later the animals were treated with compound <b>3a</b> at 60 mg/kg by oral gavage BID for 8 or 21 days. Control animals lost weight and succumbed to infection by day 12 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C,D). Animals treated with 60 mg/kg for 8 days eventually succumbed to infection, although they lasted significantly longer than controls (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D). Treatment with 60 mg/kg for 21 days led to significantly prolonger survival, and two animals survived beyond 30 days (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D), after which they gained weight (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C), suggesting they were cured of infection. The brain of these surviving animals was homogenized and injected into recipient Ifngr1<sup>–/–</sup> mice that were not treated with compound. These recipient animals, which are normally highly susceptible and unable to control infection, remained seronegative (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf" class="ext-link">Figure S1B,C</a>), confirming that the donor mice had been cured during treatment. In a follow-up study, we repeated this trial using animals that were treated with 60, 90, or 120 mg/kg BID for 8 days (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf" class="ext-link">Figure S2</a>). The survival of mice treated for 8 days with either 60, 90, or 120 mg/kg was similar, while greater survival was achieved with treatment at 60 mg/kg for 21 days (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>E). Collectively, these findings indicate that the efficacy of <b>3a</b> is driven primarily by total time of exposure over an extended time period. This result may reflect the fact that CDPK1 inhibitors are expected to act to block egress and invasion but may not have an effect on bradyzoites while they are intracellular.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Efficacy of <b>3a</b> in protecting against reactivation of chronic infection in immunocompromised mice. (A) A mixture of male and female Ifngr1<sup>–/–</sup> mice was infected with five tissue cysts of the type II ME49 strain by oral gavage. Mice were given sulfadiazine (0.25 g/L in drinking water) from day 3 to day 22 to suppress tachyzoite growth and prevent death during the acute phase. At 48 h after removal of sulfadiazine, compound <b>3a</b> was administered by oral gavage at the doses indicated for 8 or 21 successive days. (B) PK of animals dosed orally with 60, 90, or 120 mg/kg BID (<i>n</i> = 3 animals per group). Free plasma levels are plotted relative to EC<sub>50</sub>, 3 × EC<sub>50</sub>, and EC<sub>90</sub> levels. (C) Weight loss following removal of sulfadiazine and administration of <b>3a</b>. (D) Survival curves for mice following removal of sulfadiazine and administration of <b>3a</b> at the indicated doses. Control animals received vehicle control (0.5% CMC, 0.1% Tween 80). For (C) and (D), 8 animals were used for the control and 6 animals each for the treatment groups. (E) Comparison of percent survival vs time and concentration of treatment with <b>3a</b> (<i>n</i> = 6 animals per group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54312" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54312" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We generated several series of novel PP CDPK1 inhibitors to explore SAR and metabolism profiles of an expanded range of analogs. Modification of the R<sub>1</sub> position to include pyridyl rings with N in the 2-position allowed appending various functional groups on the 5-position of the ring that imparted greater metabolic stability including Cl, CF<sub>3</sub>, and CN groups. Interestingly, an OH group in the same position was tolerated, likely due to a different binding mode of the pyridyl ring. Addition of small cycloalkyl groups or other substituted small heterocyclic groups at R<sub>2</sub> also improved potency and stability. By several rounds of optimizing potency, selectivity, and metabolic profiles, we selected the set of top leads <b>3a</b>, <b>6j</b>, and <b>10c</b> for further characterization of their safety profile and metabolism in different species. Of the three top leads, compound <b>3a</b> was chosen for advanced evaluation in murine models of toxoplasmosis. Lead PP <b>3a</b> prevented lethal acute infection, prolonged the survival of immunocompromised mice, and resulted in cure of chronic infection in ∼25% of animals. Collectively, our studies and their findings identify not only promising new PP CDPK1 inhibitors and SAR but also important models and parametric analysis for further evaluation of inhibitors for advancement to clinical trials for treatment of both acute and chronic toxoplasmosis.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Synthetic Chemistry</h3><div class="NLM_p last">All synthetic chemistry and DMPK were performed at WuXi App Tec at their China facilities in Tianjin and Shanghai. Proton NMR spectra were recorded on a Varian 400 MHz NMR with chemical shifts δ recorded in ppm relative to TMS. LCMS were taken on a quadrupole mass spectrometer on Shimadzu LCMS 2010 (column Sepax ODS 50 mm × 2.0 mm, 5 μm) or Agilent 1200 HPLC, 1956 MSD (column Shim-pack XR-ODS 30 mm × 3.0 mm, 2.2 μm) operating in ES (+) ionization mode. All final compounds were greater than 95% purity based on HPLC UV% AUC as determined at 214, 254, and 280 nm wavelengths. Structures were confirmed by <sup>1</sup>H NMR and LC/MS. Final compounds in this manuscript are not known to interfere with the assays herein (i.e., they are not PAINS). Detailed synthetic chemistry and analytical analyses are found in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Parasite Strains and Culture</h3><div class="NLM_p last"><i>In vitro</i> growth inhibition experiments were conducted with the 2F clone of the type I RH strain <i>T. gondii</i>, a transgenic line that expresses β-galactosidase.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> We also used additional <i>T. gondii</i> strains representing type 2 (ME49Δ<i>hx</i>::FLUC strain) and type 3 lineages (CTG-FLUX), that were derived independently, as described previously.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The type 2 ME49Δ<i>hx</i>::FLUC strain was used for the reactivation studies in immunocompromised mice, as described below. Tachyzoites of each strain were grown in monolayers of human foreskin fibroblasts (HFF, obtained from the Boothroyd laboratory at Stanford University) maintained in complete medium (DMEM containing 10% FBS, 10 mM glutamine, and 10 μg/mL gentamycin) incubated at 37 °C in 5% CO<sub>2</sub>. <i>In vitro</i> cultures were shown to be mycoplasma negative using the e-Myco plus kit (Intron Biotechnology).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Enzyme Expression and Purification</h3><div class="NLM_p last">Full-length <i>T. gondii</i> wild type or Gly128 Met (G128M) mutant CDPK1 enzymes were expressed with a C-terminal His tag in pET22b(+), as described previously.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> For protein purification, CDPK1 was expressed BL21 (DE3)V2RpAcYc-LIC+LamP <i>E. coli</i>, which contains the LamP phosphatase. As a control, we also expressed cDNA fragment encoding human Src (hSrc) kinase domain in BL21, as described previously.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Following overnight growth in Terrific Broth at 37 °C, bacterial cultures were diluted 1:100 and grown for 3 h at 37 °C (OD = 0.6–0.8), then induced with 0.3 mM IPTG during overnight growth at 15 or 30 °C. Cells were lysed using CellLytic B cell lysis reagent (Sigma-Aldrich) and soluble proteins purified using HIS-select nickel affinity gel. Purified proteins were dialyzed against storage buffer (i.e., 50 mM Tris-HCL, pH 7.5, 150 mM NaCl) and stored in 25% glycerol containing 0.5 mM DTT at −80 °C. Protein purity and concentrations were determined by SDS–PAGE and staining with Coomassie Blue (Invitrogen).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Enzyme Assays</h3><div class="NLM_p">CDPK1 activity was monitored based on phosphorylation of syntide-2 peptide (Callbiochem) that was detected using mAb MS-6E6 (MBL Intl. Corp.) using an ELISA protocol described previously.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Reactions were conducted at 30 °C for 20–40 min in 20 mM HEPES, pH 7.5, 10 mM MgCl<sub>2</sub>, 1 mM DTT, 2.5 mM CaCl<sub>2</sub>, 0.1 mM EGTA, 0.005% Tween 20. Kinase reactions included 25 μM ATP (the <i>K</i><sub>m</sub> for the enzyme) using 25 nM of kinase per reaction. For comparison of the inhibition of wild type and G128M mutant CDPKA, 100 nM enzyme was used for both enzymes as the mutant enzyme is slightly less active. To determine the potency of inhibitors, duplicate wells were treated with a range of compound concentrations from 20 μM to 0.13 nM containing 1% DMSO final, as described previously.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Individual IC<sub>50</sub> values were determined from three or more independent biological replicates each containing two technical replicates.</div><div class="NLM_p last">Human Src activity was monitored by phosphorylation of the Abltide peptide (EAIYAAPFAKKK, Enzo Life Sciences) that was detected using a monoclonal antibody to phosphotyrosine (Sigma) using an ELISA protocol similar to that used for CDPK1 above. Kinase reactions were conducted in 50 mM Tris-HCl, pH 7.5, 10 mM MgCl<sub>2</sub>, 2.5 nM MnCl<sub>2</sub>, 0.2 mM DTT, 0.5 mM EGTA. Reactions were conducted using 5 μM ATP (the <i>K</i><sub>m</sub> for the enzyme) or 1 mM ATP (physiological) using 75 nM kinase per reaction. Compounds were tested at 10 μM in duplicate, in two biological replicates. For compounds that showed >50% inhibition at 10 μM, serial dilutions from 10 μM to 0.5 nM were tested in duplicate to derive IC<sub>50</sub> values.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> In Vitro Growth Assays</h3><div id="secz" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> β-Galactosidase Assays</h4><div class="NLM_p last">Parasite growth inhibition assays were conducted using the type I RH strain, 2F clone that expresses bacterial β-galactosidase (β-gal), as described previously.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Compounds dissolved in DMSO as 10 mM stocks were stored at −80 °C until use and then diluted in medium to reach final concentrations. HFF monolayers grown in 96 well plates were inoculated with 5 × 10<sup>2</sup> parasites containing dilutions of compounds ranging from 10 μM to 0.17 nM plus 0.1% DMSO (or 0.1% DMSO alone). The plates were centrifuged at 300<i>g</i> for 5 min and returned to culture at 37 °C, 5% CO<sub>2</sub> for 72 h. At the end of the incubation period, the monolayer was lysed in 1% Triton X-100 and β-gal activity monitored using 1 mM chlorophenol red-β-<span class="smallcaps smallerCapital">d</span>-galactopyranoside by absorption at 570 nm, as described previously.<a onclick="showRef(event, 'cit15c'); return false;" href="javascript:void(0);" class="ref cit15c">(15c)</a> Reported EC<sub>50</sub> values were determined from three or more independent biological replicates, each containing two technical replicates.</div></div><div id="secy" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Luciferase Assays</h4><div class="NLM_p last">HFF monolayers grown in 96 well plates were inoculated with 5 × 10<sup>3</sup> of luciferase expressing parasites containing dilutions of compounds ranging from 10 μM to 0.51 nM plus 0.1% DMSO (or 0.1% DMSO alone). Parasites were allowed to replicate for 72 h prior to preparation for luciferase assay. The luciferase assay was conducted using the luciferase assay system (Promega, E1501) using the following processing steps: After 72 h, culture medium was removed and 40 μL of 1× cell culture lysis buffer (1× CCLR, Promega, E1531) was added to each well and incubated for 10 min at room temperature (RT) with gentle shaking. Plates were read with a Cytation3 imaging multimode plate reader (Biotek) using the following protocol: injection of 100 μL of luciferase assay reagent per well, shake 0:01 s, and read for 10 s. Reported EC<sub>50</sub> values were determined from three or more independent biological replicates, each containing two technical replicates.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Host Toxicity Assays</h3><div class="NLM_p">The following host cell lines were obtained from ATCC (<a href="https://www.atcc.org/" class="extLink">https://www.atcc.org/</a>): hCMEC cells D3, brain endothelium cells (ATCC CCL-239); HepG2, hepatocellular carcinoma cells (ATCC HB-8065); SH-SY5Y, neuroblastoma cells (ATCC CRL-2266); Caco-2, intestinal epithelium cells (ATCC HTB-37); MDCK (NBL-2), canine kidney cells (ATCC CCL-34). Cells were grown in medium according to ATCC recommendation and maintained at 37 °C, 5% CO<sub>2</sub>.</div><div class="NLM_p last">Host cell lines were plated at 15 000 cells/well and grown in recommended medium (ATCC) and allowed to adhere for 4 h at 37 °C, 5% CO<sub>2</sub>. Compounds diluted to 20 μM in 0.2% (v/v) DMSO, or DMSO alone, were then added, and cells were incubated for an additional 72 h. Following the incubation period, samples were evaluated using a cell proliferation assay (CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay, Promega Corporation). As a positive control, mitomycin C (20 μM) was included in each plate. Reported values were derived from three independent experiments with two technical replicates each.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Animal Studies</h3><div class="NLM_p last">Animals were obtained from Jackson Laboratories, or bred locally, and housed at Washington University in accordance with the U.S.A. Public Health Service Policy on Humane Care and Use of Laboratory Animals. Animals were maintained in an Association for Assessment and Accreditation of Laboratory Animal Care approved facilities, and studies were approved by the Institutional Animal Studies Committee at the School of Medicine, Washington University in St. Louis. Animal studies conducted at WuXi AppTec in China and Evotec in the U.K. were performed in accordance approved institutional and national guidelines at these respective sites.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Chronic Infections in Mice</h3><div class="NLM_p last">CD-1 outbred mice were inoculated with 200 tachyzoites of the type 2 ME49Δ<i>hx</i>::FLUC line that had been grown in HFF cells <i>in vitro</i>, as described above. At 1–2 months after infection, chronically infected mice were euthanized and brains removed and homogenized by mincing using 20–22 gauge needles. A portion of the homogenate was fixed in formalin, stained with <i>Dolichos biflorus</i> lectin (DBL) conjugated to FITC, and cysts were counted by microscopic examination, as described previously.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Cysts from chronically infected CD-1 mice were used to initiate infections in recipient mice by oral gavage.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> PK Studies</h3><div class="NLM_p">Initial PK studies were conducted by Evotec Manchester UK in accordance with institutional guidelines. The compound <b>3a</b> was dissolved in 0.5% carboxymethyl cellulose (CMC) and administered to fasted female CD1 mice (6–8 weeks old) by oral gavage (10 mg/kg) or iv inoculation (3 mg/kg). Animals were sampled at 0.5, 1, 4, 8, and 24 h. Plasma concentrations were determined by LC–MS/MS in comparisons to standards, and data were analyzed using Phoenix WinNonlin 6.3 with a linear/log trapezoidal calculation method. No adverse effects were observed during the study.</div><div class="NLM_p last">Subsequent PK studies were conducted by WuXi AppTech, China, in accordance with institutional guidelines. Adult female mice were orally gavaged with <b>3a</b> in 0.5% CMC 0.1% Tween 80 at doses of 60, 90, and 120 mg/kg at time 0 and 12 h later. Animals were sampled by drawing plasma at 0.5, 2, 12, 13, 16, 20, and 24 h. Plasma concentrations were determined by LC–MS/MS in comparisons to standards, and data were analyzed using Phoenix WinNonlin 6.3 with a linear/log trapezoidal calculation method. No adverse effects were observed during the study.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Acute Challenge Model</h3><div class="NLM_p last">Acute challenge studies were conducted by the Evotec Manchester UK in accordance with institutional guidelines. Adult female CD1 mice (8–10 weeks old) were inoculated ip with 3000 tachyzoites of a type I RH strain expressing firefly luciferase,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> which had been grown <i>in vitro</i> in HFF monolayers as described above. At 24 h postinfection, animals were treated by oral gavage (100–200 μL total volume) with compounds diluted in 0.5% CMC for 7 consecutive days. Twelve animals were used for each group treated with compounds, and nine animals received vehicle only as a control. Animals were monitored for weight loss (and sacrificed when weight loss reached >20%, body temperature dropped below 34 °C or they were unable to reach food or water) and imaged for bioluminescence as described below. At 15 days postinfection, lung and brain tissues from surviving animals were removed, homogenized, and 0.1 mL of homogenate was injected ip into recipient CD1 mice that were not treated with compounds. Recipient animals were followed for weight loss, bioluminescence, and survival, as described above.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Chronic Reactivation Model</h3><div class="NLM_p last">Studies using the chronic infection model were conducted at Washington University using a previously described model to monitor the ability of compounds to prevent reactivation of toxoplasmosis.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Male or female Ifngr1<sup>–/–</sup> mice (the proportion of each was roughly 50/50 and they were divided equally by sex among the groups) were orally infected with 5 cysts of the type 2 ME49Δ<i>hx</i>::FLUC line, obtained from the brains of chronically infected wild type CD-1 mice. Animals were treated with sulfadiazine (0.25 g/L in the drinking water) from day 3 to day 22. Animals were tested to confirm infection by collecting blood at 21 days and testing using <i>T. gondii</i> antigen-specific ELISA, as previously described.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Animals that did not have strongly positive titers (i.e., OD ≥ 0.8) were removed from the experiment. At 48 h after removal of the sulfadiazine, compounds (dissolved in 0.5% CMC, 0.1% Tween 80) were administered by oral gavage for a total of 8 or 21 days. Animals were monitored for weight loss, bioluminescence imaging, and survival for 30 days. At the end of 30 days, surviving animals were sacrificed humanely and the brains removed and homogenized. A portion of each brain (generally 20%) was inoculated into Ifngr1<sup>–/–</sup> mice, and the recipients were monitored for infection by tracking signs of illness, mortality, and serological conversion at 30 days postinoculation.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Bioluminescence Imaging</h3><div class="NLM_p last">Mice were anesthetized by inhalation with 2% isoflurane and injected ip with <span class="smallcaps smallerCapital">d</span>-luciferin (Biosynth AG) (stock 15 mg/mL, administered as 10 μL per gram of body weight) just prior to imaging. Animals were monitored for bioluminescence using a Xenogen IVIS200 instrument. Data were analyzed using the Xenogen Living Image software (Caliper Life Sciences).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Kinetic Solubility</h3><div class="NLM_p last">Kinetic solubility analysis was conducted by WuXi AppTec, China. Compounds were dissolved at 10 mM in DMSO and diluted to 200 μM in 50 mM phosphate buffer, pH 7.4 (2% DMSO final). After incubation for 24 h at a controlled temperature at 25 °C, undissolved material was separated by filtering. The filtrate was analyzed by HPLC equipped with UV. Kinetic solubility was calculated based on comparison with external standards and expressed in μM.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Protein Binding Studies</h3><div class="NLM_p last">Protein binding studies were performed by WuXi AppTech, China. Compounds (final concentration 2 μM in 0.5% DMSO) were added to plasma, and protein binding was tested by equilibrium dialysis. Plasma samples containing test and control compounds (2 μM, 150 μL) were added to the donor sides, and 150 μL dialysis buffer was added to the receiver sides of a HTD device (HTDialysis LLC, Gales Ferry, CT, USA). The plate was then rotated at approximately 100 rpm in a humidified incubator with 5% CO<sub>2</sub> at 37 °C for 4 h. At the end of the dialysis period, samples (50 μL) were taken from both the donor side and the receiver side of the dialysis device and analyzed by LC/MS/MS. Values were reported as ng/mL and converted to % of protein bound.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Plasma to Brain Ratio</h3><div class="NLM_p last">Determination of the ratio of plasma to brain levels was conducted by WuXi AppTech, China. Adult female CD1 mice were given compounds by oral gavage at a single dose of 10 mg/kg suspended in 0.5% CMC. At 8 h postinoculation, animals were euthanized and plasma (EDTA-K2 collection) and brain tissue recovered. Blood was collected form the saphenous vein into EDTAK2 tubes, centrifuged for 15 min at 4 °C, and plasma was collected. Following removal of the brain, it was blotted on filter paper, weighed, and homogenized in 4× volumes of water using a polytron at 4 °C. Homogenates were placed on dry ice until analysis. Compound concentrations were determined from the supernatants after protein precipitation by LC/MS/MS in comparison to standards expressed as ng/mL for plasma and ng/g for tissue homogenates. The brain/plasma ratio was calculated as [individual brain concentration (ng/g)]/[individual plasma concentration (ng/mL)].</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Microsome Stability Assay</h3><div class="NLM_p last">Microsome stability assays were conducted by WuXi AppTech, China. Compounds were prepared at 10 μM in 1% DMSO in 100 mM potassium phosphate buffer (PB). Compounds (10 μL/well) were added to 96-well plates containing microsomes (80 μL/well) diluted with 100 mM PB to a final protein concentration of 0.5 mg/mL. The plates were preincubated in a 37 °C water bath for 10 m followed by addition of 10 μL/well 10 mM NADPH (β-nicotinamide adenine dinucleotide phosphate, final concentration of 1 mM). Plates were incubated for 5, 10, 20, 30, 60 min and stopped by addition of 300 μL/well of stop solution. The plates were then sealed and shaken for 10 min prior to centrifugation at 4000 rpm, 4 °C for 20 min, and the supernatant was analyzed by LC–MS/MS. Stability of compounds was expressed as intrinsic clearance (Cl<sub>int</sub>) in mL min<sup>–1</sup> kg<sup>–1</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Hepatocyte Stability Assay</h3><div class="NLM_p last">Hepatocyte stability assays were conducted by WuXi AppTech, China. Cryopreserved human hepatocytes were thawed, suspended in Williams’ medium E, and diluted to a final concentration of 0.5 × 10<sup>6</sup> cells/mL. Cell suspensions (198 μL/well) were added to all 96-well plates followed by the addition of 2 μL/well control or test compounds (1.0 μM, 1% DMSO final). Plates were placed in a 95% humidified, 5% CO<sub>2</sub> incubator at 37 °C and 800 rpm to initiate the reactions. At time-points 5, 10, 20, 30, 60 min, plates were removed from the incubator, and 20 μL/well of the corresponding sample was transferred to a quenching plate containing 80 μL/well of stop solution. The plates were then sealed and shaken for 10 min prior to centrifugation at 4000 rpm and 4 °C for 20 min. Supernatants were analyzed by LC–MS/MS analysis. Stability of compounds in the presence of hepatocytes was expressed as the rate of loss of the parent compound in (mL/min)/10<sup>6</sup> cells.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> MDCK Uptake and Efflux</h3><div class="NLM_p last">Compounds were tested by WuXi AppTec for bidirectional permeability and efflux in MDCK cells expressing the human MDR1 efflux pump. MDR1-MDCK II cells at passage number 21 were seeded on 96-well transport inserts and cultured for 7 days before being used for the transport experiment. Compounds were added at 2.0 μM final concentration to the apical vs basolateral side of transport inserts. Samples were taken at 0 and 150 min from both the donor and receiver chambers and analyzed by LC/MS/MS. Transfer from apical to basolateral (A to B) and basolateral to apical (B to A) direction was expressed as the mean rate of exchange per 10<sup>6</sup> cells in cm/s and the ratio used to determine the efflux ratio.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Aldehyde Oxidase</h3><div class="NLM_p last">The susceptibility of compounds to aldehyde oxidase (AO) in human liver S9 fraction was tested by WuXi AppTec, China. Compounds were incubated at 1.0 μM with human liver S9 at 37 °C for up to 90 min in the presence or absence of an AO inhibitor, raloxifene. The parent compound was measured by LC/MS/MS, and values were expressed as the rate of decay of the parent compound in mL/min/mg.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> CYP Inhibition Assays</h3><div class="NLM_p last">Compounds were tested by WuXi AppTec for inhibition of CYP enzymes. Human liver microsomes were incubated for 10 min in the presence of test compound at various concentrations (50–0.05 μM) and with a selective substrate for each CYP isozyme (at <i>K</i><sub>m</sub>). The formation of the selective metabolite from its substrate was measured by liquid chromatography/mass spectrometry (LC/MS/MS). Substrates used for each Cyp enzyme included: 1A2 (phenacetin), 2C9 (diclofenac), 2C19 (S-mephenytoin), 2D6 (dextromethorphan), 3A4-M (midazolam). Values were reported as the EC<sub>50</sub> concentration for inhibition of substrate conversion for each respective CYP.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> hERG Channel Activity</h3><div class="NLM_p">Compounds were tested by WuXi AppTec for inhibition of hERG (human ether-à-go-go-related gene) potassium channels stably expressed in a CHO cell line using manual patch-clamp technique.</div><div id="sec4_21_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Cell Culture</h4><div class="NLM_p last">CHO-K1 cells expressing hERG (Aviva Biosciences) were cultured in F12 (Invitrogen, USA) supplemented with 10% fetal bovine serum (HyClone, USA), 100 μg/mL G418 (Invitrogen, USA), and 100 μg/mL hygromycin B (Invitrogen, USA) at 37 °C in a humidified atmosphere of air with 5% CO<sub>2</sub>. For patch-clamp recording, cells were harvested from the culture flask by 2 min digestion with TrypLE (Invitrogen, USA) and plated in 35 mm cell culture dishes.</div></div><div id="secw" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Electrophysiology</h4><div class="NLM_p last">hERG channel currents were recorded using a MultiClamp 700B amplifier and pCLAMP 10.2 software (Molecular Devices, USA) and were filtered at 10 kHz. Patch electrodes with resistances of 2–5 MΩ were pulled with a vertical micropipette puller (PC-10 Puller, NARISHIGE, Japan). The extracellular solution (mM) consisted of the following: NaCl 145, KCl 4, CaCl<sub>2</sub> 2, MgCl<sub>2</sub> 1, HEPES 10, glucose 10 (pH adjusted to 7.4 with NaOH and osmolarity adjusted to ∼295). The pipet solution (mM) consisted of the following: KCl 120, KOH 31.25, CaCl<sub>2</sub> 5.374, MgCl<sub>2</sub> 1.75, Na<sub>2</sub>ATP 4, EGTA 10, and HEPES 10 (pH adjusted to 7.2 with KOH and osmolarity adjusted to ∼285). Amitriptyline (Sigma, USA) was dissolved in dimethyl sulfoxide (DMSO) to obtain a stock solution of 30 mM stored at −20 °C. The final concentration of DMSO in the solution was no more than 0.3%, which had no effect on hERG current.</div></div><div id="sec4_21_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Data Analysis</h4><div class="NLM_p last">All recorded data were analyzed with Clampfit 10.2 (Molecular Devices, USA), Excel 2003(Microsoft), and GraphPad Prism 5.0. The concentration–response curve was fitted by logistic equation of <i>I</i>/<i>I</i><sub>control</sub> = Bottom + (Top – Bottom)/(1 + 10<sup>((logIC50–<i>X</i>)·HillSlope)</sup>), where <i>X</i> is the logarithm of drug concentration, <i>I</i>/<i>I</i><sub>control</sub> is the normalized peak current amplitude, Top is 1, and Bottom is equal to a value. Data were expressed as the IC<sub>50</sub> concentration that inhibited 50% of hERG activity. Compounds were tested over a range of concentrations from 0.3 to 30 μM.</div></div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Ames Test</h3><div class="NLM_p last">A liquid microplate format Mini Ames assay, conducted by WuXi AppTec, China, was used to test the potential mutagenicity of compounds. Briefly, bacteria of <i>S. typhimurium</i> TA98 and TA100 strains were inoculated into growth medium (Xenometrix) at 37 °C, 200 rpm overnight. The overnight culture was diluted into exposure medium (Xenometrix) in 24-microwell plate and incubated with the test compounds at 6 dose levels of 5, 2.5, 0.5, 0.1, 0.02, and 0.004 mg/mL at 37 °C, 250 rpm for 90 min. The test was performed in the presence or absence of 4.5% Aroclor induced rat S9 fraction (Xenometrix). Parallel samples of <i>S. typhimurium</i> TA98 and TA100 without S9 were treated with 2.0 μg/mL 2-nitrofluorene and 0.1 μg/mL 4-nitroquinoline-<i>N</i>-oxide as positive controls. Additionally, samples of <i>S. typhimurium</i> TA98 and TA100 with S9 were treated with 1.0 μg/mL 2-aminoanthracene and 1.25 μg/mL aminoanthracene as positive controls. After treatment, 24-well plate cultures were diluted in indicator medium (Xenometrix) and aliquoted into 48 wells of a 384-well plate (50 μL per well) that was incubated for 48-h at 37 °C to allow revertant bacteria to form colonies. An increase of >2-fold in the number of positive wells over the baseline (solvent control), for more than one test doses within a dose–response, was classified as positive.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Micronucleus</h3><div class="NLM_p">A micronucleus test was conducted by WuXi AppTec, China, to test the potential mutagenicity of compounds.</div><div id="sec4_23_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Cell Culture</h4><div class="NLM_p last">CHO-K1 cells were cultured in F12K (Gibco) media supplemented with 1% 100× penicillin–streptomycin (Hyclone) and 10% fetal bovine serum (Hyclone) in humidified atmosphere with 5% CO<sub>2</sub> in air at 37 °C.</div></div><div id="sec4_23_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Metabolic Activation System</h4><div class="NLM_p last">Sprague Dawley rat liver S9 fraction (MOLTOX) was induced with Aroclor 1254. The S9 mix contained 0.3 mL of S9 and 100 μL of NADP and 25 μL of glucose 6-phosphate per mL.</div></div><div id="sec4_23_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>In Vitro</i> Micronucleus Assay</h4><div class="NLM_p">CHO-K1 cells were added to 96-well plates (Greiner) at 4000 cells/well (100 μL, −S9) or 5000 cells/well (100 mL, +S9) and incubated overnight. Test compounds were diluted from 1000 μM with 3-fold dilution over 10 points. Bleomycin sulfate was diluted from 28 μM with 2-fold dilution over 8 points. Cyclophosphamide was diluted from 400 μM with 2-fold dilution over 8 points. The final DMSO concentration was 1% for all test compounds and controls.</div><div class="NLM_p last">In the first study design, cells were continuously treated for 24 h without metabolic activation (24 h −S9). In the second study design, cells were treated in the presence of S9 mix for 3 h (3 h + 2% S9), washed once with warm media, and cultured in fresh F12K media for 22 h. At the end of 24 h, cells were washed with fresh medium and cultured in F12K medium containing 6 μg/mL of cytochalasin B for an additional 24 h. Cells were stained with 2.5 μg/mL Hoechst dye solution and 1 μM calcein-AM in 10 μL of warm PBS for 30 min, washed, and examined for the frequency of binucleate cells. A positive result was defined as an over 3-fold concentration-dependent increase in the percentage of micronucleated cells compared to control values.</div></div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Human Kinome-Wide Screen</h3><div class="NLM_p last">Compounds were screened for inhibition of 485 human kinases using the SelectScreen Biochemical Kinase Profiling Service from Thermo-Fisher. Compounds were analyzed for inhibition using one of three assays: Z’Lyte assay, Adapta assay, and LanthaScreen Eu Kinase binding assay. Compounds were tested at 1 μM final in 1% DMSO. For the Z’ Lyte and Adapta assays, the ATP concentration matched the respective <i>K</i><sub>m</sub> for each enzyme, while the LanthaScreen is a direct binding assay run in the absence ATP. For each of the assays, buffers optimized for each kinase were utilized, according to the manufacturer’s protocol. Values were expressed as % inhibition = (1 – (activity in the absence of compound/activity in the presence of compound) × 100) as an average of duplicate samples run in parallel. Results were visualized using the Interactive Human Kinome tree available at Cell Signaling Technology (<a href="https://www.cellsignal.com/contents/science-protein-kinases/protein-kinases-interactive-human-kinome/kinases-human-kinome" class="extLink">https://www.cellsignal.com/contents/science-protein-kinases/protein-kinases-interactive-human-kinome/kinases-human-kinome</a>).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>In Vitro</i> Safety Panel</h3><div class="NLM_p last">A total of 78 target enzymes and biological functions including calcium signaling, nuclear hormones, kinases, ion channels, and various enzymes were analyzed for compound <b>3a</b> using the Safety 47 panel from Eurofins, DiscoverX. Compounds were tested at 10 μM final concentration in 1% DMSO using assay buffers optimized for each target, as determined by the manufacturer. Results were reported as % of response from two replicate data points ((1 – activity in the presence of compound/activity in the absence of compound) × 100).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Statistics</h3><div class="NLM_p last">Statistical analyses were performed using Prism (GraphPad Inc.). IC<sub>50</sub> and EC<sub>50</sub> values were determined using normalized, log-transformed (concentration) data fit with nonlinear regression analysis based on sigmoidal dose–response curves with variable slope. Comparisons of survival curves were conducted using a Mantel–Cox test. The minimum <i>P</i> value considered significant was ≥0.05, and specific cutoffs are given in each of the figure legends.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00419" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00419?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00419</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Supplementary figures and tables and detailed chemical synthesis; chemistry spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formulas strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf">jm0c00419_si_001.pdf (9.36 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_002.csv">jm0c00419_si_002.csv (13.0 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00419" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James W. Janetka</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis. Missouri 63110, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9888-5411" title="Orcid link">http://orcid.org/0000-0002-9888-5411</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8de7ece3e8f9e6ece7cdfaf8fef9e1a3e8e9f8"><span class="__cf_email__" data-cfemail="3d575c535849565c577d4a484e495113585948">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">L. David Sibley</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology, Washington University
School of Medicine, St. Louis, Missouri 63110, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7110-0285" title="Orcid link">http://orcid.org/0000-0001-7110-0285</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#23504a414f465a63545650574f0d464756"><span class="__cf_email__" data-cfemail="93e0faf1fff6ead3e4e6e0e7ffbdf6f7e6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allen T. Hopper</span> - <span class="hlFld-Affiliation affiliation">Vyera
Pharmaceuticals, 600
Third Avenue, New York, New
York 10016, United
States</span>; 
    <span>Present Address:
                        A.T.H.: Sage Therapeutics, 215 First Street, Cambridge, MA 02142</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ziping Yang</span> - <span class="hlFld-Affiliation affiliation">Vyera
Pharmaceuticals, 600
Third Avenue, New York, New
York 10016, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Barks</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology, Washington University
School of Medicine, St. Louis, Missouri 63110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Savari Dhason</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology, Washington University
School of Medicine, St. Louis, Missouri 63110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiuling Wang</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology, Washington University
School of Medicine, St. Louis, Missouri 63110, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The work reported here was supported by a Sponsored Research Agreement to Washington University from Vyera Pharmaceuticals. Washington University and Vyera hold joint intellectual property related to this manuscript that is covered by several pending patent applications.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83353" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83353" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Julie Gould, Andy Wise, Rajesh Odera, and Peter Warn, Evotec UK, for their assistance in performing studies with the acute infection model. We also acknowledge the helpful support of Yan Pan, Zhiyan Chi, Tao Xiong, Xiangling Wang, Yuting Ding, Wujian Ju, Jie Wang, and Xiaoxia Jiao, at WuXi AppTec, China, who conducted the <i>in vitro</i> ADME assays described here. We acknowledge the important contribution of the chemistry team at WuXi, including the following individuals: Jian Zhou, Xiaojie Zhang, and Zhongyuan Wang. Finally, we are grateful to Stephen Thomas and Nick Pelliccione from Vyera Pharmaceuticals for their help in coordinating the studies described here.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">CDPK1</td><td class="NLM_def"><p class="first last">calcium dependent protein kinase 1</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-à-go-go-related gene</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PP</td><td class="NLM_def"><p class="first last">pyrazolopyrimidine</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26103" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26103" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span> <i>Toxoplasmosis of Animals and Humans</i>; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>, <span class="NLM_year">2010</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">313</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=1-313&author=J.+P.+Dubey&title=Toxoplasmosis+of+Animals+and+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26btitle%3DToxoplasmosis%2520of%2520Animals%2520and%2520Humans%26pub%3DCRC%2520Press%26date%3D2010%26spage%3D1%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>, <span> </span><span class="NLM_article-title">The Life Cycle of <i>Toxoplasma gondii</i></span>. In  <i>Toxoplasma: Molecular and Cellular Biology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, J. W.</span>, <span class="NLM_string-name">Soldati, D.</span></span>, Eds.; <span class="NLM_publisher-name">Horizon Bioscience</span>: <span class="NLM_publisher-loc">Norfolk, U.K.</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">16</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2FB978-012369542-0%2F50003-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=3-16&author=J.+P.+Dubeyauthor=J.+W.+Ajioka&author=D.+Soldati&title=Toxoplasma%3A+Molecular+and+Cellular+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FB978-012369542-0%2F50003-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-012369542-0%252F50003-9%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520Life%2520Cycle%2520of%2520Toxoplasma%2520gondii%26btitle%3DToxoplasma%253A%2520Molecular%2520and%2520Cellular%2520Biology%26aulast%3DAjioka%26aufirst%3DJ.%2BW.%26pub%3DHorizon%2520Bioscience%26date%3D2007%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patwardhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinai, A. P.</span></span> <span> </span><span class="NLM_article-title">Novel approaches reveal that <i>Toxoplasma gondii</i> bradyzoites within tissue cysts are dynamic andreplicating entities in vivo</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e01155-15</span> <span class="refDoi"> DOI: 10.1128/mBio.01155-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FmBio.01155-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=26350965" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&issue=5&author=E.+Wattsauthor=Y.+Zhaoauthor=A.+Dharaauthor=B.+Ellerauthor=A.+Patwardhanauthor=A.+P.+Sinai&title=Novel+approaches+reveal+that+Toxoplasma+gondii+bradyzoites+within+tissue+cysts+are+dynamic+andreplicating+entities+in+vivo&doi=10.1128%2FmBio.01155-15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FmBio.01155-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01155-15%26sid%3Dliteratum%253Aachs%26aulast%3DWatts%26aufirst%3DE.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DDhara%26aufirst%3DA.%26aulast%3DEller%26aufirst%3DB.%26aulast%3DPatwardhan%26aufirst%3DA.%26aulast%3DSinai%26aufirst%3DA.%2BP.%26atitle%3DNovel%2520approaches%2520reveal%2520that%2520Toxoplasma%2520gondii%2520bradyzoites%2520within%2520tissue%2520cysts%2520are%2520dynamic%2520andreplicating%2520entities%2520in%2520vivo%26jtitle%3DmBio%26date%3D2015%26volume%3D6%26issue%3D5%26doi%3D10.1128%2FmBio.01155-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bhadra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobb, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span> <span> </span><span class="NLM_article-title">Donor CD8+ T cells prevent <i>Toxoplasma gondii</i> de-encystation but fail to rescue the exhausted endogenous CD8+ T cell population</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3414</span>– <span class="NLM_lpage">3425</span>, <span class="refDoi"> DOI: 10.1128/IAI.00784-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FIAI.00784-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=23817617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCmurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=3414-3425&issue=9&author=R.+Bhadraauthor=D.+A.+Cobbauthor=I.+A.+Khan&title=Donor+CD8%2B+T+cells+prevent+Toxoplasma+gondii+de-encystation+but+fail+to+rescue+the+exhausted+endogenous+CD8%2B+T+cell+population&doi=10.1128%2FIAI.00784-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Donor CD8+ T cells prevent Toxoplasma gondii de-encystation but fail to rescue the exhausted endogenous CD8+ T cell population</span></div><div class="casAuthors">Bhadra, Rajarshi; Cobb, Dustin A.; Khan, Imtiaz A.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3414-3425</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">1098-5522</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Functional exhaustion of CD8+ T cells due to increased expression of inhibitory mol. PD-1 (Programmed Death-1) causes reactivation of latent disease during later phases of chronic toxoplasmosis.  Onset of disease recrudescence results in decreased parasite cyst burden concomitant with parasites undergoing stage conversion from a primarily encysted, quiescent bradyzoite to a fast-replicating, highly motile tachyzoite.  Thus, reduced cyst burden is one of the early hallmarks of disease recrudescence.  This was further validated by depleting gamma interferon (IFN-γ), a cytokine known to control latent toxoplasmosis, in chronically infected prerecrudescent mice.  Since CD8+ T cells (an important source of IFN-γ) lose their functionality during the later phases of chronic toxoplasmosis, we next examd. if adoptive transfer of functional CD8+ T cells from acutely infected donors to the chronically infected prerecrudescent hosts could impede parasite de-encystation and rescue exhausted CD8+ T cells.  While the transfer of immune CD8+ T cells temporarily restricted the breakdown of cysts, the exhausted endogenous CD8+ T cell population was not rescued.  Over time, the donor population got deleted, resulting in parasite de-encystation and host mortality.  Considering that donor CD8+ T cells fail to become long-lived, one of the cardinal features of memory CD8+ T cells, it bears the implication that memory CD8 differentiation is impaired during chronic toxoplasmosis.  Moreover, our data strongly suggest that while adoptive immunotherapy can prevent parasite de-encystation transiently, reduced antigen burden in the chronic phase by itself is insufficient for rescue of exhausted CD8+ T cells.  The conclusions of this study have profound ramifications in designing immunotherapeutics against chronic toxoplasmosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpofhC0pfj1w7Vg90H21EOLACvtfcHk0lgR7b-ZKYTnkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCmurzF&md5=7157a35ac31357280abfebcabd22d3bc</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1128%2FIAI.00784-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00784-12%26sid%3Dliteratum%253Aachs%26aulast%3DBhadra%26aufirst%3DR.%26aulast%3DCobb%26aufirst%3DD.%2BA.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26atitle%3DDonor%2520CD8%252B%2520T%2520cells%2520prevent%2520Toxoplasma%2520gondii%2520de-encystation%2520but%2520fail%2520to%2520rescue%2520the%2520exhausted%2520endogenous%2520CD8%252B%2520T%2520cell%2520population%26jtitle%3DInfect.%2520Immun.%26date%3D2013%26volume%3D81%26issue%3D9%26spage%3D3414%26epage%3D3425%26doi%3D10.1128%2FIAI.00784-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escajadillo, A.</span></span> <span> </span><span class="NLM_article-title">Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.4269/ajtmh.1987.36.517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.4269%2Fajtmh.1987.36.517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=3578650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADyaL2s3htVOqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1987&pages=517-522&author=J.+K.+Frenkelauthor=A.+Escajadillo&title=Cyst+rupture+as+a+pathogenic+mechanism+of+toxoplasmic+encephalitis&doi=10.4269%2Fajtmh.1987.36.517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis</span></div><div class="casAuthors">Frenkel J K; Escajadillo A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of tropical medicine and hygiene</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-22</span>
        ISSN:<span class="NLM_cas:issn">0002-9637</span>.
    </div><div class="casAbstract">Seemingly intact cysts and sequential stages of disintegrating cysts of Toxoplasma were identified immunohistologically within developing microglial nodules in a Panamanian night monkey (Aotus lemurinus).  This monkey had been successfully immunized and challenged 5 months earlier.  This supports the hypothesis that glial nodules unassociated with Toxoplasma tachyzoites may represent the tombstone of a Toxoplasma cyst.  Disintegration of cysts may give rise to clinical encephalitis in the presence of apparently adequate immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQr2YqyF9iY_oxhnOQkIHOxfW6udTcc2eYmJdQ9XvwrKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s3htVOqsw%253D%253D&md5=0ba6191c6a21b744d44729ca198b4891</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.1987.36.517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.1987.36.517%26sid%3Dliteratum%253Aachs%26aulast%3DFrenkel%26aufirst%3DJ.%2BK.%26aulast%3DEscajadillo%26aufirst%3DA.%26atitle%3DCyst%2520rupture%2520as%2520a%2520pathogenic%2520mechanism%2520of%2520toxoplasmic%2520encephalitis%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D1987%26volume%3D36%26spage%3D517%26epage%3D522%26doi%3D10.4269%2Fajtmh.1987.36.517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, J. K.</span></span> <span> </span><span class="NLM_article-title">The <i>Toxoplasma gondii</i> oocyst from cat feces</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1084/jem.132.4.636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1084%2Fjem.132.4.636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=4927658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADyaE3MXivFajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=1970&pages=636-662&issue=4&author=J.+P.+Dubeyauthor=N.+L.+Millerauthor=J.+K.+Frenkel&title=The+Toxoplasma+gondii+oocyst+from+cat+feces&doi=10.1084%2Fjem.132.4.636"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii oocyst from cat feces</span></div><div class="casAuthors">Dubey, J. P.; Miller, Nancy L.; Frenkel, J. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">636-62</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    </div><div class="casAbstract">Coccidian oocysts resembling those of Isospora bigemina were excreted by cats fed Toxoplasma cysts, trophozoites, or oocysts.  Oocysts could not be sepd. from infectivity by filtration, by continuous particle electrophoresis, or by d. gradient centrifugation.  Excystation of oocysts was followed by an increase in titer of Toxoplasma infectivity.  Unsporulated oocysts in fresh cat feces were noninfectious to mince, but oocyst sporulation was assocd. quant. with the development of infectivity at different temps. and conditions of oxygenation; max. oocyst sporulation at 48 hr correlated with the development of max.  Toxoplasma infectivity.  H2SO4 (1-2%) and K2Cr2O7 (2.5%) were the best preservatives for sporulation of oocysts and for the development of Toxoplasma infectivity.  Low sporulation rates in 0.1% formalin, 20% EtOH, and water were assocd. with low infectivity in these reagents.  Oocysts, sporocysts, and sporozoites were stained specifically with Toxoplasma antibody in the indirect fluorescent antibody test.  Typical coccidian stages, schizonts and male and female gametocytes were found in the epithelium of the small intestine of kittens fed Toxoplasma cysts.  The classification of T. gondii is discussed in relation to that of other isosporan coccidia of cats and dogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonExDvHAtIj7Vg90H21EOLACvtfcHk0liHKqugO1K7sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXivFajsg%253D%253D&md5=db70ab7b71a52a32075ebe18633cf0bf</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1084%2Fjem.132.4.636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.132.4.636%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DMiller%26aufirst%3DN.%2BL.%26aulast%3DFrenkel%26aufirst%3DJ.%2BK.%26atitle%3DThe%2520Toxoplasma%2520gondii%2520oocyst%2520from%2520cat%2520feces%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1970%26volume%3D132%26issue%3D4%26spage%3D636%26epage%3D662%26doi%3D10.1084%2Fjem.132.4.636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. L.</span></span> <span> </span><span class="NLM_article-title"><i>Toxoplasma gondii</i> in cats: fecal stages identified as coccidian oocysts</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">896</span>, <span class="refDoi"> DOI: 10.1126/science.167.3919.893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1126%2Fscience.167.3919.893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=4903651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADyaE3c%252Fot1Kguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=1970&pages=893-896&author=J.+K.+Frenkelauthor=J.+P.+Dubeyauthor=N.+L.+Miller&title=Toxoplasma+gondii+in+cats%3A+fecal+stages+identified+as+coccidian+oocysts&doi=10.1126%2Fscience.167.3919.893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts</span></div><div class="casAuthors">Frenkel J K; Dubey J P; Miller N L</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">3919</span>),
    <span class="NLM_cas:pages">893-6</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Isospora-type oocysts were excreted by cats following the ingestion of Toxoplasma fromn infected mice.  Oocysts appeared 3 to 5 days after cyst. were ingested and 8 to 10 days after trophozoites were ingested, and also 21 to 24 days after the administration of infective fecal suspensions from cats.  A close quanititative and biologic correlation between oocysts and Toxoplasma infectivity of the feces was observed which could not be separated by density gradient centrifugation and filtration methods.  Toxoplasma is an intestinal coccidian of cats which is fecally spread.  It has evolved to multiply in brain and muscle and in other species, making it possible for carnivorism to become another means of transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE0mwzDXU9t3p3bfzSLaX5fW6udTcc2eYmJdQ9XvwrKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3c%252Fot1Kguw%253D%253D&md5=4c5e90c6ae2a1405bb1f0d199e8e86bf</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1126%2Fscience.167.3919.893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.167.3919.893%26sid%3Dliteratum%253Aachs%26aulast%3DFrenkel%26aufirst%3DJ.%2BK.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DMiller%26aufirst%3DN.%2BL.%26atitle%3DToxoplasma%2520gondii%2520in%2520cats%253A%2520fecal%2520stages%2520identified%2520as%2520coccidian%2520oocysts%26jtitle%3DScience%26date%3D1970%26volume%3D167%26spage%3D893%26epage%3D896%26doi%3D10.1126%2Fscience.167.3919.893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span> <span> </span><span class="NLM_article-title">Foodborne toxoplasmosis</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">845</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1093/cid/cis508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1093%2Fcid%2Fcis508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=22618566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADC%252BC38nlsVahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=845-851&author=J.+L.+Jonesauthor=J.+P.+Dubey&title=Foodborne+toxoplasmosis&doi=10.1093%2Fcid%2Fcis508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Foodborne toxoplasmosis</span></div><div class="casAuthors">Jones Jeffrey L; Dubey J P</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">845-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Toxoplasmosis can be due to congenital infection or acquired infection after birth and is one of the leading illnesses associated with foodborne hospitalizations and deaths.  Undercooked meat, especially pork, lamb, and wild game meat, and soil contaminated with cat feces on raw fruits and vegetables are the major sources of foodborne transmission for humans.  The new trend in the production of free-range organically raised meat could increase the risk of Toxoplasma gondii contamination of meat.  Foodborne transmission can be prevented by production practices that reduce T. gondii in meat, adequate cooking of meat, washing of raw fruits and vegetables, prevention of cross contamination in the kitchen, and measures that decrease spread of viable oocysts into the environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZHBKCRvyu4vEeosoOnpOLfW6udTcc2eZH6ZgfUH6L47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nlsVahsQ%253D%253D&md5=1cc4f6e240f27c8c02286f77039cac79</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcis508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcis508%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DJ.%2BL.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26atitle%3DFoodborne%2520toxoplasmosis%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26spage%3D845%26epage%3D851%26doi%3D10.1093%2Fcid%2Fcis508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span> <span> </span><span class="NLM_article-title">Waterborne toxoplasmosis--recent developments</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2009.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.exppara.2009.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=19324041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252FltlWitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2010&pages=10-25&issue=1&author=J.+L.+Jonesauthor=J.+P.+Dubey&title=Waterborne+toxoplasmosis%2D%2Drecent+developments&doi=10.1016%2Fj.exppara.2009.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Waterborne toxoplasmosis--recent developments</span></div><div class="casAuthors">Jones J L; Dubey J P</div><div class="citationInfo"><span class="NLM_cas:title">Experimental parasitology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Humans become infected with Toxoplasma gondii mainly by ingesting uncooked meat containing viable tissue cysts or by ingesting food or water contaminated with oocysts from the feces of infected cats.  Circumstantial evidence suggests that oocyst-induced infections in humans are clinically more severe than tissue cyst-acquired infections.  Until recently, waterborne transmission of T. gondii was considered uncommon, but a large human outbreak linked to contamination of a municipal water reservoir in Canada by wild felids and the widespread infection of marine mammals in the USA provided reasons to question this view.  The present paper examines the possible importance of T. gondii transmission by water.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8Al8ZjJ5UXo2y4bB4mnvYfW6udTcc2eZH6ZgfUH6L47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252FltlWitA%253D%253D&md5=4065ec5c0037bed3350aef8a21074502</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2009.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2009.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DJ.%2BL.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26atitle%3DWaterborne%2520toxoplasmosis--recent%2520developments%26jtitle%3DExp.%2520Parasitol.%26date%3D2010%26volume%3D124%26issue%3D1%26spage%3D10%26epage%3D25%26doi%3D10.1016%2Fj.exppara.2009.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liesenfeld, O.</span></span> <span> </span><span class="NLM_article-title">Toxoplasmosis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">1965</span>– <span class="NLM_lpage">1976</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(04)16412-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2FS0140-6736%2804%2916412-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=15194258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVemuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2004&pages=1965-1976&author=J.+G.+Montoyaauthor=O.+Liesenfeld&title=Toxoplasmosis&doi=10.1016%2FS0140-6736%2804%2916412-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasmosis</span></div><div class="casAuthors">Montoya, J. G.; Liesenfeld, O.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">9425</span>),
    <span class="NLM_cas:pages">1965-1976</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Toxoplasma gondii is a protozoan parasite that infects up to a third of the world's population.  Infection is mainly acquired by ingestion of food or water that is contaminated with oocysts shed by cats or by eating undercooked or raw meat contg. tissue cysts.  Primary infection is usually subclin. but in some patients cervical lymphadenopathy or ocular disease can be present.  Infection acquired during pregnancy may cause severe damage to the fetus.  In immunocompromised patients, reactivation of latent disease can cause life-threatening encephalitis.  Diagnosis of toxoplasmosis can be established by direct detection of the parasite or by serol. techniques.  The most commonly used therapeutic regimen, and probably the most effective, is the combination of pyrimethamine with sulfadiazine and folinic acid.  This Seminar provides an overview and update on management of patients with acute infection, pregnant women who acquire infection during gestation, fetuses or infants who are congenitally infected, those with ocular disease, and immunocompromised individuals.  Controversy about the effectiveness of primary and secondary prevention in pregnant women is discussed.  Important topics of current and future research are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjtqSI8fuY4rVg90H21EOLACvtfcHk0lgauwUQZzu2eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVemuro%253D&md5=7fe37d0af87e4bbff2e087b416dcf5c0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2804%2916412-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252804%252916412-X%26sid%3Dliteratum%253Aachs%26aulast%3DMontoya%26aufirst%3DJ.%2BG.%26aulast%3DLiesenfeld%26aufirst%3DO.%26atitle%3DToxoplasmosis%26jtitle%3DLancet%26date%3D2004%26volume%3D363%26spage%3D1965%26epage%3D1976%26doi%3D10.1016%2FS0140-6736%2804%2916412-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Luft, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remington, J. S.</span></span> <span> </span><span class="NLM_article-title">Toxoplasmic encephalitis in AIDS</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1093/clinids/15.2.211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1093%2Fclinids%2F15.2.211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1520757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADyaK38zpt12ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1992&pages=211-222&author=B.+J.+Luftauthor=J.+S.+Remington&title=Toxoplasmic+encephalitis+in+AIDS&doi=10.1093%2Fclinids%2F15.2.211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasmic encephalitis in AIDS</span></div><div class="casAuthors">Luft B J; Remington J S</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-22</span>
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    </div><div class="casAbstract">Involvement of the central nervous system (CNS) is common in patients with advanced disease due to human immunodeficiency virus (HIV).  Symptoms range from lethargy and apathy to coma, incoordination and ataxia to hemiparesis, loss of memory to severe dementia, and focal to major motor seizures.  Involvement may be closely associated with HIV infection per se, as in the AIDS dementia complex, but is frequently caused by opportunistic pathogens such as Toxoplasma gondii and Cryptococcus neoformans or malignancies such as primary lymphoma of the CNS.  The clinical presentations of attendant and direct CNS involvement are remarkably non-specific and overlapping, yet a correct diagnosis is critical to successful intervention.  Toxoplasmic encephalitis is one of the most common and most treatable causes of AIDS-associated pathology of the CNS.  A great deal has been learned in the last 10 years about its unique presentation in the HIV-infected patient with advanced disease.  Drs.  Benjamin J.  Luft of the State University of New York at Stony Brook and Jack S.  Remington of the Stanford University School of Medicine and Palo Alto Medical Foundation's Research Institute have studied T. gondii for many years and are two of the leading experts in the field.  This commentary comprises an update of their initial review (J Infect Dis 1988;157:1-6) and a presentation of the current approaches to diagnosing and managing toxoplasmic encephalitis in HIV-infected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9-IOPR6i3Oc-crCu0nI_sfW6udTcc2eZRjMRCSZOKmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zpt12ntw%253D%253D&md5=a99d76ccc0406e74e81a3522f997cdb6</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1093%2Fclinids%2F15.2.211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fclinids%252F15.2.211%26sid%3Dliteratum%253Aachs%26aulast%3DLuft%26aufirst%3DB.%2BJ.%26aulast%3DRemington%26aufirst%3DJ.%2BS.%26atitle%3DToxoplasmic%2520encephalitis%2520in%2520AIDS%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D1992%26volume%3D15%26spage%3D211%26epage%3D222%26doi%3D10.1093%2Fclinids%2F15.2.211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Israelski, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remington, J. S.</span></span> <span> </span><span class="NLM_article-title">Toxoplasmosis in the non-AIDS immunocompromised host</span>. <i>Curr. Clin. Top. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=8397917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADyaK2c%252FgtVGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=322-356&author=D.+M.+Israelskiauthor=J.+S.+Remington&title=Toxoplasmosis+in+the+non-AIDS+immunocompromised+host"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasmosis in the non-AIDS immunocompromised host</span></div><div class="casAuthors">Israelski D M; Remington J S</div><div class="citationInfo"><span class="NLM_cas:title">Current clinical topics in infectious diseases</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">322-56</span>
        ISSN:<span class="NLM_cas:issn">0195-3842</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTywXsaUPD8jYMcDoIzZtNkfW6udTcc2eZRjMRCSZOKmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FgtVGjsQ%253D%253D&md5=3406defb6b29dc6140e9eb0a1ada956c</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsraelski%26aufirst%3DD.%2BM.%26aulast%3DRemington%26aufirst%3DJ.%2BS.%26atitle%3DToxoplasmosis%2520in%2520the%2520non-AIDS%2520immunocompromised%2520host%26jtitle%3DCurr.%2520Clin.%2520Top.%2520Infect.%2520Dis.%26date%3D1993%26volume%3D13%26spage%3D322%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunay, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajurel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhakal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liesenfeld, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, J. G.</span></span> <span> </span><span class="NLM_article-title">Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e00057-17</span> <span class="refDoi"> DOI: 10.1128/CMR.00057-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FCMR.00057-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=30209035" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&issue=4&author=I.+R.+Dunayauthor=K.+Gajurelauthor=R.+Dhakalauthor=O.+Liesenfeldauthor=J.+G.+Montoya&title=Treatment+of+toxoplasmosis%3A+historical+perspective%2C+animal+models%2C+and+current+clinical+practice&doi=10.1128%2FCMR.00057-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FCMR.00057-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00057-17%26sid%3Dliteratum%253Aachs%26aulast%3DDunay%26aufirst%3DI.%2BR.%26aulast%3DGajurel%26aufirst%3DK.%26aulast%3DDhakal%26aufirst%3DR.%26aulast%3DLiesenfeld%26aufirst%3DO.%26aulast%3DMontoya%26aufirst%3DJ.%2BG.%26atitle%3DTreatment%2520of%2520toxoplasmosis%253A%2520historical%2520perspective%252C%2520animal%2520models%252C%2520and%2520current%2520clinical%2520practice%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2018%26volume%3D31%26issue%3D4%26doi%3D10.1128%2FCMR.00057-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remington, J. S.</span></span> <span> </span><span class="NLM_article-title">The diagnosis and treatment of toxoplasmosis</span>. <i>Eur. J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1007/BF02001573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1007%2FBF02001573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=6861739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADyaL3s3jsVCgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1983&pages=95-104&author=R.+E.+McCabeauthor=J.+S.+Remington&title=The+diagnosis+and+treatment+of+toxoplasmosis&doi=10.1007%2FBF02001573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">The diagnosis and treatment of toxoplasmosis</span></div><div class="casAuthors">McCabe R E; Remington J S</div><div class="citationInfo"><span class="NLM_cas:title">European journal of clinical microbiology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-104</span>
        ISSN:<span class="NLM_cas:issn">0722-2211</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQl1NvOzTGOgwaK-_ZudimnfW6udTcc2eZRjMRCSZOKmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s3jsVCgsQ%253D%253D&md5=954c24a84e8327cf99ee0372443805fa</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1007%2FBF02001573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02001573%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DR.%2BE.%26aulast%3DRemington%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520diagnosis%2520and%2520treatment%2520of%2520toxoplasmosis%26jtitle%3DEur.%2520J.%2520Clin.%2520Microbiol.%26date%3D1983%26volume%3D2%26spage%3D95%26epage%3D104%26doi%3D10.1007%2FBF02001573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Harari, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casoy, J.</span></span> <span> </span><span class="NLM_article-title">Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: A systematic review</span>. <i>Drugs R&amp;D</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1007/s40268-017-0206-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1007%2Fs40268-017-0206-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=28879584" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=523-544&issue=4&author=R.+R.+Ben-Harariauthor=E.+Goodwinauthor=J.+Casoy&title=Adverse+event+profile+of+pyrimethamine-based+therapy+in+toxoplasmosis%3A+A+systematic+review&doi=10.1007%2Fs40268-017-0206-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1007%2Fs40268-017-0206-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40268-017-0206-8%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Harari%26aufirst%3DR.%2BR.%26aulast%3DGoodwin%26aufirst%3DE.%26aulast%3DCasoy%26aufirst%3DJ.%26atitle%3DAdverse%2520event%2520profile%2520of%2520pyrimethamine-based%2520therapy%2520in%2520toxoplasmosis%253A%2520A%2520systematic%2520review%26jtitle%3DDrugs%2520R%2526amp%253BD%26date%3D2017%26volume%3D17%26issue%3D4%26spage%3D523%26epage%3D544%26doi%3D10.1007%2Fs40268-017-0206-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Frenal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubremetz, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebrun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldati-Favre, D.</span></span> <span> </span><span class="NLM_article-title">Gliding motility powers invasion and egress in Apicomplexa</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1038/nrmicro.2017.86</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fnrmicro.2017.86" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=28867819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVekur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=645-660&issue=11&author=K.+Frenalauthor=J.+F.+Dubremetzauthor=M.+Lebrunauthor=D.+Soldati-Favre&title=Gliding+motility+powers+invasion+and+egress+in+Apicomplexa&doi=10.1038%2Fnrmicro.2017.86"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Gliding motility powers invasion and egress in Apicomplexa</span></div><div class="casAuthors">Frenal, Karine; Dubremetz, Jean-Francois; Lebrun, Maryse; Soldati-Favre, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">645-660</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Protozoan parasites have developed elaborate motility systems that facilitate infection and dissemination.  For example, amoebae use actin-rich membrane extensions called pseudopodia, whereas Kinetoplastida are propelled by microtubule-contg. flagella.  By contrast, the motile and invasive stages of the Apicomplexa - a phylum that contains the important human pathogens Plasmodium falciparum (which causes malaria) and Toxoplasma gondii (which causes toxoplasmosis) - have a unique machinery called the glideosome, which is composed of an actomyosin system that underlies the plasma membrane.  The glideosome promotes substrate-dependent gliding motility, which powers migration across biol. barriers, as well as active host cell entry and egress from infected cells.  In this Review, we discuss the discovery of the principles that govern gliding motility, the characterization of the mol. machinery involved, and its impact on parasite invasion and egress from infected cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0EoYvUAhbgrVg90H21EOLACvtfcHk0ljHI2pkwmgZSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVekur3O&md5=e0381f39faa4b2e88a2a59173ff839e6</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro.2017.86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro.2017.86%26sid%3Dliteratum%253Aachs%26aulast%3DFrenal%26aufirst%3DK.%26aulast%3DDubremetz%26aufirst%3DJ.%2BF.%26aulast%3DLebrun%26aufirst%3DM.%26aulast%3DSoldati-Favre%26aufirst%3DD.%26atitle%3DGliding%2520motility%2520powers%2520invasion%2520and%2520egress%2520in%2520Apicomplexa%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2017%26volume%3D15%26issue%3D11%26spage%3D645%26epage%3D660%26doi%3D10.1038%2Fnrmicro.2017.86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">How apicomplexan parasites move in and out of cells</span>. <i>Curr. Opin. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">592</span>– <span class="NLM_lpage">598</span>, <span class="refDoi"> DOI: 10.1016/j.copbio.2010.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.copbio.2010.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=20580218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1OmsrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=592-598&author=L.+D.+Sibley&title=How+apicomplexan+parasites+move+in+and+out+of+cells&doi=10.1016%2Fj.copbio.2010.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">How apicomplexan parasites move in and out of cells</span></div><div class="casAuthors">Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">592-598</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Apicomplexan parasites utilize a unique form of gliding motility' to traverse across substrates, migrate through tissues, and invade into and finally egress from their vertebrate host cells.  Parasite gliding relies on the treadmilling of surface adhesins linked to short actin filaments that are translocated rearward by stationary small myosin motors.  New details reveal mechanistic insight into the coordinated release and processing of adhesins, the complexity of adhesin-substrate interactions, the regulation of the actin-myosin motor complex, and the formation of a novel junction at the host-parasite interface.  These activities are carefully orchestrated to provide an efficient process for motility that is essential for parasite survival.  The parasite-specific nature of many of these steps reveals several essential points that may be targeted for intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYtFm2_k1IUrVg90H21EOLACvtfcHk0ljHI2pkwmgZSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1OmsrnP&md5=f2b346d747b1de86a1e6f614ff668bfc</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2010.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2010.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DHow%2520apicomplexan%2520parasites%2520move%2520in%2520and%2520out%2520of%2520cells%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2010%26volume%3D21%26spage%3D592%26epage%3D598%26doi%3D10.1016%2Fj.copbio.2010.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lourido, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>465</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1038/nature09022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fnature09022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=20485436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1Oisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=359-362&author=S.+Louridoauthor=J.+Shumanauthor=C.+Zhangauthor=K.+M.+Shokatauthor=R.+Huiauthor=L.+D.+Sibley&title=Calcium-dependent+protein+kinase+1+is+an+essential+regulator+of+exocytosis+in+Toxoplasma&doi=10.1038%2Fnature09022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma</span></div><div class="casAuthors">Lourido, Sebastian; Shuman, Joel; Zhang, Chao; Shokat, Kevan M.; Hui, Raymond; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7296</span>),
    <span class="NLM_cas:pages">359-362</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calcium-regulated exocytosis is a ubiquitous process in eukaryotes, whereby secretory vesicles fuse with the plasma membrane and release their contents in response to an intracellular calcium surge.  This process regulates various cellular functions such as plasma membrane repair in plants and animals, the discharge of defensive spikes in Paramecium, and the secretion of insulin from pancreatic cells, immune modulators from lymphocytes, and chem. transmitters from neurons.  In animal cells, serine/threonine kinases including cAMP-dependent protein kinase, protein kinase C and calmodulin kinases have been implicated in calcium-signal transduction leading to regulated secretion.  Although plants and protozoa also regulate secretion by means of intracellular calcium, the method by which these signals are relayed has not been explained.  Here we show that the Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) is an essential regulator of calcium-dependent exocytosis in this opportunistic human pathogen.  Conditional suppression of TgCDPK1 revealed that it controls calcium-dependent secretion of specialized organelles called micronemes, resulting in a block of essential phenotypes including parasite motility, host-cell invasion, and egress.  These phenotypes were recapitulated by using a chem. biol. approach in which pyrazolopyrimidine-derived compds. specifically inhibited TgCDPK1 and disrupted the parasite's life cycle at stages dependent on microneme secretion.  Inhibition was specific to TgCDPK1, because expression of a resistant mutant kinase reversed sensitivity to the inhibitor.  TgCDPK1 is conserved among apicomplexans and belongs to a family of kinases shared with plants and ciliates, suggesting that related CDPKs may have a function in calcium-regulated secretion in other organisms.  Because this kinase family is absent from mammalian hosts, it represents a validated target that may be exploitable for chemotherapy against T. gondii and related apicomplexans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5sWOGpkZQn7Vg90H21EOLACvtfcHk0ljHI2pkwmgZSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1Oisr0%253D&md5=750f6bf5c933759605574d4a2ab5accc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature09022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09022%26sid%3Dliteratum%253Aachs%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DShuman%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DHui%26aufirst%3DR.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DCalcium-dependent%2520protein%2520kinase%25201%2520is%2520an%2520essential%2520regulator%2520of%2520exocytosis%2520in%2520Toxoplasma%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D359%26epage%3D362%26doi%3D10.1038%2Fnature09022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keyloun, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castaneda, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRocher, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inampudi, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakaki, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napuli, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, C.</span></span> <span> </span><span class="NLM_article-title"><i>Toxoplasma gondii</i> calcium-dependent protein kinase 1 is a target for selective kinase inhibitors</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1038/nsmb.1818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fnsmb.1818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=20436472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVyiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=602-607&author=K.+K.+Ojoauthor=E.+T.+Larsonauthor=K.+R.+Keylounauthor=L.+J.+Castanedaauthor=A.+E.+DeRocherauthor=K.+K.+Inampudiauthor=J.+E.+Kimauthor=T.+L.+Arakakiauthor=R.+C.+Murphyauthor=L.+Zhangauthor=A.+J.+Napuliauthor=D.+J.+Malyauthor=C.+L.+M.+J.+Verlindeauthor=F.+S.+Bucknerauthor=M.+Parsonsauthor=W.+G.+J.+Holauthor=E.+A.+Merrittauthor=C.+Van+Voorhis&title=Toxoplasma+gondii+calcium-dependent+protein+kinase+1+is+a+target+for+selective+kinase+inhibitors&doi=10.1038%2Fnsmb.1818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors</span></div><div class="casAuthors">Ojo, Kayode K.; Larson, Eric T.; Keyloun, Katelyn R.; Castaneda, Lisa J.; De Rocher, Amy E.; Inampudi, Krishna K.; Kim, Jessica E.; Arakaki, Tracy L.; Murphy, Ryan C.; Zhang, Li; Napuli, Alberto J.; Maly, Dustin J.; Verlinde, Christophe L. M. J.; Buckner, Frederick S.; Parsons, Marilyn; Hol, Wim G. J.; Merritt, Ethan A.; Van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">602-607</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">New drugs are needed to treat toxoplasmosis.  Toxoplasma gondii calcium-dependent protein kinases (TgCDPKs) are attractive targets because they are absent in mammals.  We show that TgCDPK1 is inhibited by low nanomolar levels of bumped kinase inhibitors (BKIs), compds. inactive against mammalian kinases.  Cocrystal structures of TgCDPK1 with BKIs confirm that the structural basis for selectivity is due to the unique glycine gatekeeper residue in the ATP-binding site.  We show that BKIs interfere with an early step in T. gondii infection of human cells in culture.  Furthermore, we show that TgCDPK1 is the in vivo target of BKIs because T. gondii expressing a glycine to methionine gatekeeper mutant enzyme show significantly decreased sensitivity to BKIs.  Thus, design of selective TgCDPK1 inhibitors with low host toxicity may be achievable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiGhHqXpYi-7Vg90H21EOLACvtfcHk0lgY0Mp3KAOfnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVyiurk%253D&md5=f1630eba0dd5dec19e8a095c041996b1</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1818%26sid%3Dliteratum%253Aachs%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DKeyloun%26aufirst%3DK.%2BR.%26aulast%3DCastaneda%26aufirst%3DL.%2BJ.%26aulast%3DDeRocher%26aufirst%3DA.%2BE.%26aulast%3DInampudi%26aufirst%3DK.%2BK.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DArakaki%26aufirst%3DT.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNapuli%26aufirst%3DA.%2BJ.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%2BM.%2BJ.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DVan%2BVoorhis%26aufirst%3DC.%26atitle%3DToxoplasma%2520gondii%2520calcium-dependent%2520protein%2520kinase%25201%2520is%2520a%2520target%2520for%2520selective%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D602%26epage%3D607%26doi%3D10.1038%2Fnsmb.1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wernimont, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finerty, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allali-Hassani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senisterra, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempel, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lourido, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, R.</span></span> <span> </span><span class="NLM_article-title">Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.1038/nsmb.1795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fnsmb.1795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=20436473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVyhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=596-601&author=A.+K.+Wernimontauthor=J.+D.+Artzauthor=P.+Finertyauthor=Y.+Linauthor=M.+Amaniauthor=A.+Allali-Hassaniauthor=G.+Senisterraauthor=M.+Vedadiauthor=W.+Tempelauthor=F.+Mackenzieauthor=I.+Chauauthor=S.+Louridoauthor=L.+D.+Sibleyauthor=R.+Hui&title=Structures+of+apicomplexan+calcium-dependent+protein+kinases+reveal+mechanism+of+activation+by+calcium&doi=10.1038%2Fnsmb.1795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium</span></div><div class="casAuthors">Wernimont, Amy K.; Artz, Jennifer D.; Finerty, Patrick, Jr.; Lin, Yu-Hui; Amani, Mehrnaz; Allali-Hassani, Abdellah; Senisterra, Guillermo; Vedadi, Masoud; Tempel, Wolfram; MacKenzie, Farrell; Chau, Irene; Lourido, Sebastian; Sibley, L. David; Hui, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calcium-dependent protein kinases (CDPKs) have pivotal roles in the calcium-signaling pathway in plants, ciliates and apicomplexan parasites and comprise a calmodulin-dependent kinase (CaMK)-like kinase domain regulated by a calcium-binding domain in the C terminus.  To understand this intramol. mechanism of activation, we solved the structures of the autoinhibited (apo) and activated (calcium-bound) conformations of CDPKs from the apicomplexan parasites Toxoplasma gondii and Cryptosporidium parvum.  In the apo form, the C-terminal CDPK activation domain (CAD) resembles a calmodulin protein with an unexpected long helix in the N terminus that inhibits the kinase domain in the same manner as CaMKII.  Calcium binding triggers the reorganization of the CAD into a highly intricate fold, leading to its relocation around the base of the kinase domain to a site remote from the substrate binding site.  This large conformational change constitutes a distinct mechanism in calcium signal-transduction pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPNbf5csvAT7Vg90H21EOLACvtfcHk0lgY0Mp3KAOfnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVyhsr0%253D&md5=7e34915b35107e30227a6a786f397da7</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1795%26sid%3Dliteratum%253Aachs%26aulast%3DWernimont%26aufirst%3DA.%2BK.%26aulast%3DArtz%26aufirst%3DJ.%2BD.%26aulast%3DFinerty%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DAmani%26aufirst%3DM.%26aulast%3DAllali-Hassani%26aufirst%3DA.%26aulast%3DSenisterra%26aufirst%3DG.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DTempel%26aufirst%3DW.%26aulast%3DMackenzie%26aufirst%3DF.%26aulast%3DChau%26aufirst%3DI.%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26aulast%3DHui%26aufirst%3DR.%26atitle%3DStructures%2520of%2520apicomplexan%2520calcium-dependent%2520protein%2520kinases%2520reveal%2520mechanism%2520of%2520activation%2520by%2520calcium%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D596%26epage%3D601%26doi%3D10.1038%2Fnsmb.1795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubersax, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petsch, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matheos, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blethrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">A chemical switch for inhibitor-sensitive alleles of any protein kinase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>407</i></span> (<span class="NLM_issue">6802</span>),  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1038/35030148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2F35030148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=11014197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntF2ntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=395-401&issue=6802&author=A.+C.+Bishopauthor=J.+A.+Ubersaxauthor=D.+T.+Petschauthor=D.+P.+Matheosauthor=N.+S.+Grayauthor=J.+Blethrowauthor=E.+Shimizuauthor=J.+Z.+Tsienauthor=P.+G.+Schultzauthor=M.+D.+Roseauthor=J.+L.+Woodauthor=D.+O.+Morganauthor=K.+M.+Shokat&title=A+chemical+switch+for+inhibitor-sensitive+alleles+of+any+protein+kinase&doi=10.1038%2F35030148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical switch for inhibitor-sensitive alleles of any protein kinase</span></div><div class="casAuthors">Bishop, Anthony C.; Ubersax, Jeffrey A.; Petsch, Dejah T.; Matheos, Dina P.; Gray, Nathanael S.; Blethrow, Justin; Shimizu, Eiji; Tsien, Joe Z.; Schultz, Peter G.; Rose, Mark D.; Wood, John L.; Morgan, David O.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6802</span>),
    <span class="NLM_cas:pages">395-401</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein kinases have proved to be largely resistant to the design of highly specific inhibitors, even with the aid of combinatorial chem.  The lack of these reagents has complicated efforts to assign specific signaling roles to individual kinases.  Here we describe a chem. genetic strategy for sensitizing protein kinases to cell-permeable mols. that do not inhibit wild-type kinases.  From two inhibitor scaffolds, we have identified potent and selective inhibitors for sensitized kinases from five distinct subfamilies.  Tyrosine and serine/threonine kinases are equally amenable to this approach.  We have analyzed a budding yeast strain carrying an inhibitor-sensitive form of the cyclin-dependent kinase Cdc28 (CDK1) in place of the wild-type protein.  Specific inhibition of Cdc28 in vivo caused a pre-mitotic cell-cycle arrest that is distinct from the G1 arrest typically obsd. in temp.-sensitive cdc28 mutants.  The mutation that confers inhibitor-sensitivity is easily identifiable from primary sequence alignments.  Thus, this approach can be used to systematically generate conditional alleles of protein kinases, allowing for rapid functional characterization of members of this important gene family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqipYQXO52a6rVg90H21EOLACvtfcHk0lgY0Mp3KAOfnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntF2ntL4%253D&md5=736782d1116a86dfc0dd6ab9a9aeec0a</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1038%2F35030148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35030148%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DA.%2BC.%26aulast%3DUbersax%26aufirst%3DJ.%2BA.%26aulast%3DPetsch%26aufirst%3DD.%2BT.%26aulast%3DMatheos%26aufirst%3DD.%2BP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DBlethrow%26aufirst%3DJ.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DTsien%26aufirst%3DJ.%2BZ.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DRose%26aufirst%3DM.%2BD.%26aulast%3DWood%26aufirst%3DJ.%2BL.%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520chemical%2520switch%2520for%2520inhibitor-sensitive%2520alleles%2520of%2520any%2520protein%2520kinase%26jtitle%3DNature%26date%3D2000%26volume%3D407%26issue%3D6802%26spage%3D395%26epage%3D401%26doi%3D10.1038%2F35030148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Acquisition of inhibitor-sensitive protein kinases through protein design</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1016/S0163-7258(98)00060-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2FS0163-7258%2898%2900060-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10454210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=337-346&issue=2%E2%80%933&author=A.+C.+Bishopauthor=K.+M.+Shokat&title=Acquisition+of+inhibitor-sensitive+protein+kinases+through+protein+design&doi=10.1016%2FS0163-7258%2898%2900060-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Acquisition of inhibitor-sensitive protein kinases through protein design</span></div><div class="casAuthors">Bishop, Anthony C.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">337-346</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with many refs.  Protein phosphorylation is the major post-translational modification used by eukaryotic cells to control cellular signaling.  Protein kinases have emerged as attractive drug targets because heightened protein kinase activity has been assocd. with several proliferative diseases, most notably cancer and restenosis.  Until now, it has been very difficult to confirm the utility of protein kinases as inhibitor targets because very few small mols. that selectively inhibit one particular kinase are known.  Discovery of highly specific kinase inhibitors has been slow because the protein family contains approx. 2000 members, all of which share a conserved active site fold.  Recent work in several labs. has sought to circumvent the problem of kinase structural degeneracy by engineering drug sensitivity into Src family tyrosine kinases and mitogen-activated protein kinases through site-directed mutagenesis.  By introducing a unique non-naturally occurring amino acid into a conserved region of the enzyme's binding site, a target protein kinase can be rapidly sensitized to a small mol.  Introduction of the engineered kinase into a cell line or animal model should greatly expedite the investigation of protein kinase inhibition as a viable drug treatment.  The purpose of this review is to summarize these recent advances in protein kinase drug sensitization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHyUn8jWhYxrVg90H21EOLACvtfcHk0lhL4P6l1l6v6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOhtb8%253D&md5=2b7a3a56e3cf5645d361c61d05224733</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900060-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900060-6%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DA.%2BC.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DAcquisition%2520of%2520inhibitor-sensitive%2520protein%2520kinases%2520through%2520protein%2520design%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D82%26issue%3D2%25E2%2580%25933%26spage%3D337%26epage%3D346%26doi%3D10.1016%2FS0163-7258%2898%2900060-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span> <span> </span><span class="NLM_article-title">Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2803</span>– <span class="NLM_lpage">2810</span>, <span class="refDoi"> DOI: 10.1021/jm201725v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201725v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2803-2810&issue=6&author=E.+T.+Larsonauthor=K.+K.+Ojoauthor=R.+C.+Murphyauthor=S.+M.+Johnsonauthor=Z.+Zhangauthor=J.+E.+Kimauthor=D.+J.+Leiblyauthor=A.+M.+Foxauthor=M.+C.+Reidauthor=E.+J.+Daleauthor=B.+G.+Pereraauthor=J.+Kimauthor=S.+N.+Hewittauthor=W.+G.+Holauthor=C.+L.+Verlindeauthor=E.+Fanauthor=W.+C.+Van+Voorhisauthor=D.+J.+Malyauthor=E.+A.+Merritt&title=Multiple+determinants+for+selective+inhibition+of+apicomplexan+calcium-dependent+protein+kinase+CDPK1&doi=10.1021%2Fjm201725v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Determinants for Selective Inhibition of Apicomplexan Calcium-Dependent Protein Kinase CDPK1</span></div><div class="casAuthors">Larson, Eric T.; Ojo, Kayode K.; Murphy, Ryan C.; Johnson, Steven M.; Zhang, Zhongsheng; Kim, Jessica E.; Leibly, David J.; Fox, Anna M. W.; Reid, Molly C.; Dale, Edward J.; Perera, B. Gayani K.; Kim, Jae; Hewitt, Stephen N.; Hol, Wim G. J.; Verlinde, Christophe L. M. J.; Fan, Erkang; Van Voorhis, Wesley C.; Maly, Dustin J.; Merritt, Ethan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2803-2810</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Diseases caused by the apicomplexan protozoans Toxoplasma gondii and Cryptosporidium parvum are a major health concern.  The life cycle of these parasites is regulated by a family of calcium-dependent protein kinases (CDPKs) that have no direct homologs in the human host.  Fortuitously, CDPK1 from both parasites contains a rare glycine gatekeeper residue adjacent to the ATP-binding pocket.  This has allowed creation of a series of C3-substituted pyrazolopyrimidine compds. that are potent inhibitors selective for CDPK1 over a panel of human kinases.  Here we demonstrate that selectivity is further enhanced by modification of the scaffold at the C1 position.  The explanation for this unexpected result is provided by crystal structures of the inhibitors bound to CDPK1 and the human kinase c-SRC.  Furthermore, the insight gained from these studies was applied to transform an alternative ATP-competitive scaffold lacking potency and selectivity for CDPK1 into a low nanomolar inhibitor of this enzyme with no activity against SRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxAUMMe3qUybVg90H21EOLACvtfcHk0lhL4P6l1l6v6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOgsLo%253D&md5=c8aae3a6d1811aaa2d1316eb98fa8251</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1021%2Fjm201725v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201725v%26sid%3Dliteratum%253Aachs%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DJohnson%26aufirst%3DS.%2BM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DLeibly%26aufirst%3DD.%2BJ.%26aulast%3DFox%26aufirst%3DA.%2BM.%26aulast%3DReid%26aufirst%3DM.%2BC.%26aulast%3DDale%26aufirst%3DE.%2BJ.%26aulast%3DPerera%26aufirst%3DB.%2BG.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHewitt%26aufirst%3DS.%2BN.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26atitle%3DMultiple%2520determinants%2520for%2520selective%2520inhibition%2520of%2520apicomplexan%2520calcium-dependent%2520protein%2520kinase%2520CDPK1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D6%26spage%3D2803%26epage%3D2810%26doi%3D10.1021%2Fjm201725v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellanos-Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keyloun, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhandari, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of calcium-dependent protein kinase 1 (CDPK1) from <i>C. parvum</i> and <i>T. gondii</i></span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1021/ml100096t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100096t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVWitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=331-335&issue=7&author=R.+C.+Murphyauthor=K.+K.+Ojoauthor=E.+T.+Larsonauthor=A.+Castellanos-Gonzalezauthor=B.+G.+Pereraauthor=K.+R.+Keylounauthor=J.+E.+Kimauthor=J.+G.+Bhandariauthor=N.+R.+Mullerauthor=C.+L.+Verlindeauthor=A.+C.+Whiteauthor=E.+A.+Merrittauthor=W.+C.+Van+Voorhisauthor=D.+J.+Maly&title=Discovery+of+potent+and+selective+inhibitors+of+calcium-dependent+protein+kinase+1+%28CDPK1%29+from+C.+parvum+and+T.+gondii&doi=10.1021%2Fml100096t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii</span></div><div class="casAuthors">Murphy, Ryan C.; Ojo, Kayode K.; Larson, Eric T.; Castellanos-Gonzalez, Alejandro; Perera, B. Gayani K.; Keyloun, Katelyn R.; Kim, Jessica E.; Bhandari, Janhavi G.; Muller, Natascha R.; Verlinde, Christophe L. M. J.; White, A. Clinton, Jr.; Merritt, Ethan A.; Van Voorhis, Wesley C.; Maly, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">331-335</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protozoans Cryptosporidium parvum and Toxoplasma gondii are parasites of major health concern to humans.  Both parasites contain a group of calcium-dependent protein kinases (CDPKs) which are found in plants and ciliates but not in humans or fungi.  Here, we describe a series of potent inhibitors that target CDPK1 in C. parvum (CpCDPK1) and T. gondii (TgCDPK1).  These inhibitors are highly selective for CpCDPK1 and TgCDPK1 over the mammalian kinases SRC and ABL.  Furthermore, they are able to block an early stage of C. parvum invasion of HCT-8 host cells, which is similar to their effects on T. gondii invasion of human fibroblasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotf_PwbMLWELVg90H21EOLACvtfcHk0ljtnaCOunC5pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVWitbw%253D&md5=cace2277e9057a4895456006a12fb312</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fml100096t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100096t%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DCastellanos-Gonzalez%26aufirst%3DA.%26aulast%3DPerera%26aufirst%3DB.%2BG.%26aulast%3DKeyloun%26aufirst%3DK.%2BR.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DBhandari%26aufirst%3DJ.%2BG.%26aulast%3DMuller%26aufirst%3DN.%2BR.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DWhite%26aufirst%3DA.%2BC.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520calcium-dependent%2520protein%2520kinase%25201%2520%2528CDPK1%2529%2520from%2520C.%2520parvum%2520and%2520T.%2520gondii%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26issue%3D7%26spage%3D331%26epage%3D335%26doi%3D10.1021%2Fml100096t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lourido, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by <i>Toxoplasma gondii</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3068</span>– <span class="NLM_lpage">3077</span>, <span class="refDoi"> DOI: 10.1021/jm4001314</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001314" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslSgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3068-3077&author=S.+Louridoauthor=C.+Zhangauthor=M.+S.+Lopezauthor=K.+Tangauthor=J.+Barksauthor=Q.+Wangauthor=S.+A.+Wildmanauthor=K.+M.+Shokatauthor=L.+D.+Sibley&title=Optimizing+small+molecule+inhibitors+of+calcium-dependent+protein+kinase+1+to+prevent+infection+by+Toxoplasma+gondii&doi=10.1021%2Fjm4001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Small Molecule Inhibitors of Calcium-Dependent Protein Kinase 1 to Prevent Infection by Toxoplasma gondii</span></div><div class="casAuthors">Lourido, Sebastian; Zhang, Chao; Lopez, Michael S.; Tang, Keliang; Barks, Jennifer; Wang, Qiuling; Wildman, Scott A.; Shokat, Kevan M.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3068-3077</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toxoplasma gondii is sensitive to bulky pyrazolo [3,4-d] pyrimidine (PP) inhibitors due to the presence of a Gly gatekeeper in the essential calcium dependent protein kinase 1 (CDPK1).  Here we synthesized a no. of new derivs. of 3-methyl-benzyl-PP (3-MB-PP, or 1).  The potency of PP analogs in inhibiting CDPK1 enzyme activity in vitro (low nM IC50 values) and blocking parasite growth in host cell monolayers in vivo (low μM EC50 values) were highly correlated and occurred in a CDPK1-specific manner.  Chem. modification of the PP scaffold to increase half-life in the presence of microsomes in vitro led to identification of compds. with enhanced stability while retaining activity.  Several of these more potent compds. were able to prevent lethal infection with T. gondii in the mouse model.  Collectively, the strategies outlined here provide a route for development of more effective compds. for treatment of toxoplasmosis and perhaps related parasitic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBcv37M-6fobVg90H21EOLACvtfcHk0ljtnaCOunC5pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslSgt78%253D&md5=352bb9e5b5304656aab52da763202b68</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1021%2Fjm4001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001314%26sid%3Dliteratum%253Aachs%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DTang%26aufirst%3DK.%26aulast%3DBarks%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DOptimizing%2520small%2520molecule%2520inhibitors%2520of%2520calcium-dependent%2520protein%2520kinase%25201%2520to%2520prevent%2520infection%2520by%2520Toxoplasma%2520gondii%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3068%26epage%3D3077%26doi%3D10.1021%2Fjm4001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vidadala, R. S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulverson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCloskey, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitman, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, S. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span> <span> </span><span class="NLM_article-title">7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-based inhibitors of calcium-dependent protein kinase 1 have distinct inhibitory and oral pharmacokinetic characteristics compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-based inhibitors</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.7b00224</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00224" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFWgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=516-522&issue=4&author=R.+S.+R.+Vidadalaauthor=M.+Golkowskiauthor=M.+A.+Hulversonauthor=R.+Choiauthor=M.+C.+McCloskeyauthor=G.+R.+Whitmanauthor=W.+Huangauthor=S.+L.+M.+Arnoldauthor=L.+K.+Barrettauthor=E.+Fanauthor=E.+A.+Merrittauthor=W.+C.+Van+Voorhisauthor=K.+K.+Ojoauthor=D.+J.+Maly&title=7+H-Pyrrolo%5B2%2C3-+d%5Dpyrimidin-4-amine-based+inhibitors+of+calcium-dependent+protein+kinase+1+have+distinct+inhibitory+and+oral+pharmacokinetic+characteristics+compared+with+1+H-Pyrazolo%5B3%2C4-+d%5Dpyrimidin-4-amine-based+inhibitors&doi=10.1021%2Facsinfecdis.7b00224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">7H-Pyrrolo[2,3-d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1H-Pyrazolo[3,4-d]pyrimidin-4-amine-Based Inhibitors</span></div><div class="casAuthors">Vidadala, Rama S. R.; Golkowski, Martin; Hulverson, Matthew A.; Choi, Ryan; McCloskey, Molly C.; Whitman, Grant R.; Huang, Wenlin; Arnold, Samuel L. M.; Barrett, Lynn K.; Fan, Erkang; Merritt, Ethan A.; Van Voorhis, Wesley C.; Ojo, Kayode K.; Maly, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">516-522</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibitors of Cryptosporidium calcium-dependent protein kinase 1 (CpCDPK1) based on the 1H-pyrazolo[3,4-d]pyrimidin-4-amine (pyrazolopyrimidine, PP) scaffold are effective in both in vitro and in vivo models of cryptosporidiosis.  However, the search for distinct safety and pharmacokinetic (PK) properties has motivated the exploration of alternative scaffolds.  Here, the authors describe a series of 7H-pyrrolo[2,3-d]pyrimidin-4-amine (pyrrolopyrimidine, PrP)-based analogs of PP CpCDPK1 inhibitors.  Most of the PrP-based inhibitors described potently inhibit the CpCDPK1 enzyme, demonstrate no toxicity against mammalian cells, and block proliferation of the C. parvum parasite in the low micromolar range.  Interestingly, certain substituents that show reduced CpCDPK1 potency when displayed from a PP scaffold provided notably enhanced efficacy in the context of a PrP scaffold.  PK studies on these paired compds. show that some PrP analogs have distinct physiochem. properties compared with their PP counterparts.  These results demonstrate that inhibitors based on a PrP scaffold are distinct therapeutic alternatives to previously developed PP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS1Vv28yqKuLVg90H21EOLACvtfcHk0ljB-_taYUp_Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFWgsLo%253D&md5=ddd10343bf7e8144694b4df10325dbcf</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00224%26sid%3Dliteratum%253Aachs%26aulast%3DVidadala%26aufirst%3DR.%2BS.%2BR.%26aulast%3DGolkowski%26aufirst%3DM.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DChoi%26aufirst%3DR.%26aulast%3DMcCloskey%26aufirst%3DM.%2BC.%26aulast%3DWhitman%26aufirst%3DG.%2BR.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DArnold%26aufirst%3DS.%2BL.%2BM.%26aulast%3DBarrett%26aufirst%3DL.%2BK.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3D7%2520H-Pyrrolo%255B2%252C3-%2520d%255Dpyrimidin-4-amine-based%2520inhibitors%2520of%2520calcium-dependent%2520protein%2520kinase%25201%2520have%2520distinct%2520inhibitory%2520and%2520oral%2520pharmacokinetic%2520characteristics%2520compared%2520with%25201%2520H-Pyrazolo%255B3%252C4-%2520d%255Dpyrimidin-4-amine-based%2520inhibitors%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26issue%3D4%26spage%3D516%26epage%3D522%26doi%3D10.1021%2Facsinfecdis.7b00224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vidadala, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulverson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambriski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruzual, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRocher, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddaramaiah, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freiberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isoherranen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doggett, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span> <span> </span><span class="NLM_article-title">Development of an orally available and central nervous system (CNS) penetrant <i>Toxoplasma gondii</i> calcium-dependent protein kinase 1 (TgCDPK1) inhibitor with minimal human ether-a-go-go-related gene (hERG) activity for the treatment of toxoplasmosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6531</span>– <span class="NLM_lpage">6546</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00760</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSrsr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6531-6546&issue=13&author=R.+S.+Vidadalaauthor=K.+L.+Rivasauthor=K.+K.+Ojoauthor=M.+A.+Hulversonauthor=J.+A.+Zambriskiauthor=I.+Bruzualauthor=T.+L.+Schultzauthor=W.+Huangauthor=Z.+Zhangauthor=S.+Scheeleauthor=A.+E.+DeRocherauthor=R.+Choiauthor=L.+K.+Barrettauthor=L.+K.+Siddaramaiahauthor=W.+G.+Holauthor=E.+Fanauthor=E.+A.+Merrittauthor=M.+Parsonsauthor=G.+Freibergauthor=K.+Marshauthor=D.+J.+Kempfauthor=V.+B.+Carruthersauthor=N.+Isoherranenauthor=J.+S.+Doggettauthor=W.+C.+Van+Voorhisauthor=D.+J.+Maly&title=Development+of+an+orally+available+and+central+nervous+system+%28CNS%29+penetrant+Toxoplasma+gondii+calcium-dependent+protein+kinase+1+%28TgCDPK1%29+inhibitor+with+minimal+human+ether-a-go-go-related+gene+%28hERG%29+activity+for+the+treatment+of+toxoplasmosis&doi=10.1021%2Facs.jmedchem.6b00760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis</span></div><div class="casAuthors">Vidadala, Rama Subba Rao; Rivas, Kasey L.; Ojo, Kayode K.; Hulverson, Matthew A.; Zambriski, Jennifer A.; Bruzual, Igor; Schultz, Tracey L.; Huang, Wenlin; Zhang, Zhongsheng; Scheele, Suzanne; DeRocher, Amy E.; Choi, Ryan; Barrett, Lynn K.; Siddaramaiah, Latha Kallur; Hol, Wim G. J.; Fan, Erkang; Merritt, Ethan A.; Parsons, Marilyn; Freiberg, Gail; Marsh, Kennan; Kempf, Dale J.; Carruthers, Vern B.; Isoherranen, Nina; Doggett, J. Stone; Van Voorhis, Wesley C.; Maly, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6531-6546</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New therapies are needed for the treatment of toxoplasmosis, which is a disease caused by the protozoan parasite Toxoplasma gondii.  To this end, we previously developed a potent and selective inhibitor (compd. 1) of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) that possesses antitoxoplasmosis activity in vitro and in vivo.  Unfortunately, 1 has potent human ether-a-go-go-related gene (hERG) inhibitory activity, assocd. with long Q-T syndrome, and consequently presents a cardiotoxicity risk.  Here, we describe the identification of an optimized TgCDPK1 inhibitor 32, which does not have a hERG liability and possesses a favorable pharmacokinetic profile in small and large animals. 32(I) is CNS-penetrant and highly effective in acute and latent mouse models of T. gondii infection, significantly reducing the amt. of parasite in the brain, spleen, and peritoneal fluid and reducing brain cysts by >85%.  These properties make 32 a promising lead for the development of a new antitoxoplasmosis therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps5haum1lCNbVg90H21EOLACvtfcHk0ljB-_taYUp_Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSrsr%252FM&md5=8eb12f3703985ad69b921f1495858081</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00760%26sid%3Dliteratum%253Aachs%26aulast%3DVidadala%26aufirst%3DR.%2BS.%26aulast%3DRivas%26aufirst%3DK.%2BL.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DZambriski%26aufirst%3DJ.%2BA.%26aulast%3DBruzual%26aufirst%3DI.%26aulast%3DSchultz%26aufirst%3DT.%2BL.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DScheele%26aufirst%3DS.%26aulast%3DDeRocher%26aufirst%3DA.%2BE.%26aulast%3DChoi%26aufirst%3DR.%26aulast%3DBarrett%26aufirst%3DL.%2BK.%26aulast%3DSiddaramaiah%26aufirst%3DL.%2BK.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DFreiberg%26aufirst%3DG.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DCarruthers%26aufirst%3DV.%2BB.%26aulast%3DIsoherranen%26aufirst%3DN.%26aulast%3DDoggett%26aufirst%3DJ.%2BS.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3DDevelopment%2520of%2520an%2520orally%2520available%2520and%2520central%2520nervous%2520system%2520%2528CNS%2529%2520penetrant%2520Toxoplasma%2520gondii%2520calcium-dependent%2520protein%2520kinase%25201%2520%2528TgCDPK1%2529%2520inhibitor%2520with%2520minimal%2520human%2520ether-a-go-go-related%2520gene%2520%2528hERG%2529%2520activity%2520for%2520the%2520treatment%2520of%2520toxoplasmosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D13%26spage%3D6531%26epage%3D6546%26doi%3D10.1021%2Facs.jmedchem.6b00760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRocher, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span> <span> </span><span class="NLM_article-title">Development of <i>Toxoplasma gondii</i> calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2416</span>– <span class="NLM_lpage">2426</span>, <span class="refDoi"> DOI: 10.1021/jm201713h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201713h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVeksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2416-2426&issue=5&author=S.+M.+Johnsonauthor=R.+C.+Murphyauthor=J.+A.+Geigerauthor=A.+E.+DeRocherauthor=Z.+Zhangauthor=K.+K.+Ojoauthor=E.+T.+Larsonauthor=B.+G.+Pereraauthor=E.+J.+Daleauthor=P.+Heauthor=M.+C.+Reidauthor=A.+M.+Foxauthor=N.+R.+Muellerauthor=E.+A.+Merrittauthor=E.+Fanauthor=M.+Parsonsauthor=W.+C.+Van+Voorhisauthor=D.+J.+Maly&title=Development+of+Toxoplasma+gondii+calcium-dependent+protein+kinase+1+%28TgCDPK1%29+inhibitors+with+potent+anti-toxoplasma+activity&doi=10.1021%2Fjm201713h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitors with Potent Anti-Toxoplasma Activity</span></div><div class="casAuthors">Johnson, Steven M.; Murphy, Ryan C.; Geiger, Jennifer A.; DeRocher, Amy E.; Zhang, Zhongsheng; Ojo, Kayode K.; Larson, Eric T.; Perera, B. Gayani K.; Dale, Edward J.; He, Panqing; Reid, Molly C.; Fox, Anna M. W.; Mueller, Natascha R.; Merritt, Ethan A.; Fan, Erkang; Parsons, Marilyn; Van Voorhis, Wesley C.; Maly, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2416-2426</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toxoplasmosis is a disease of prominent health concern that is caused by the protozoan parasite Toxoplasma gondii.  Proliferation of T. gondii is dependent on its ability to invade host cells, which is mediated in part by calcium-dependent protein kinase 1 (CDPK1).  We have developed ATP competitive inhibitors of TgCDPK1 that block invasion of parasites into host cells, preventing their proliferation.  The presence of a unique glycine gatekeeper residue in TgCDPK1 permits selective inhibition of the parasite enzyme over human kinases.  These potent TgCDPK1 inhibitors do not inhibit the growth of human cell lines and represent promising candidates as toxoplasmosis therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxuYszPit90rVg90H21EOLACvtfcHk0lgkOvp1JcFa9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVeksb8%253D&md5=862ac0e5066f60d7eeaccc723c2c4e75</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fjm201713h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201713h%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BM.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DGeiger%26aufirst%3DJ.%2BA.%26aulast%3DDeRocher%26aufirst%3DA.%2BE.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DPerera%26aufirst%3DB.%2BG.%26aulast%3DDale%26aufirst%3DE.%2BJ.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DReid%26aufirst%3DM.%2BC.%26aulast%3DFox%26aufirst%3DA.%2BM.%26aulast%3DMueller%26aufirst%3DN.%2BR.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3DDevelopment%2520of%2520Toxoplasma%2520gondii%2520calcium-dependent%2520protein%2520kinase%25201%2520%2528TgCDPK1%2529%2520inhibitors%2520with%2520potent%2520anti-toxoplasma%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D5%26spage%3D2416%26epage%3D2426%26doi%3D10.1021%2Fjm201713h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Bakkouri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">452</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2015.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.tips.2015.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=26002073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVWitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=452-460&issue=7&author=R.+Huiauthor=M.+El+Bakkouriauthor=L.+D.+Sibley&title=Designing+selective+inhibitors+for+calcium-dependent+protein+kinases+in+apicomplexans&doi=10.1016%2Fj.tips.2015.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans</span></div><div class="casAuthors">Hui, Raymond; El Bakkouri, Majida; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">452-460</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Apicomplexan parasites cause some of the most severe human diseases, including malaria (caused by Plasmodium), toxoplasmosis, and cryptosporidiosis.  Treatments are limited by the lack of effective drugs and development of resistance to available agents.  By exploiting novel features of protein kinases in these parasites, it may be possible to develop new treatments.  We summarize here recent advances in identifying small mol. inhibitors against a novel family of plant-like, calcium-dependent kinases that are uniquely expanded in apicomplexan parasites.  Anal. of the 3D structure, activation mechanism, and sensitivity to small mols. had identified several attractive chem. scaffolds that are potent and selective inhibitors of these parasite kinases.  Further optimization of these leads may yield promising new drugs for treatment of these parasitic infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-4M4FEBeFQrVg90H21EOLACvtfcHk0lgkOvp1JcFa9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVWitLk%253D&md5=0081edfce5d381c6a34c396b011c24b8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DR.%26aulast%3DEl%2BBakkouri%26aufirst%3DM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DDesigning%2520selective%2520inhibitors%2520for%2520calcium-dependent%2520protein%2520kinases%2520in%2520apicomplexans%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26issue%3D7%26spage%3D452%26epage%3D460%26doi%3D10.1016%2Fj.tips.2015.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doggett, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulverson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, S. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggs, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemphill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mealey, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A. O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span> <span> </span><span class="NLM_article-title">Extended-spectrum antiprotozoal bumped kinase inhibitors: A review</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2017.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.exppara.2017.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=28065755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2017&pages=71-83&author=W.+C.+Van%0AVoorhisauthor=J.+S.+Doggettauthor=M.+Parsonsauthor=M.+A.+Hulversonauthor=R.+Choiauthor=S.+L.+M.+Arnoldauthor=M.+W.+Riggsauthor=A.+Hemphillauthor=D.+K.+Howeauthor=R.+H.+Mealeyauthor=A.+O.+T.+Lauauthor=E.+A.+Merrittauthor=D.+J.+Malyauthor=E.+Fanauthor=K.+K.+Ojo&title=Extended-spectrum+antiprotozoal+bumped+kinase+inhibitors%3A+A+review&doi=10.1016%2Fj.exppara.2017.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-spectrum antiprotozoal bumped kinase inhibitors: A review</span></div><div class="casAuthors">Van Voorhis, Wesley C.; Doggett, J. Stone; Parsons, Marilyn; Hulverson, Matthew A.; Choi, Ryan; Arnold, Samuel; Riggs, Michael W.; Hemphill, Andrew; Howe, Daniel K.; Mealey, Robert H.; Lau, Audrey O. T.; Merritt, Ethan A.; Maly, Dustin J.; Fan, Erkang; Ojo, Kayode K.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71-83</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Many life-cycle processes in parasites are regulated by protein phosphorylation.  Hence, disruption of essential protein kinase function has been explored for therapy of parasitic diseases.  However, the difficulty of inhibiting parasite protein kinases to the exclusion of host orthologues poses a practical challenge.  A possible path around this difficulty is the use of bumped kinase inhibitors for targeting calcium dependent protein kinases that contain atypically small gatekeeper residues and are crucial for pathogenic apicomplexan parasites' survival and proliferation.  In this review, we review efficacy against the kinase target, the parasite growth in vitro, and in animal infection models, as well as the relevant pharmacokinetic and safety parameters of bumped-kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryqXFGOQxay7Vg90H21EOLACvtfcHk0lgkOvp1JcFa9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KhsLw%253D&md5=cb59a64078058058bacae1e4f9948303</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2017.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2017.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DDoggett%26aufirst%3DJ.%2BS.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DChoi%26aufirst%3DR.%26aulast%3DArnold%26aufirst%3DS.%2BL.%2BM.%26aulast%3DRiggs%26aufirst%3DM.%2BW.%26aulast%3DHemphill%26aufirst%3DA.%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DMealey%26aufirst%3DR.%2BH.%26aulast%3DLau%26aufirst%3DA.%2BO.%2BT.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26atitle%3DExtended-spectrum%2520antiprotozoal%2520bumped%2520kinase%2520inhibitors%253A%2520A%2520review%26jtitle%3DExp.%2520Parasitol.%26date%3D2017%26volume%3D180%26spage%3D71%26epage%3D83%26doi%3D10.1016%2Fj.exppara.2017.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doggett, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span> <span> </span><span class="NLM_article-title">Bumped kinase inhibitor 1294 treats established <i>Toxoplasma gondii</i> infection</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3547</span>– <span class="NLM_lpage">3549</span>, <span class="refDoi"> DOI: 10.1128/AAC.01823-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FAAC.01823-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=24687502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADC%252BC2crptV2ktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=3547-3549&issue=6&author=J.+S.+Doggettauthor=K.+K.+Ojoauthor=E.+Fanauthor=D.+J.+Malyauthor=W.+C.+Van+Voorhis&title=Bumped+kinase+inhibitor+1294+treats+established+Toxoplasma+gondii+infection&doi=10.1128%2FAAC.01823-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection</span></div><div class="casAuthors">Doggett J Stone; Ojo Kayode K; Van Voorhis Wesley C; Fan Erkang; Maly Dustin J</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial agents and chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3547-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Toxoplasma gondii is a unicellular parasite that causes severe brain and eye disease.  Current drugs for T. gondii are limited by toxicity.  Bumped kinase inhibitors (BKIs) selectively inhibit calcium-dependent protein kinases of the apicomplexan pathogens T. gondii, cryptosporidia, and plasmodia.  A lead anti-Toxoplasma BKI, 1294, has been developed to be metabolically stable and orally bioavailable.  Herein, we demonstrate the oral efficacy of 1294 against toxoplasmosis in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOnucFrtFbhz0O18WR3iAofW6udTcc2eZwpJj1TjZlWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crptV2ktA%253D%253D&md5=17e39dbc0043221abd603d23ad7176b5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.01823-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01823-13%26sid%3Dliteratum%253Aachs%26aulast%3DDoggett%26aufirst%3DJ.%2BS.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DBumped%2520kinase%2520inhibitor%25201294%2520treats%2520established%2520Toxoplasma%2520gondii%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D6%26spage%3D3547%26epage%3D3549%26doi%3D10.1128%2FAAC.01823-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutaganira, F. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhason, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radke, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddirala, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Bakkouri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of calcium dependent protein kinase 1 (CDPK1) by pyrazolopyrimidine analogs decreases establishment and reoccurrence of central nervous system disease by <i>Toxoplasma gondii</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">9976</span>– <span class="NLM_lpage">9989</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01192</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01192" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFensbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9976-9989&issue=24&author=F.+U.+Rutaganiraauthor=J.+Barksauthor=M.+S.+Dhasonauthor=Q.+Wangauthor=M.+S.+Lopezauthor=S.+Longauthor=J.+B.+Radkeauthor=N.+G.+Jonesauthor=A.+R.+Maddiralaauthor=J.+W.+Janetkaauthor=M.+El+Bakkouriauthor=R.+Huiauthor=K.+M.+Shokatauthor=L.+D.+Sibley&title=Inhibition+of+calcium+dependent+protein+kinase+1+%28CDPK1%29+by+pyrazolopyrimidine+analogs+decreases+establishment+and+reoccurrence+of+central+nervous+system+disease+by+Toxoplasma+gondii&doi=10.1021%2Facs.jmedchem.7b01192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii</span></div><div class="casAuthors">Rutaganira, Florentine U.; Barks, Jennifer; Dhason, Mary Savari; Wang, Qiuling; Lopez, Michael S.; Long, Shaojun; Radke, Joshua B.; Jones, Nathaniel G.; Maddirala, Amarendar R.; Janetka, James W.; El Bakkouri, Majida; Hui, Raymond; Shokat, Kevan M.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9976-9989</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Calcium dependent protein kinase 1 (CDPK1) is an essential enzyme in the opportunistic pathogen Toxoplasma gondii.  CDPK1 controls multiple processes that are crit. to the intracellular replicative cycle of T. gondii including secretion of adhesins, motility, invasion, and egress.  Remarkably, CDPK1 contains a small glycine gatekeeper residue in the ATP binding pocket making it sensitive to ATP-competitive inhibitors with bulky substituents that complement this expanded binding pocket.  Here the authors explored structure-activity relationships of a series of pyrazolopyrimidine inhibitors of CDPK1 with the goal of increasing selectivity over host enzymes, improving antiparasite potency, and improving metabolic stability.  The resulting lead compd. 24 exhibited excellent enzyme inhibition and selectivity for CDPK1 and potently inhibited parasite growth in vitro.  Compd. 24 was also effective at treating acute toxoplasmosis in the mouse, reducing dissemination to the central nervous system, and decreasing reactivation of chronic infection in severely immunocompromised mice.  These findings provide proof of concept for the development of small mol. inhibitors of CDPK1 for treatment of CNS toxoplasmosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR_eZs2pZPQ7Vg90H21EOLACvtfcHk0li48FAj6KmMjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFensbzO&md5=27908eedbcadb1132f254fda63336842</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01192%26sid%3Dliteratum%253Aachs%26aulast%3DRutaganira%26aufirst%3DF.%2BU.%26aulast%3DBarks%26aufirst%3DJ.%26aulast%3DDhason%26aufirst%3DM.%2BS.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DLong%26aufirst%3DS.%26aulast%3DRadke%26aufirst%3DJ.%2BB.%26aulast%3DJones%26aufirst%3DN.%2BG.%26aulast%3DMaddirala%26aufirst%3DA.%2BR.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DEl%2BBakkouri%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DR.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DInhibition%2520of%2520calcium%2520dependent%2520protein%2520kinase%25201%2520%2528CDPK1%2529%2520by%2520pyrazolopyrimidine%2520analogs%2520decreases%2520establishment%2520and%2520reoccurrence%2520of%2520central%2520nervous%2520system%2520disease%2520by%2520Toxoplasma%2520gondii%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D24%26spage%3D9976%26epage%3D9989%26doi%3D10.1021%2Facs.jmedchem.7b01192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidadala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulverson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isoherranen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comess, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span> <span> </span><span class="NLM_article-title">A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>209</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1093/infdis/jit522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1093%2Finfdis%2Fjit522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=24123773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2cXit1Smtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2014&pages=275-284&issue=2&author=K.+K.+Ojoauthor=R.+T.+Eastmanauthor=R.+Vidadalaauthor=Z.+Zhangauthor=K.+L.+Rivasauthor=R.+Choiauthor=J.+D.+Lutzauthor=M.+C.+Reidauthor=A.+M.+Foxauthor=M.+A.+Hulversonauthor=M.+Kennedyauthor=N.+Isoherranenauthor=L.+M.+Kimauthor=K.+M.+Comessauthor=D.+J.+Kempfauthor=C.+L.+Verlindeauthor=X.+Z.+Suauthor=S.+H.+Kappeauthor=D.+J.+Malyauthor=E.+Fanauthor=W.+C.+Van+Voorhis&title=A+specific+inhibitor+of+PfCDPK4+blocks+malaria+transmission%3A+chemical-genetic+validation&doi=10.1093%2Finfdis%2Fjit522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A Specific Inhibitor of PfCDPK4 Blocks Malaria Transmission: Chemical-genetic Validation</span></div><div class="casAuthors">Ojo, Kayode K.; Eastman, Richard T.; Vidadala, Rama Subba Rao; Zhang, Zhongsheng; Rivas, Kasey L.; Choi, Ryan; Lutz, Justin D.; Reid, Molly C.; Fox, Anna M. W.; Hulverson, Matthew A.; Kennedy, Mark; Isoherranen, Nina; Kim, Laura M.; Comess, Kenneth M.; Kempf, Dale J.; Verlinde, Christophe L. M. J.; Su, Xin-zhuan; Kappe, Stefan H. I.; Maly, Dustin J.; Fan, Erkang; Van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-284</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Malaria parasites are transmitted by mosquitoes, and blocking parasite transmission is crit. in reducing or eliminating malaria in endemic regions.  Here, we report the pharmacol. characterization of a new class of malaria transmission-blocking compds. that acts via the inhibition of Plasmodia CDPK4 enzyme.  We demonstrate that these compds. achieved selectivity over mammalian kinases by capitalizing on a small serine gatekeeper residue in the active site of the Plasmodium CDPK4 enzyme.  To directly confirm the mechanism of action of these compds., we generated P. falciparum parasites that express a drug-resistant methionine gatekeeper (S147M) CDPK4 mutant.  Mutant parasites showed a shift in exflagellation EC50 relative to the wild-type strains in the presence of compd. 1294, providing chem.-genetic evidence that CDPK4 is the target of the compd.  Pharmacokinetic analyses suggest that coformulation of this transmission-blocking agent with asexual stage antimalarials such as artemisinin combination therapy (ACT) is a promising option for drug delivery that may reduce transmission of malaria including drug-resistant strains.  Ongoing studies include refining the compds. to improve efficacy and toxicol. properties for efficient blocking of malaria transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4SsoTjMi12LVg90H21EOLACvtfcHk0li48FAj6KmMjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXit1Smtg%253D%253D&md5=cc5499eca2d177bfa8cb1c523eb54525</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjit522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjit522%26sid%3Dliteratum%253Aachs%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DEastman%26aufirst%3DR.%2BT.%26aulast%3DVidadala%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRivas%26aufirst%3DK.%2BL.%26aulast%3DChoi%26aufirst%3DR.%26aulast%3DLutz%26aufirst%3DJ.%2BD.%26aulast%3DReid%26aufirst%3DM.%2BC.%26aulast%3DFox%26aufirst%3DA.%2BM.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DKennedy%26aufirst%3DM.%26aulast%3DIsoherranen%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DL.%2BM.%26aulast%3DComess%26aufirst%3DK.%2BM.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DSu%26aufirst%3DX.%2BZ.%26aulast%3DKappe%26aufirst%3DS.%2BH.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520PfCDPK4%2520blocks%2520malaria%2520transmission%253A%2520chemical-genetic%2520validation%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2014%26volume%3D209%26issue%3D2%26spage%3D275%26epage%3D284%26doi%3D10.1093%2Finfdis%2Fjit522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dobrowolski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">933</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81071-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2FS0092-8674%2800%2981071-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=8601316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADyaK28XhvFKjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1996&pages=933-939&issue=6&author=J.+M.+Dobrowolskiauthor=L.+D.+Sibley&title=Toxoplasma+invasion+of+mammalian+cells+is+powered+by+the+actin+cytoskeleton+of+the+parasite&doi=10.1016%2FS0092-8674%2800%2981071-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite</span></div><div class="casAuthors">Dobrowolski, Janice M.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">933-9</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Toxoplasma gondii is an obligate intracellular parasite that invades a wide range of vertebrate host cells.  The authors demonstrate that invasion is crit. dependent on actin filaments in the parasite, but not the host cell.  Invasion into cytochalasin D (CD)-resistant host cells was blocked by CD, whereas parasite mutants invaded wild-type host cells in the presence of drug.  CD resistance in Toxoplasma was mediated by a point mutation in the single-copy actin gene ACT1.  Transfection of the mutant act1 allele into wild-type Toxoplasma conferred motility and invasion in the presence of CD.  Thus, host cell invasion by Toxoplasma, and likely by related Apicomplexans, is actively powered by an actin-based contractile system in the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBjrv4y6LxarVg90H21EOLACvtfcHk0lhxPaH9aTQ2OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvFKjs70%253D&md5=55242bdb0bb9ce4a0128139630de7085</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981071-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981071-5%26sid%3Dliteratum%253Aachs%26aulast%3DDobrowolski%26aufirst%3DJ.%2BM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DToxoplasma%2520invasion%2520of%2520mammalian%2520cells%2520is%2520powered%2520by%2520the%2520actin%2520cytoskeleton%2520of%2520the%2520parasite%26jtitle%3DCell%26date%3D1996%26volume%3D84%26issue%3D6%26spage%3D933%26epage%3D939%26doi%3D10.1016%2FS0092-8674%2800%2981071-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, Y.</span></span> <span> </span><span class="NLM_article-title">Efficient synthesis of cyclopropylhydrazine salts</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">30</span>),  <span class="NLM_fpage">4102</span>– <span class="NLM_lpage">4104</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2014.05.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.tetlet.2014.05.098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCqtrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=4102-4104&issue=30&author=T.+Shibueauthor=Y.+Fukuda&title=Efficient+synthesis+of+cyclopropylhydrazine+salts&doi=10.1016%2Fj.tetlet.2014.05.098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis of cyclopropylhydrazine salts</span></div><div class="casAuthors">Shibue, Taku; Fukuda, Yasumichi</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4102-4104</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">An efficient procedure for the synthesis of cyclopropylhydrazine in salt form is reported.  Copper-catalyzed addn. of cyclopropylboronic acid to the azo group of di-tert-Bu azodicarboxylate and subsequent deprotection gave the cyclopropylhydrazine salts in high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmYCON6GrI-rVg90H21EOLACvtfcHk0lhxPaH9aTQ2OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqtrbO&md5=21f0f0be3454dbef4ed5a4fe10542e9d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2014.05.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2014.05.098%26sid%3Dliteratum%253Aachs%26aulast%3DShibue%26aufirst%3DT.%26aulast%3DFukuda%26aufirst%3DY.%26atitle%3DEfficient%2520synthesis%2520of%2520cyclopropylhydrazine%2520salts%26jtitle%3DTetrahedron%2520Lett.%26date%3D2014%26volume%3D55%26issue%3D30%26spage%3D4102%26epage%3D4104%26doi%3D10.1016%2Fj.tetlet.2014.05.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neidlein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikelj, D.</span></span> <span> </span><span class="NLM_article-title">A facilesynthesis of dialkoxycarbonylketene-ethylene, dicyanoketene-ethylene, and alkoxycarbonyl(cyano)ketene-ethylene acetals</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>1988</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">983</span>, <span class="refDoi"> DOI: 10.1055/s-1988-27775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1055%2Fs-1988-27775" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1988&publication_year=1988&pages=981-983&issue=12&author=R.+Neidleinauthor=D.+Kikelj&title=A+facilesynthesis+of+dialkoxycarbonylketene-ethylene%2C+dicyanoketene-ethylene%2C+and+alkoxycarbonyl%28cyano%29ketene-ethylene+acetals&doi=10.1055%2Fs-1988-27775"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1055%2Fs-1988-27775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1988-27775%26sid%3Dliteratum%253Aachs%26aulast%3DNeidlein%26aufirst%3DR.%26aulast%3DKikelj%26aufirst%3DD.%26atitle%3DA%2520facilesynthesis%2520of%2520dialkoxycarbonylketene-ethylene%252C%2520dicyanoketene-ethylene%252C%2520and%2520alkoxycarbonyl%2528cyano%2529ketene-ethylene%2520acetals%26jtitle%3DSynthesis%26date%3D1988%26volume%3D1988%26issue%3D12%26spage%3D981%26epage%3D983%26doi%3D10.1055%2Fs-1988-27775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miah, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champigny, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percy, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Procopiou, P. A.</span></span> <span> </span><span class="NLM_article-title">Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">5327</span>– <span class="NLM_lpage">5340</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.bmc.2017.07.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=28801066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSiur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=5327-5340&issue=20&author=A.+H.+Miahauthor=A.+C.+Champignyauthor=R.+H.+Gravesauthor=S.+T.+Hodgsonauthor=J.+M.+Percyauthor=P.+A.+Procopiou&title=Identification+of+pyrazolopyrimidine+arylsulfonamides+as+CC-chemokine+receptor+4+%28CCR4%29+antagonists&doi=10.1016%2Fj.bmc.2017.07.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists</span></div><div class="casAuthors">Miah, Afjal H.; Champigny, Aurelie C.; Graves, Rebecca H.; Hodgson, Simon T.; Percy, Jonathan M.; Procopiou, Panayiotis A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5327-5340</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel 4-aminoindazole sulfonamide hit (13) was identified as a human CCR4 antagonists from testing a focussed library of compds. in the primary GTPγS assay.  Replacing the indazole core with a pyrazolopyrimidine, and introduction of a methoxy group adjacent to the sulfonamide substituent, resulted in the identification of pyrazolopyrimidine 37a, which exhibited good binding affinity in the GTPγS assay (pIC50 = 7.2), low lipophilicity (c log P = 2.2, chromlog D7.4 = 2.4), high LE (0.41), high soly. (CLND soly. ≥581 μM), and an excellent PK profile in both the rat (F = 62%) and the dog (F = 100%).  Further SAR investigation of the pyrazolopyrimidine suggested that substitution at N1 is tolerated, providing a suitable vector to modulate the properties, and increase the potency in a lead optimization campaign.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-B5cBac9FfrVg90H21EOLACvtfcHk0ljjW8cDWdVftA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSiur3F&md5=70d9ea63989eb24ce0bff5745751f846</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DMiah%26aufirst%3DA.%2BH.%26aulast%3DChampigny%26aufirst%3DA.%2BC.%26aulast%3DGraves%26aufirst%3DR.%2BH.%26aulast%3DHodgson%26aufirst%3DS.%2BT.%26aulast%3DPercy%26aufirst%3DJ.%2BM.%26aulast%3DProcopiou%26aufirst%3DP.%2BA.%26atitle%3DIdentification%2520of%2520pyrazolopyrimidine%2520arylsulfonamides%2520as%2520CC-chemokine%2520receptor%25204%2520%2528CCR4%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26issue%3D20%26spage%3D5327%26epage%3D5340%26doi%3D10.1016%2Fj.bmc.2017.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winzer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguado-Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manser, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Mora, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemphill, A.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans <i>Toxoplasma gondii</i> and <i>Neospora caninum</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">6361</span>– <span class="NLM_lpage">6374</span>, <span class="refDoi"> DOI: 10.1128/AAC.01236-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FAAC.01236-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=26248379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=6361-6374&issue=10&author=P.+Winzerauthor=J.+Mullerauthor=A.+Aguado-Martinezauthor=M.+Rahmanauthor=V.+Balmerauthor=V.+Manserauthor=L.+M.+Ortega-Moraauthor=K.+K.+Ojoauthor=E.+Fanauthor=D.+J.+Malyauthor=W.+C.+Van+Voorhisauthor=A.+Hemphill&title=In+vitro+and+in+vivo+effects+of+the+bumped+kinase+inhibitor+1294+in+the+related+cyst-forming+apicomplexans+Toxoplasma+gondii+and+Neospora+caninum&doi=10.1128%2FAAC.01236-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro and In Vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans toxoplasma gondii and Neospora caninum</span></div><div class="casAuthors">Winzer, Pablo; Muller, Joachim; Aguado-Martinez, Adriana; Rahman, Mahbubur; Balmer, Vreni; Manser, Vera; Miguel, Ortega-Mora Luis; Ojo, Kayode K.; Fan, Erkang; Maly, Dustin J.; C. Van Voorhis, Wesley; Hemphill, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6361-6374</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report on the in vitro effects of the bumped kinase inhibitor 1294 (BKI-1294) in cultures of virulent Neospora caninum isolates Nc-Liverpool (Nc-Liv) and Nc-Spain7 and in two strains of Toxoplasma gondii (RH and ME49), all grown in human foreskin fibroblasts.  In these parasites, BKI-1294 acted with 50% inhibitory concns. (IC50s) ranging from 20 nM (T. gondii RH) to 360 nM (N. caninum Nc-Liv), and exposure of intracellular stages to 1294 led to the nondisjunction of newly formed tachyzoites, resulting in the formation of multinucleated complexes similar to complexes previously obsd. in BKI-1294- treated N. caninum beta-galactosidase-expressing parasites.  However, such complexes were not seen in a transgenic T. gondii strain that expressed CDPK1 harboring a mutation (G to M) in the gatekeeper residue.  In T. gondii ME49 and N. caninum Nc-Liv, exposure of cultures to BKI-1294 resulted in the elevated expression of mRNA coding for the bradyzoite marker BAG1.  Unlike in bradyzoites, SAG1 expression was not repressed.  Immunofluorescence also showed that these multinucleated complexes expressed SAG1 and BAG1 and the monoclonal antibody CC2, which binds to a yet unidentified bradyzoite antigen, also exhibited increased labeling.  In a pregnant mouse model, BKI-1294 efficiently inhibited vertical transmission in BALB/c mice exptl. infected with one of the two virulent isolates Nc-Liv or Nc-Spain7, demonstrating proof of concept that this compd. protected offspring from vertical transmission and disease.  The obsd. deregulated antigen expression effect may enhance the immune response during BKI-1294 therapy and will be the subject of future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv-Uw_Y4GsNLVg90H21EOLACvtfcHk0ljjW8cDWdVftA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWqtL0%253D&md5=e17f0f2cd7e095e95d6df945f6bf3d49</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.01236-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01236-15%26sid%3Dliteratum%253Aachs%26aulast%3DWinzer%26aufirst%3DP.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DAguado-Martinez%26aufirst%3DA.%26aulast%3DRahman%26aufirst%3DM.%26aulast%3DBalmer%26aufirst%3DV.%26aulast%3DManser%26aufirst%3DV.%26aulast%3DOrtega-Mora%26aufirst%3DL.%2BM.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DHemphill%26aufirst%3DA.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520effects%2520of%2520the%2520bumped%2520kinase%2520inhibitor%25201294%2520in%2520the%2520related%2520cyst-forming%2520apicomplexans%2520Toxoplasma%2520gondii%2520and%2520Neospora%2520caninum%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26issue%3D10%26spage%3D6361%26epage%3D6374%26doi%3D10.1128%2FAAC.01236-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemae, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiwa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakoshi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recuenco, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwanaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span> <span> </span><span class="NLM_article-title">Identification of mutations in TgMAPK1 of <i>Toxoplasma gondii</i> conferring resistance to 1NM-PP1</span>. <i>Int. J. Parasitol.: Drugs Drug Resist.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.ijpddr.2013.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.ijpddr.2013.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=24533298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADC%252BC2cvls1ensg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=93-101&author=T.+Sugiauthor=K.+Kobayashiauthor=H.+Takemaeauthor=H.+Gongauthor=A.+Ishiwaauthor=F.+Murakoshiauthor=F.+C.+Recuencoauthor=T.+Iwanagaauthor=T.+Horimotoauthor=H.+Akashiauthor=K.+Kato&title=Identification+of+mutations+in+TgMAPK1+of+Toxoplasma+gondii+conferring+resistance+to+1NM-PP1&doi=10.1016%2Fj.ijpddr.2013.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of mutations in TgMAPK1 of Toxoplasma gondii conferring resistance to 1NM-PP1</span></div><div class="casAuthors">Sugi Tatsuki; Takemae Hitoshi; Gong Haiyan; Ishiwa Akiko; Murakoshi Fumi; Recuenco Frances C; Iwanaga Tatsuya; Horimoto Taisuke; Akashi Hiroomi; Kobayashi Kyousuke; Kato Kentaro</div><div class="citationInfo"><span class="NLM_cas:title">International journal for parasitology. Drugs and drug resistance</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-101</span>
        ISSN:<span class="NLM_cas:issn">2211-3207</span>.
    </div><div class="casAbstract">Toxoplasma gondii is an important food and waterborne pathogen that causes severe disease in immunocompromised patients.  Bumped kinase inhibitors (BKIs) have an antiparasitic effect on T. gondii tachyzoite growth by targeting T. gondii calmodulin-domain protein kinase 1 (TgCDPK1).  To identify mutations that confer resistance to BKIs, chemical mutagenesis was performed, followed by selection in media containing either 250 or 1000 nM 1NM-PP1.  Whole-genome sequence analysis of resistant clones revealed single nucleotide mutations in T. gondii mitogen-activated protein kinase 1 (TgMAPK1) at amino acids 162 (L162Q) and 171 (I171N).  Plasmid constructs having the TgMAPK1 L162Q mutant sequence successfully replaced native TgMAPK1 genome locus in the presence of 1000 nM 1NM-PP1.  The inhibitory effect of 1NM-PP1 on cell division observed in the parent clone was decreased in 1NM-PP1-resistant clones; however, effects on parasite invasion and calcium-induced egress were similar in both parent and resistant clones.  A plasmid construct expressing the full length TgMAPK1 splicing isoform with L162Q mutation successfully complemented TgMAPK1 function in the pressure of 250 nM 1NM-PP1 in plaque assay. 1NM-PP1-resistant clones showed resistance to other BKIs (3MB-PP1 and 3BrB-PP1) with different levels.  Here we identify TgMAPK1 as a novel target for 1NM-PP1 activity.  This inhibitory effect is mediated through inhibition of tachyzoite cell division, and can be overcome through mutations at multiple residues in TgMAPK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0kT6fDiRpcRjv2lLSLOxFfW6udTcc2eb2cL6nITxnXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvls1ensg%253D%253D&md5=7835bea69c668c29fee552ac0b59afb2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpddr.2013.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpddr.2013.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DSugi%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DTakemae%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DH.%26aulast%3DIshiwa%26aufirst%3DA.%26aulast%3DMurakoshi%26aufirst%3DF.%26aulast%3DRecuenco%26aufirst%3DF.%2BC.%26aulast%3DIwanaga%26aufirst%3DT.%26aulast%3DHorimoto%26aufirst%3DT.%26aulast%3DAkashi%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520mutations%2520in%2520TgMAPK1%2520of%2520Toxoplasma%2520gondii%2520conferring%2520resistance%2520to%25201NM-PP1%26jtitle%3DInt.%2520J.%2520Parasitol.%253A%2520Drugs%2520Drug%2520Resist.%26date%3D2013%26volume%3D3%26spage%3D93%26epage%3D101%26doi%3D10.1016%2Fj.ijpddr.2013.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witucki, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraybill, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubersax, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blethrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Structural basis for selective inhibition of Src family kinases by PP1</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">678</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(99)80118-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2FS1074-5521%2899%2980118-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10467133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFaqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=671-678&issue=9&author=Y.+Liuauthor=A.+Bishopauthor=L.+Wituckiauthor=B.+Kraybillauthor=E.+Shimizuauthor=J.+Tsienauthor=J.+Ubersaxauthor=J.+Blethrowauthor=D.+O.+Morganauthor=K.+M.+Shokat&title=Structural+basis+for+selective+inhibition+of+Src+family+kinases+by+PP1&doi=10.1016%2FS1074-5521%2899%2980118-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for selective inhibition of Src family kinases by PP1</span></div><div class="casAuthors">Liu, Yi; Bishop, Anthony; Witucki, Laurie; Kraybill, Brian; Shimizu, Eiji; Tsien, Joe; Ubersax, Jeff; Blethrow, Justin; Morgan, David O.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">671-678</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that can target individual kinases are powerful tools for use in signal transduction research.  It is difficult to find such compds. because of the enormous no. of protein kinases and the highly conserved nature of their catalytic domains.  Recently, a novel, potent, Src family selective tyrosine kinase inhibitor was reported (PP1).  Here, we study the structural basis for this inhibitor's specificity for Src family kinases.  A single residue corresponding to Ile338 (v-Src numbering; Thr338 in c-Src) in Src family tyrosine kinases largely controls PP1's ability to inhibit protein kinases.  Mutation of Ile338 to a larger residue such as methionine or phenylalanine in v-Src makes this inhibitor less potent.  Conversely, mutation of Ile338 to alanine or glycine increases PP1's potency.  PP1 can inhibit Ser/Thr kinases if the residue corresponding to Ile338 in v-Src is mutated to glycine.  We have accurately predicted several non-Src family kinases that are moderately (IC50 ∼1 μM) inhibited by PP1, including c-Abl and the MAP kinase p38.  Our mutagenesis studies of the ATP-binding site in both tyrosine kinases and Ser/Thr kinases explain why PP1 is a specific inhibitor of Src family tyrosine kinases.  Detn. of the structural basis of inhibitor specificity will aid in the design of more potent and more selective protein kinase inhibitors.  The ability to desensitize a particular kinase to PP1 inhibition of residue 338 or conversely to sensitize a kinase to PP1 inhibition by mutation should provide a useful basis for chem. genetic studies of kinase signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC8HNYPVy4RLVg90H21EOLACvtfcHk0lg0znHm_p4ahA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFaqur4%253D&md5=4d09cc5fb95c2ed5d538c02f356c0842</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980118-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980118-5%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DBishop%26aufirst%3DA.%26aulast%3DWitucki%26aufirst%3DL.%26aulast%3DKraybill%26aufirst%3DB.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DTsien%26aufirst%3DJ.%26aulast%3DUbersax%26aufirst%3DJ.%26aulast%3DBlethrow%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DStructural%2520basis%2520for%2520selective%2520inhibition%2520of%2520Src%2520family%2520kinases%2520by%2520PP1%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26issue%3D9%26spage%3D671%26epage%3D678%26doi%3D10.1016%2FS1074-5521%2899%2980118-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swapna, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjithomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karamycheva, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunk, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothroyd, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darde, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Miranda, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gennari, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeij, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grigg, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissinger, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roos, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic <i>Toxoplasma gondii</i> genomes</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">10147</span>, <span class="refDoi"> DOI: 10.1038/ncomms10147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fncomms10147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=26738725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=10147&author=H.+Lorenziauthor=A.+Khanauthor=M.+S.+Behnkeauthor=S.+Namasivayamauthor=L.+S.+Swapnaauthor=M.+Hadjithomasauthor=S.+Karamychevaauthor=D.+Pinneyauthor=B.+P.+Brunkauthor=J.+W.+Ajiokaauthor=D.+Ajzenbergauthor=J.+C.+Boothroydauthor=J.+P.+Boyleauthor=M.+L.+Dardeauthor=M.+A.+Diaz-Mirandaauthor=J.+P.+Dubeyauthor=H.+M.+Fritzauthor=S.+M.+Gennariauthor=B.+D.+Gregoryauthor=K.+Kimauthor=J.+P.+Saeijauthor=C.+Suauthor=M.+W.+Whiteauthor=X.+Q.+Zhuauthor=D.+K.+Howeauthor=B.+M.+Rosenthalauthor=M.+E.+Griggauthor=J.+Parkinsonauthor=L.+Liuauthor=J.+C.+Kissingerauthor=D.+S.+Roosauthor=L.+D.+Sibley&title=Local+admixture+of+amplified+and+diversified+secreted+pathogenesis+determinants+shapes+mosaic+Toxoplasma+gondii+genomes&doi=10.1038%2Fncomms10147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes</span></div><div class="casAuthors">Lorenzi, Hernan; Khan, Asis; Behnke, Michael S.; Namasivayam, Sivaranjani; Swapna, Lakshmipuram S.; Hadjithomas, Michalis; Karamycheva, Svetlana; Pinney, Deborah; Brunk, Brian P.; Ajioka, James W.; Ajzenberg, Daniel; Boothroyd, John C.; Boyle, Jon P.; Darde, Marie L.; Diaz-Miranda, Maria A.; Dubey, Jitender P.; Fritz, Heather M.; Gennari, Solange M.; Gregory, Brian D.; Kim, Kami; Saeij, Jeroen P. J.; Su, Chunlei; White, Michael W.; Zhu, Xing-Quan; Howe, Daniel K.; Rosenthal, Benjamin M.; Grigg, Michael E.; Parkinson, John; Liu, Liang; Kissinger, Jessica C.; Roos, David S.; David Sibley, L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10147</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Toxoplasma gondii is among the most prevalent parasites worldwide, infecting many wild and domestic animals and causing zoonotic infections in humans.  T. gondii differs substantially in its broad distribution from closely related parasites that typically have narrow, specialized host ranges.  To elucidate the genetic basis for these differences, we compared the genomes of 62 globally distributed T. gondii isolates to several closely related coccidian parasites.  Our findings reveal that tandem amplification and diversification of secretory pathogenesis determinants is the primary feature that distinguishes the closely related genomes of these biol. diverse parasites.  We further show that the unusual population structure of T. gondii is characterized by clade-specific inheritance of large conserved haploblocks that are significantly enriched in tandemly clustered secretory pathogenesis determinants.  The shared inheritance of these conserved haploblocks, which show a different ancestry than the genome as a whole, may thus influence transmission, host range, and pathogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdDKqaMZXy87Vg90H21EOLACvtfcHk0lg0znHm_p4ahA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFOrsw%253D%253D&md5=1952e8e223c43abfde12aa2f61a64cf3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fncomms10147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10147%26sid%3Dliteratum%253Aachs%26aulast%3DLorenzi%26aufirst%3DH.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DBehnke%26aufirst%3DM.%2BS.%26aulast%3DNamasivayam%26aufirst%3DS.%26aulast%3DSwapna%26aufirst%3DL.%2BS.%26aulast%3DHadjithomas%26aufirst%3DM.%26aulast%3DKaramycheva%26aufirst%3DS.%26aulast%3DPinney%26aufirst%3DD.%26aulast%3DBrunk%26aufirst%3DB.%2BP.%26aulast%3DAjioka%26aufirst%3DJ.%2BW.%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DBoothroyd%26aufirst%3DJ.%2BC.%26aulast%3DBoyle%26aufirst%3DJ.%2BP.%26aulast%3DDarde%26aufirst%3DM.%2BL.%26aulast%3DDiaz-Miranda%26aufirst%3DM.%2BA.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DFritz%26aufirst%3DH.%2BM.%26aulast%3DGennari%26aufirst%3DS.%2BM.%26aulast%3DGregory%26aufirst%3DB.%2BD.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DSaeij%26aufirst%3DJ.%2BP.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DM.%2BW.%26aulast%3DZhu%26aufirst%3DX.%2BQ.%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DRosenthal%26aufirst%3DB.%2BM.%26aulast%3DGrigg%26aufirst%3DM.%2BE.%26aulast%3DParkinson%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKissinger%26aufirst%3DJ.%2BC.%26aulast%3DRoos%26aufirst%3DD.%2BS.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DLocal%2520admixture%2520of%2520amplified%2520and%2520diversified%2520secreted%2520pathogenesis%2520determinants%2520shapes%2520mosaic%2520Toxoplasma%2520gondii%2520genomes%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D10147%26doi%3D10.1038%2Fncomms10147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">The role of aldehyde oxidase in drug metabolism</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1517/17425255.2012.663352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1517%2F17425255.2012.663352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=22335465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVOrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=487-503&issue=4&author=E.+Garattiniauthor=M.+Terao&title=The+role+of+aldehyde+oxidase+in+drug+metabolism&doi=10.1517%2F17425255.2012.663352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The role of aldehyde oxidase in drug metabolism</span></div><div class="casAuthors">Garattini, Enrico; Terao, Mineko</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">487-503</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Aldehyde oxidases (AOXs) are molybdo-flavoenzymes with complex evolutionary profiles, as the no. and types of active AOX genes vary according to the animal species considered.  Humans and higher primates have a single functional AOX1 gene, while rodents are endowed with four AOXs.  Along with the endoplasmic cytochrome P 450 system (CYP450), cytoplasmic AOX1 is the major enzyme involved in the hepatic phase I metab. of numerous xenobiotics.Areas covered: The authors review literature to highlight the fact that aldehydes are not the only AOX substrates, as aza- and oxo-heterocycles, that represent the scaffold of many drugs, are also oxidized efficiently by these enzymes.  Addnl., the ndefine the different complements of AOX isoenzymes expressed in humans and animal models used in drug metab. studies and discuss the implications.  Furthermore, the authors report on human AOX1 allelic variants that alter the activity of this enzyme.  Finally, they discuss the factors of potential importance in controlling the functional activity of AOX1.Expert opinion: There is evidence for an increasing relevance of AOX1 in the metab. and clearance of new drugs, as measures aiming at controlling CYP450-dependent metab. of prospective therapeutic agents are becoming routine.  This calls for investigations into the biol., catalytic properties and substrate specificity of human AOX1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCgeYumc6Up7Vg90H21EOLACvtfcHk0lg0znHm_p4ahA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVOrsLg%253D&md5=b7e5d6a1f1164ccd14a042aefded8a66</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1517%2F17425255.2012.663352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2012.663352%26sid%3Dliteratum%253Aachs%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520aldehyde%2520oxidase%2520in%2520drug%2520metabolism%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2012%26volume%3D8%26issue%3D4%26spage%3D487%26epage%3D503%26doi%3D10.1517%2F17425255.2012.663352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span> <span> </span><span class="NLM_article-title">Adenosine receptors as drug targets--what are the challenges?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1038/nrd3955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fnrd3955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=23535933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3sXks1Glsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=265-286&issue=4&author=J.+F.+Chenauthor=H.+K.+Eltzschigauthor=B.+B.+Fredholm&title=Adenosine+receptors+as+drug+targets%2D%2Dwhat+are+the+challenges%3F&doi=10.1038%2Fnrd3955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors as drug targets - what are the challenges?</span></div><div class="casAuthors">Chen, Jiang-Fan; Eltzschig, Holger K.; Fredholm, Bertil B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">265-286</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Adenosine signalling has long been a target for drug development, with adenosine itself or its derivs. being used clin. since the 1940s.  In addn., methylxanthines such as caffeine have profound biol. effects as antagonists at adenosine receptors.  Moreover, drugs such as dipyridamole and methotrexate act by enhancing the activation of adenosine receptors.  There is strong evidence that adenosine has a functional role in many diseases, and several pharmacol. compds. specifically targeting individual adenosine receptors - either directly or indirectly - have now entered the clinic.  However, only one adenosine receptor-specific agent - the adenosine A2A receptor agonist regadenoson (Lexiscan; Astellas Pharma) - has so far gained approval from the US Food and Drug Administration (FDA).  Here, we focus on the biol. of adenosine signalling to identify hurdles in the development of addnl. pharmacol. compds. targeting adenosine receptors and discuss strategies to overcome these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqhEzWXi1WS7Vg90H21EOLACvtfcHk0ljTcv0EeGW48w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXks1Glsrs%253D&md5=898fee7a68273ebfbd5a1d3dca307dc5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnrd3955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3955%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DAdenosine%2520receptors%2520as%2520drug%2520targets--what%2520are%2520the%2520challenges%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D4%26spage%3D265%26epage%3D286%26doi%3D10.1038%2Fnrd3955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberg, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span> <span> </span><span class="NLM_article-title">hERG K(+) channels: structure, function, and clinical significance</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1393</span>– <span class="NLM_lpage">1478</span>, <span class="refDoi"> DOI: 10.1152/physrev.00036.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1152%2Fphysrev.00036.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=22988594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KmtbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2012&pages=1393-1478&issue=3&author=J.+I.+Vandenbergauthor=M.+D.+Perryauthor=M.+J.+Perrinauthor=S.+A.+Mannauthor=Y.+Keauthor=A.+P.+Hill&title=hERG+K%28%2B%29+channels%3A+structure%2C+function%2C+and+clinical+significance&doi=10.1152%2Fphysrev.00036.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">HERG K+ channels: structure, function, and clinical significance</span></div><div class="casAuthors">Vandenberg, Jamie I.; Perry, Matthew D.; Perrin, Mark J.; Mann, Stefan A.; Ke, Ying; Hill, Adam P.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1393-1478</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The human ether-a-go-go related gene (hERG) encodes the pore-forming subunit of the rapid component of the delayed rectifier K+ channel, Kv11.1, which are expressed in the heart, various brain regions, smooth muscle cells, endocrine cells, and a wide range of tumor cell lines.  However, it is the role that Kv11.1 channels play in the heart that has been best characterized, for two main reasons.  First, it is the gene product involved in chromosome 7-assocd. long QT syndrome (LOTS), an inherited disorder assocd. with a markedly increased risk of ventricular arrhythmias and sudden cardiac death.  Second, blockade of Kv11.1, by a wide range of prescription medications, causes drug-induced QT prolongation with an increase in risk of sudden cardiac arrest.  In the first part of this review, the properties of Kv11.1 channels, including biogenesis, trafficking, gating, and pharmacol. are discussed, while the second part focuses on the pathophysiol. of Kv11.1 channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7aFPdwhDHVLVg90H21EOLACvtfcHk0ljTcv0EeGW48w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KmtbbM&md5=0a51ed516e2e5599c5acf31b8444ae6a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00036.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00036.2011%26sid%3Dliteratum%253Aachs%26aulast%3DVandenberg%26aufirst%3DJ.%2BI.%26aulast%3DPerry%26aufirst%3DM.%2BD.%26aulast%3DPerrin%26aufirst%3DM.%2BJ.%26aulast%3DMann%26aufirst%3DS.%2BA.%26aulast%3DKe%26aufirst%3DY.%26aulast%3DHill%26aufirst%3DA.%2BP.%26atitle%3DhERG%2520K%2528%252B%2529%2520channels%253A%2520structure%252C%2520function%252C%2520and%2520clinical%2520significance%26jtitle%3DPhysiol.%2520Rev.%26date%3D2012%26volume%3D92%26issue%3D3%26spage%3D1393%26epage%3D1478%26doi%3D10.1152%2Fphysrev.00036.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, A.</span></span> <span> </span><span class="NLM_article-title">The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects</span>. <i>Am. Fam. Physician</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=17708140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADC%252BD2svovFGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=391-396&issue=3&author=T.+Lynchauthor=A.+Price&title=The+effect+of+cytochrome+P450+metabolism+on+drug+response%2C+interactions%2C+and+adverse+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects</span></div><div class="casAuthors">Lynch Tom; Price Amy</div><div class="citationInfo"><span class="NLM_cas:title">American family physician</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">391-6</span>
        ISSN:<span class="NLM_cas:issn">0002-838X</span>.
    </div><div class="casAbstract">Cytochrome P450 enzymes are essential for the metabolism of many medications.  Although this class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most significant enzymes being CYP3A4 and CYP2D6.  Genetic variability (polymorphism) in these enzymes may influence a patient's response to commonly prescribed drug classes, including beta blockers and antidepressants.  Cytochrome P450 enzymes can be inhibited or induced by drugs, resulting in clinically significant drug-drug interactions that can cause unanticipated adverse reactions or therapeutic failures.  Interactions with warfarin, antidepressants, antiepileptic drugs, and statins often involve the cytochrome P450 enzymes.  Knowledge of the most important drugs metabolized by cytochrome P450 enzymes, as well as the most potent inhibiting and inducing drugs, can help minimize the possibility of adverse drug reactions and interactions.  Although genotype tests can determine if a patient has a specific enzyme polymorphism, it has not been determined if routine use of these tests will improve outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQE6VB-Pf2cThe4jJGKT5N0fW6udTcc2eafDe5bkZENArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svovFGhtQ%253D%253D&md5=68832276c56c8fb5f2818fc25bcc637f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DT.%26aulast%3DPrice%26aufirst%3DA.%26atitle%3DThe%2520effect%2520of%2520cytochrome%2520P450%2520metabolism%2520on%2520drug%2520response%252C%2520interactions%252C%2520and%2520adverse%2520effects%26jtitle%3DAm.%2520Fam.%2520Physician%26date%3D2007%26volume%3D76%26issue%3D3%26spage%3D391%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothroyd, J. C.</span></span> <span> </span><span class="NLM_article-title">Virulent strains of <i>Toxoplasma gondii</i> comprise a single clonal lineage</span>. <i>Nature (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1038/359082a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2F359082a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1992&pages=82-85&author=L.+D.+Sibleyauthor=J.+C.+Boothroyd&title=Virulent+strains+of+Toxoplasma+gondii+comprise+a+single+clonal+lineage&doi=10.1038%2F359082a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1038%2F359082a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F359082a0%26sid%3Dliteratum%253Aachs%26aulast%3DSibley%26aufirst%3DL.%2BD.%26aulast%3DBoothroyd%26aufirst%3DJ.%2BC.%26atitle%3DVirulent%2520strains%2520of%2520Toxoplasma%2520gondii%2520comprise%2520a%2520single%2520clonal%2520lineage%26jtitle%3DNature%2520%2528London%252C%2520U.%2520K.%2529%26date%3D1992%26volume%3D359%26spage%3D82%26epage%3D85%26doi%3D10.1038%2F359082a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Identification of quantitative trait loci controlling acute virulence in <i>Toxoplasma gondii</i></span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">10753</span>– <span class="NLM_lpage">10758</span>, <span class="refDoi"> DOI: 10.1073/pnas.172117099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1073%2Fpnas.172117099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=12149482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1Cht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=10753-10758&author=C.+Suauthor=D.+K.+Howeauthor=J.+P.+Dubeyauthor=J.+W.+Ajiokaauthor=L.+D.+Sibley&title=Identification+of+quantitative+trait+loci+controlling+acute+virulence+in+Toxoplasma+gondii&doi=10.1073%2Fpnas.172117099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii</span></div><div class="casAuthors">Su, Chunlei; Howe, Daniel K.; Dubey, J. P.; Ajioka, James W.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">10753-10758</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Strains of Toxoplasma gondii can be grouped into three predominant clonal lineages with members of the type I group being uniformly lethal in mice.  To elucidate the basis of this extreme virulence, a genetic cross was performed between a highly virulent type I strain (GT-1) and a less-virulent type III strain (CTG), and the phenotypes of resulting progeny were analyzed by genetic linkage mapping.  Anal. of independent recombinant progeny identified several quant. trait loci that contributed to acute virulence.  A major quant. trait locus located on chromosome VII accounted for ≈50% of the virulence phenotype, whereas a minor locus on chromosome IV, linked to the ROP1 gene, accounted for ≈10%.  These loci are conserved in other type I strains, indicating that acute virulence is controlled by discrete genes common to the type I lineage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaGd1mv6I_YbVg90H21EOLACvtfcHk0lh3MnCTYR7JQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1Cht7o%253D&md5=7677a36353d5f0e37eab2cb01a8fee1a</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.172117099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.172117099%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DC.%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DAjioka%26aufirst%3DJ.%2BW.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DIdentification%2520of%2520quantitative%2520trait%2520loci%2520controlling%2520acute%2520virulence%2520in%2520Toxoplasma%2520gondii%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D10753%26epage%3D10758%26doi%3D10.1073%2Fpnas.172117099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fentress, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashayekhi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">The polymorphic pseudokinase ROP5 controls virulence in <i>Toxoplasma gondii</i> by regulating the active kinase ROP18</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e1002992</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1002992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1371%2Fjournal.ppat.1002992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=23144612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCis7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&author=M.+S.+Behnkeauthor=S.+J.+Fentressauthor=M.+Mashayekhiauthor=L.+L.+Liauthor=G.+A.+Taylorauthor=L.+D.+Sibley&title=The+polymorphic+pseudokinase+ROP5+controls+virulence+in+Toxoplasma+gondii+by+regulating+the+active+kinase+ROP18&doi=10.1371%2Fjournal.ppat.1002992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18</span></div><div class="casAuthors">Behnke, Michael S.; Fentress, Sarah J.; Mashayekhi, Mona; Li, Lucy X.; Taylor, Gregory A.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e1002992</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Secretory polymorphic serine/threonine kinases control pathogenesis of Toxoplasma gondii in the mouse.  Genetic studies show that the pseudokinase ROP5 is essential for acute virulence, but do not reveal its mechanism of action.  Here we demonstrate that ROP5 controls virulence by blocking IFN-γ mediated clearance in activated macrophages.  ROP5 was required for the catalytic activity of the active S/T kinase ROP18, which phosphorylates host immunity related GTPases (IRGs) and protects the parasite from clearance.  ROP5 directly regulated activity of ROP18 in vitro, and both proteins were necessary to avoid IRG recruitment and clearance in macrophages.  Clearance of both the Δrop5 and Δrop18 mutants was reversed in macrophages lacking Irgm3, which is required for IRG function, and the virulence defect was fully restored in Irgm3-/- mice.  Our findings establish that the pseudokinase ROP5 controls the activity of ROP18, thereby blocking IRG mediated clearance in macrophages.  Addnl., ROP5 has other functions that are also Irgm3 and IFN-γ dependent, indicting it plays a general role in governing virulence factors that block immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovOrvMpFAA67Vg90H21EOLACvtfcHk0lh3MnCTYR7JQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCis7vP&md5=4600462dbd8bc9d56720b8af2a92354b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002992%26sid%3Dliteratum%253Aachs%26aulast%3DBehnke%26aufirst%3DM.%2BS.%26aulast%3DFentress%26aufirst%3DS.%2BJ.%26aulast%3DMashayekhi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%2BL.%26aulast%3DTaylor%26aufirst%3DG.%2BA.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DThe%2520polymorphic%2520pseudokinase%2520ROP5%2520controls%2520virulence%2520in%2520Toxoplasma%2520gondii%2520by%2520regulating%2520the%2520active%2520kinase%2520ROP18%26jtitle%3DPLoS%2520Pathog.%26date%3D2012%26volume%3D8%26doi%3D10.1371%2Fjournal.ppat.1002992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quezado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nath, A.</span></span> <span> </span><span class="NLM_article-title">HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">662</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2016.149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fnrneurol.2016.149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=27786246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqs7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=662-674&issue=11&author=L.+N.+Bowenauthor=B.+Smithauthor=D.+Reichauthor=M.+Quezadoauthor=A.+Nath&title=HIV-associated+opportunistic+CNS+infections%3A+pathophysiology%2C+diagnosis+and+treatment&doi=10.1038%2Fnrneurol.2016.149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment</span></div><div class="casAuthors">Bowen, Lauren N.; Smith, Bryan; Reich, Daniel; Quezado, Martha; Nath, Avindra</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">662-674</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nearly 30 years after the advent of antiretroviral therapy (ART), CNS opportunistic infections remain a major cause of morbidity and mortality in HIV-pos. individuals.  Unknown HIV-pos. disease status, antiretroviral drug resistance, poor drug compliance, and recreational drug abuse are factors that continue to influence the morbidity and mortality of infections.  The clin. and radiog. pattern of CNS opportunistic infections is unique in the setting of HIV infection: opportunistic infections in HIV-pos. patients often have characteristic clin. and radiol. presentations that can differ from the presentation of opportunistic infections in immunocompetent patients and are often sufficient to establish the diagnosis.  ART in the setting of these opportunistic infections can lead to a paradoxical worsening caused by an immune reconstitution inflammatory syndrome (IRIS).  In this Review, we discuss several of the most common CNS opportunistic infections: cerebral toxoplasmosis, progressive multifocal leukoencephalopathy (PML), tuberculous meningitis, cryptococcal meningitis and cytomegalovirus infection, with an emphasis on clin. pearls, pathol. findings, MRI findings and treatment.  Moreover, we discuss the risk factors, pathophysiol. and management of IRIS.  We also summarize the challenges that remain in management of CNS opportunistic infections, which includes the lack of phase II and III clin. trials, absence of antimicrobials for infections such as PML, and controversy regarding the use of corticosteroids for treatment of IRIS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDjBQM53c5lLVg90H21EOLACvtfcHk0lh3MnCTYR7JQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqs7nN&md5=e1ab369550e394f982d573c6c33e14d5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2016.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2016.149%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DL.%2BN.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DReich%26aufirst%3DD.%26aulast%3DQuezado%26aufirst%3DM.%26aulast%3DNath%26aufirst%3DA.%26atitle%3DHIV-associated%2520opportunistic%2520CNS%2520infections%253A%2520pathophysiology%252C%2520diagnosis%2520and%2520treatment%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2016%26volume%3D12%26issue%3D11%26spage%3D662%26epage%3D674%26doi%3D10.1038%2Fnrneurol.2016.149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, R. E.</span></span> <span> </span><span class="NLM_article-title">Antitoxoplasma Chemotherapy</span>. In  <i>Toxoplasmosis: A Comprehensive Clinical Guide</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joynson, D. H. M.</span>, <span class="NLM_string-name">Wreghitt, T. G.</span></span>, Eds.; <span class="NLM_publisher-name">Cambridge University Press</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2001</span>; pp  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">359</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1017%2FCBO9780511527005.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=319-359&author=R.+E.+McCabeauthor=D.+H.+M.+Joynson&author=T.+G.+Wreghitt&title=Toxoplasmosis%3A+A+Comprehensive+Clinical+Guide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1017%2FCBO9780511527005.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1017%252FCBO9780511527005.015%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DR.%2BE.%26atitle%3DAntitoxoplasma%2520Chemotherapy%26btitle%3DToxoplasmosis%253A%2520A%2520Comprehensive%2520Clinical%2520Guide%26aulast%3DJoynson%26aufirst%3DD.%2BH.%2BM.%26pub%3DCambridge%2520University%2520Press%26date%3D2001%26spage%3D319%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, L. J.</span></span> <span> </span><span class="NLM_article-title">A patatin-like protein protects <i>Toxoplasma gondii</i> from degradation in a nitric oxide-dependent manner</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1128/IAI.05543-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FIAI.05543-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=22006568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=55-61&issue=1&author=C.+M.+Tobinauthor=L.+J.+Knoll&title=A+patatin-like+protein+protects+Toxoplasma+gondii+from+degradation+in+a+nitric+oxide-dependent+manner&doi=10.1128%2FIAI.05543-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner</span></div><div class="casAuthors">Tobin, Crystal M.; Knoll, Laura J.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toxoplasma gondii is an obligate intracellular parasite that uses immune cells to disseminate throughout its host.  T. gondii can persist and even slowly replicate in activated host macrophages by reducing the antimicrobial effects of mols. such as nitric oxide (NO).  A T. gondii patatin-like protein called TgPL1 was previously shown to be important for survival in activated macrophages.  Here we show that a T. gondii mutant with a deletion of the TgPL1 gene (ΔTgPL1) is degraded in activated macrophages.  This degrdn. phenotype is abolished by the removal of NO by the use of an inducible NO synthase (iNOS) inhibitor or iNOS-deficient macrophages.  The exogenous addn. of NO to macrophages results in reduced parasite growth but not the degrdn. of ΔTgPL1 parasites.  These results suggest that NO is necessary but not sufficient for the degrdn. of ΔTgPL1 parasites in activated macrophages.  While some patatin-like proteins have phospholipase A2 (PLA2) activity, recombinant TgPL1 purified from Escherichia coli does not have phospholipase activity.  This result was not surprising, as TgPL1 contains a G-to-S change at the predicted catalytic serine residue.  An epitope-tagged version of TgPL1 partially colocalized with a dense granule protein in the parasitophorous vacuole space.  These results may suggest that TgPL1 moves to the parasitophorous vacuole to protect parasites from nitric oxide by an undetd. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU1uPDCKZvk7Vg90H21EOLACvtfcHk0lgSb-IpwY0Uhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlGitw%253D%253D&md5=4adbe39d3ed61bdd9d57a539cbe58e5f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FIAI.05543-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.05543-11%26sid%3Dliteratum%253Aachs%26aulast%3DTobin%26aufirst%3DC.%2BM.%26aulast%3DKnoll%26aufirst%3DL.%2BJ.%26atitle%3DA%2520patatin-like%2520protein%2520protects%2520Toxoplasma%2520gondii%2520from%2520degradation%2520in%2520a%2520nitric%2520oxide-dependent%2520manner%26jtitle%3DInfect.%2520Immun.%26date%3D2012%26volume%3D80%26issue%3D1%26spage%3D55%26epage%3D61%26doi%3D10.1128%2FIAI.05543-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nawas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title"><i>Toxoplasma gondii</i> strains defective in oral transmission are also defective in developmental stage differentiation</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2580</span>– <span class="NLM_lpage">2590</span>, <span class="refDoi"> DOI: 10.1128/IAI.00085-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FIAI.00085-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=17339346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsV2msbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2007&pages=2580-2590&issue=5&author=B.+Fuxauthor=J.+Nawasauthor=A.+Khanauthor=D.+B.+Gillauthor=C.+Suauthor=L.+D.+Sibley&title=Toxoplasma+gondii+strains+defective+in+oral+transmission+are+also+defective+in+developmental+stage+differentiation&doi=10.1128%2FIAI.00085-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii strains defective in oral transmission are also defective in developmental stage differentiation</span></div><div class="casAuthors">Fux, Blima; Nawas, Julie; Khan, Asis; Gill, Darcy B.; Su, Chunlei; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2580-2590</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toxoplasma gondii undergoes differentiation from rapidly growing tachyzoites to slowly growing bradyzoites during its life cycle in the intermediate host, and conversion can be induced in vitro by stress.  Representative strains of the three clonal lineages showed equal capacity to differentiate into bradyzoites in vitro, as evidenced by induction of bradyzoite antigen 1, staining with Dolichos biflorus lectin (DBL), pepsin resistance, and oral infectivity in mice.  The authors also examd. several recently described exotic strains of T. gondii, which are genetically diverse and have a different ancestry from the clonal lineages.  The exotic strain COUG was essentially like the clonal lineages and showed a high capacity to induce bradyzoites in vitro and in vivo, consistent with its ability to be efficiently transmitted by the oral route.  In contrast, exotic strains MAS and FOU, which are defective in oral transmission, showed a decreased potential to develop into bradyzoites in vitro.  This defect was evident from reduced staining with DBL and the cyst antigen CST1, failure to down-regulate tachyzoite antigens, such as tachyzoite surface antigens 1 and 2A, and decreased resistance to pepsin treatment.  Despite normal in vitro differentiation, the exotic strains CAST and GPHT also showed decreased oral transmission, due to formation of smaller cysts and a lower tissue burden during chronic infection, traits also shared by MAS and FOU.  Collectively, these findings reveal that the limited oral transmission in some strains of T. gondii is due to inefficient differentiation to the bradyzoite form, leading to defects in the formation of tissue cysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobxeb1fjjTGbVg90H21EOLACvtfcHk0lgSb-IpwY0Uhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsV2msbg%253D&md5=599861869356140a243b3f20fca000ba</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2FIAI.00085-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00085-07%26sid%3Dliteratum%253Aachs%26aulast%3DFux%26aufirst%3DB.%26aulast%3DNawas%26aufirst%3DJ.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DGill%26aufirst%3DD.%2BB.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DToxoplasma%2520gondii%2520strains%2520defective%2520in%2520oral%2520transmission%2520are%2520also%2520defective%2520in%2520developmental%2520stage%2520differentiation%26jtitle%3DInfect.%2520Immun.%26date%3D2007%26volume%3D75%26issue%3D5%26spage%3D2580%26epage%3D2590%26doi%3D10.1128%2FIAI.00085-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dunay, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Artemisone and artemiside control acute and reactivated toxoplasmosis in the murine model</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4450</span>– <span class="NLM_lpage">4456</span>, <span class="refDoi"> DOI: 10.1128/AAC.00502-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FAAC.00502-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=19635951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KkurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=4450-4456&author=I.+R.+Dunayauthor=W.+C.+Chanauthor=R.+K.+Haynesauthor=L.+D.+Sibley&title=Artemisone+and+artemiside+control+acute+and+reactivated+toxoplasmosis+in+the+murine+model&doi=10.1128%2FAAC.00502-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40aR"><div class="casContent"><span class="casTitleNuber">40a</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model</span></div><div class="casAuthors">Dunay, Ildiko R.; Chan, Wing Chi; Haynes, Richard K.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4450-4456</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Immunocompromised patients are at risk of developing toxoplasmosis, and although chemotherapy is available, std. treatments are often complicated by severe side effects.  Artemisinin is a new highly potent antimalarial drug that has activity against Toxoplasma gondii in vitro.  However, artemisinin derivs. have previously been ineffective in vivo using a rat model of toxoplasmosis.  In the present study, the efficacy of several new artemisinin derivates was investigated for treatment of mice infected with the parasite Toxoplasma gondii.  Artemiside and artemisone displayed better inhibition than either artemisinin or artesunate against the parasite in vitro.  Artemiside and artemisone treatment controlled parasite replication in vivo, and mice survived the acute infection.  In a murine model of reactivated toxoplasmosis, both drugs increased survival, although artemiside was more effective.  These results indicate that these newer derivs. of artemisinin may have potential for treatment of toxoplasmosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2MtmJjyOHtbVg90H21EOLACvtfcHk0lgSb-IpwY0Uhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KkurjJ&md5=e86b366adcbd75b40fc3101344613137</span></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1128%2FAAC.00502-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00502-09%26sid%3Dliteratum%253Aachs%26aulast%3DDunay%26aufirst%3DI.%2BR.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DHaynes%26aufirst%3DR.%2BK.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DArtemisone%2520and%2520artemiside%2520control%2520acute%2520and%2520reactivated%2520toxoplasmosis%2520in%2520the%2520murine%2520model%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D4450%26epage%3D4456%26doi%3D10.1128%2FAAC.00502-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit40b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dunay, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimesaat, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushrab, F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arasteh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liesenfeld, O.</span></span> <span> </span><span class="NLM_article-title">Atovaquone maintenance therapy prevents reactivation of toxopasmic encepahalitis in the murine model of reactivated toxoplasmosis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4848</span>– <span class="NLM_lpage">4854</span>, <span class="refDoi"> DOI: 10.1128/AAC.48.12.4848-4854.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FAAC.48.12.4848-4854.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=15561866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKmt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=4848-4854&author=I.+R.+Dunayauthor=M.+M.+Heimesaatauthor=F.+N.+Bushrabauthor=R.+H.+Mullerauthor=H.+Stockerauthor=K.+Arastehauthor=M.+Kurowskiauthor=R.+Fitznerauthor=K.+Bornerauthor=O.+Liesenfeld&title=Atovaquone+maintenance+therapy+prevents+reactivation+of+toxopasmic+encepahalitis+in+the+murine+model+of+reactivated+toxoplasmosis&doi=10.1128%2FAAC.48.12.4848-4854.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40bR"><div class="casContent"><span class="casTitleNuber">40b</span><div class="casTitle"><span class="NLM_cas:atitle">Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis</span></div><div class="casAuthors">Dunay, Ildiko R.; Heimesaat, Markus M.; Bushrab, Faris Nadiem; Mueller, Rainer H.; Stocker, Hartmut; Arasteh, Keikawus; Kurowski, Michael; Fitzner, Rudolf; Borner, Klaus; Liesenfeld, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4848-4854</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Acute therapy with pyrimethamine plus sulfadiazine is the treatment of choice for reactivated toxoplasmic encephalitis (TE).  Acute therapy is followed by lifelong maintenance therapy (secondary prophylaxis) with the same drugs at lower dosages.  The use of pyrimethamine plus sulfadiazine is hampered by severe side effects including allergic reactions and hematotoxicity.  Alternative treatment regimens with pyrimethamine plus clindamycin or other antiparasitic drugs are less efficacious.  Atovaquone nanosuspensions show excellent therapeutic effects for "acute" i.v. treatment of reactivated TE in a murine model.  In the present study, the therapeutic efficacy of atovaquone for oral "maintenance" therapy was investigated.  Mice with a targeted mutation in the interferon regulatory factor 8 gene were latently infected with Toxoplasma gondii, developed reactivated TE, and received acute i.v. therapy with atovaquone nanosuspensions.  Mice were then treated orally with atovaquone suspension or other antiparasitic drugs to prevent relapse of TE.  Maintenance therapy with atovaquone at daily doses of 50 or 100 mg/kg (body wt.) protected mice against reactivated TE and death.  This maintenance treatment was superior to std. therapy with pyrimethamine plus sulfadiazine.  The latter combination was superior to the combination of pyrimethamine plus clindamycin.  Inflammatory changes in the brain parenchyma and meninges, as well as parasite nos., in the brains of mice confirmed the therapeutic efficacy of atovaquone for maintenance therapy.  Atovaquone was detectable in sera, brains, livers, and lungs of infected mice by high-performance liq. chromatog. and/or mass spectrometry.  In conclusion, atovaquone appears to be superior to the std. maintenance therapy regimens in a murine model of reactivated TE.  The therapeutic efficacy of atovaquone for maintenance therapy against TE should be further investigated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKPKQMmt7eL7Vg90H21EOLACvtfcHk0liXmpVCvSbcKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKmt7vJ&md5=3a5c765f82509aa8b1121dbb28720c33</span></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.12.4848-4854.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.12.4848-4854.2004%26sid%3Dliteratum%253Aachs%26aulast%3DDunay%26aufirst%3DI.%2BR.%26aulast%3DHeimesaat%26aufirst%3DM.%2BM.%26aulast%3DBushrab%26aufirst%3DF.%2BN.%26aulast%3DMuller%26aufirst%3DR.%2BH.%26aulast%3DStocker%26aufirst%3DH.%26aulast%3DArasteh%26aufirst%3DK.%26aulast%3DKurowski%26aufirst%3DM.%26aulast%3DFitzner%26aufirst%3DR.%26aulast%3DBorner%26aufirst%3DK.%26aulast%3DLiesenfeld%26aufirst%3DO.%26atitle%3DAtovaquone%2520maintenance%2520therapy%2520prevents%2520reactivation%2520of%2520toxopasmic%2520encepahalitis%2520in%2520the%2520murine%2520model%2520of%2520reactivated%2520toxoplasmosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D4848%26epage%3D4854%26doi%3D10.1128%2FAAC.48.12.4848-4854.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darde, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Geographic separation of domestic and wild strains of <i>Toxoplasma gondii</i> in French Guiana correlates with a monomorphic version of chromosome1a</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e3182</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0003182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1371%2Fjournal.pntd.0003182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=25233228" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&author=A.+Khanauthor=D.+Ajzenbergauthor=A.+Mercierauthor=M.+Demarauthor=S.+Simonauthor=M.+L.+Dardeauthor=Q.+Wangauthor=S.+K.+Vermaauthor=B.+M.+Rosenthalauthor=J.+P.+Dubeyauthor=L.+D.+Sibley&title=Geographic+separation+of+domestic+and+wild+strains+of+Toxoplasma+gondii+in+French+Guiana+correlates+with+a+monomorphic+version+of+chromosome1a&doi=10.1371%2Fjournal.pntd.0003182"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0003182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0003182%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DMercier%26aufirst%3DA.%26aulast%3DDemar%26aufirst%3DM.%26aulast%3DSimon%26aufirst%3DS.%26aulast%3DDarde%26aufirst%3DM.%2BL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DRosenthal%26aufirst%3DB.%2BM.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DGeographic%2520separation%2520of%2520domestic%2520and%2520wild%2520strains%2520of%2520Toxoplasma%2520gondii%2520in%2520French%2520Guiana%2520correlates%2520with%2520a%2520monomorphic%2520version%2520of%2520chromosome1a%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26doi%3D10.1371%2Fjournal.pntd.0003182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volkamer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rippmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulle, S.</span></span> <span> </span><span class="NLM_article-title">KinMap: a web-based tool for interactive navigation through human kinome data</span>. <i>BMC Bioinf.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">16</span>, <span class="refDoi"> DOI: 10.1186/s12859-016-1433-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1186%2Fs12859-016-1433-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=28056780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=16&issue=1&author=S.+Eidauthor=S.+Turkauthor=A.+Volkamerauthor=F.+Rippmannauthor=S.+Fulle&title=KinMap%3A+a+web-based+tool+for+interactive+navigation+through+human+kinome+data&doi=10.1186%2Fs12859-016-1433-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">KinMap: a web-based tool for interactive navigation through human kinome data</span></div><div class="casAuthors">Eid, Sameh; Turk, Samo; Volkamer, Andrea; Rippmann, Friedrich; Fulle, Simone</div><div class="citationInfo"><span class="NLM_cas:title">BMC Bioinformatics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16/1-16/6</span>CODEN:
                <span class="NLM_cas:coden">BBMIC4</span>;
        ISSN:<span class="NLM_cas:issn">1471-2105</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Annotations of the phylogenetic tree of the human kinome is an intuitive way to visualize compd. profiling data, structural features of kinases or functional relationships within this important class of proteins.  The increasing vol. and complexity of kinase-related data underlines the need for a tool that enables complex queries pertaining to kinase disease involvement and potential therapeutic uses of kinase inhibitors.  Results: Here, we present KinMap, a user-friendly online tool that facilitates the interactive navigation through kinase knowledge by linking biochem., structural, and disease assocn. data to the human kinome tree.  To this end, preprocessed data from freely-available sources, such as ChEMBL, the Protein Data Bank, and the Center for Therapeutic Target Validation platform are integrated into KinMap and can easily be complemented by proprietary data.  The value of KinMap will be exemplarily demonstrated for uncovering new therapeutic indications of known kinase inhibitors and for prioritizing kinases for drug development efforts.  Conclusions: KinMap represents a new generation of kinome tree viewers which facilitates interactive exploration of the human kinome.  KinMap enables generation of high-quality annotated images of the human kinome tree as well as exchange of kinome-related data in scientific communications.  Furthermore, KinMap supports multiple input and output formats and recognizes alternative kinase names and links them to a unified naming scheme, which makes it a useful tool across different disciplines and applications.  A web-service of KinMap is freely available at http://www.kinhub.org/kinmap/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1M2aa8fuKALVg90H21EOLACvtfcHk0liXmpVCvSbcKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCjtLc%253D&md5=29737c7cda8d9caf75018e0d29e9a459</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1186%2Fs12859-016-1433-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12859-016-1433-7%26sid%3Dliteratum%253Aachs%26aulast%3DEid%26aufirst%3DS.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DVolkamer%26aufirst%3DA.%26aulast%3DRippmann%26aufirst%3DF.%26aulast%3DFulle%26aufirst%3DS.%26atitle%3DKinMap%253A%2520a%2520web-based%2520tool%2520for%2520interactive%2520navigation%2520through%2520human%2520kinome%2520data%26jtitle%3DBMC%2520Bioinf.%26date%3D2017%26volume%3D18%26issue%3D1%26spage%3D16%26doi%3D10.1186%2Fs12859-016-1433-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b'],'ref15':['cit15a','cit15b','cit15c'],'ref16':['cit16a','cit16b','cit16c'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34a','cit34b'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40a','cit40b'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sherlin Rosita Arokiaraj, Nargis Begum Tajuddin, Karthikeyan Muthusamy, John Marshal Jayaraj, <span class="NLM_string-name hlFld-ContribAuthor">Manikandan Alagumuthu</span>. </span><span class="cited-content_cbyCitation_article-title">TRAF2 and NCK-Interacting Kinase Inhibitors for Colorectal Cancer: In Vitro and Theoretical Validations. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2020,</strong> <em>22 </em>
                                    (11)
                                     , 608-616. <a href="https://doi.org/10.1021/acscombsci.0c00027" title="DOI URL">https://doi.org/10.1021/acscombsci.0c00027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.0c00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.0c00027%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DTRAF2%252Band%252BNCK-Interacting%252BKinase%252BInhibitors%252Bfor%252BColorectal%252BCancer%25253A%252BIn%252BVitro%252Band%252BTheoretical%252BValidations%26aulast%3DArokiaraj%26aufirst%3DSherlin%2BRosita%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14022020%26date%3D19092020%26date%3D29092020%26date%3D22092020%26volume%3D22%26issue%3D11%26spage%3D608%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir  Ogurtsov</span>, <span class="hlFld-ContribAuthor ">Oleg  Rakitin</span>. </span><span class="cited-content_cbyCitation_article-title">4-Chloro-6-(chloromethyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">Molbank</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (3)
                                     , M1253. <a href="https://doi.org/10.3390/M1253" title="DOI URL">https://doi.org/10.3390/M1253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/M1253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2FM1253%26sid%3Dliteratum%253Aachs%26jtitle%3DMolbank%26atitle%3D4-Chloro-6-%252528chloromethyl%252529-1-methyl-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidine%26aulast%3DOgurtsov%26aufirst%3DVladimir%26date%3D2021%26date%3D2021%26volume%3D2021%26issue%3D3%26spage%3DM1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumit K.  Matta</span>, <span class="hlFld-ContribAuthor ">Nicholas  Rinkenberger</span>, <span class="hlFld-ContribAuthor ">Ildiko R.  Dunay</span>, <span class="hlFld-ContribAuthor ">L. David  Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">Toxoplasma gondii infection and its implications within the central nervous system. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Microbiology</span><span> <strong>2021,</strong> <em>19 </em>
                                    (7)
                                     , 467-480. <a href="https://doi.org/10.1038/s41579-021-00518-7" title="DOI URL">https://doi.org/10.1038/s41579-021-00518-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41579-021-00518-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41579-021-00518-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Microbiology%26atitle%3DToxoplasma%252Bgondii%252Binfection%252Band%252Bits%252Bimplications%252Bwithin%252Bthe%252Bcentral%252Bnervous%252Bsystem%26aulast%3DMatta%26aufirst%3DSumit%2BK.%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D7%26spage%3D467%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lalita  Devi</span>, <span class="hlFld-ContribAuthor ">Gaurav  Sharma</span>, <span class="hlFld-ContribAuthor ">Ruchir  Kant</span>, <span class="hlFld-ContribAuthor ">Sanjeev K.  Shukla</span>, <span class="hlFld-ContribAuthor ">Namrata  Rastogi</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective synthesis of functionalized pyrazole-chalcones
              via
              a base mediated reaction of diazo compounds with pyrylium salts. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (18)
                                     , 4132-4136. <a href="https://doi.org/10.1039/D1OB00274K" title="DOI URL">https://doi.org/10.1039/D1OB00274K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00274K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00274K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRegioselective%252Bsynthesis%252Bof%252Bfunctionalized%252Bpyrazole-chalcones%252Bvia%252Ba%252Bbase%252Bmediated%252Breaction%252Bof%252Bdiazo%252Bcompounds%252Bwith%252Bpyrylium%252Bsalts%26aulast%3DDevi%26aufirst%3DLalita%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D18%26spage%3D4132%26epage%3D4136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas C.  Smith</span>, <span class="hlFld-ContribAuthor ">Cibelly  Goulart</span>, <span class="hlFld-ContribAuthor ">Jenni A.  Hayward</span>, <span class="hlFld-ContribAuthor ">Andreas  Kupz</span>, <span class="hlFld-ContribAuthor ">Catherine M.  Miller</span>, <span class="hlFld-ContribAuthor ">Giel G.  van Dooren</span>. </span><span class="cited-content_cbyCitation_article-title">Control of human toxoplasmosis. </span><span class="cited-content_cbyCitation_journal-name">International Journal for Parasitology</span><span> <strong>2021,</strong> <em>51 </em>
                                    (2-3)
                                     , 95-121. <a href="https://doi.org/10.1016/j.ijpara.2020.11.001" title="DOI URL">https://doi.org/10.1016/j.ijpara.2020.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpara.2020.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpara.2020.11.001%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520for%2520Parasitology%26atitle%3DControl%252Bof%252Bhuman%252Btoxoplasmosis%26aulast%3DSmith%26aufirst%3DNicholas%2BC.%26date%3D2021%26volume%3D51%26issue%3D2-3%26spage%3D95%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Models of (A) 2-pyridyl-5-chloro PP <b>2b</b> and (B) 2-pyridyl-5-hydroxy PP <b>4l</b> (tBu R2) based on X-ray structure of <b>1b</b> bound to CDPK1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IHP">4IHP</a>). Residues that are thought to make contacts are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Stereochemistry of <b>6j</b>: (A) structure of compound showing stereochemistry of <b>6j</b>; (B) small molecule X-ray structure of <b>6j</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Cyclopropyl R2 Library with Varied Aryl R1 Ethers (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) Exemplified by <b>3a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) di-<i>tert</i>-butyl (<i>E</i>)-diazene-1,2-dicarboxylate, Cu(OAc)<sub>2,</sub> DMF, 4 days; (b) HCI, EtOAc, 25 °C, 3 h; (c) 2-chloroethyl carbonochloridate, NaOH, MeCN, 0–90 °C, 18 h; (d) TEA, EtOH, 90 °C, 3 h; (e) formamide, 180 °C, 4 h; (f) KOH/Ph<sub>2</sub>O, 180 °C, 3 h; (g) 2-chloro-4- (trifluoromethyl)pyridine, K<sub>2</sub>CO<sub>3</sub>, DMSO, 120 °C.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2-Pyridyl-4-CF<sub>3</sub> R1 Library with Varied R2 Groups (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) Exemplified by <b>2a</b> and <b>6j</b><sup><i>a</i></sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2-Pyridyl-4-CN Ether R1 PP Compounds with Varied R2 Groups (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) Exemplified by <b>2c</b> and <b>10c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-bromoisonicotinonitrile, DMSO, K<sub>2</sub>CO<sub>3</sub>, 120 °C, 12 h; (b) H<sub>2</sub>SO<sub>4</sub>, 0 °C, 0.5 h; (c) TFAA, pyridine; (d) pyridine, MeOH; (e) MsCI, TEA, DCM,; (f) Cs<sub>2</sub>CO<sub>3</sub>, Kl, DMA, 66 °C, 40 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Phenyl Ether R1 PP Compounds with Varied R2 Groups (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) Exemplified by <b>15a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF 70 °C, 16 h; (b) BCI<sub>3</sub>, DCM, −60 to 0 °C, 3 h; (c) Boc<sub>2</sub>O, LiHMDS, THF, −60 to 20 °C, 1.5 h; (d) DAST, DCM, −60 to 20 °C, 2 h; (e) HCl, MeOH, 20 °C, 3 h; (f) 3-(trifluoromethyl)phenol, Cs<sub>2</sub>CO<sub>3</sub>, CuCI, TMHD, NMP, 200 °C, 3 h, microwave; (g) (i) 4-nitrobenzoic acid, DIAD, PPh<sub>3</sub>, toluene, 0–25 °C, 12 h, (ii) NaOH (2 M), dioxane, 25 °C, 2 h; (h) MsCI, TEA, DCM, 0–25 °C, 3 h.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of CDPK1 enzyme activity and parasite growth by lead compounds: (A) structures of three top leads; (B) inhibition of CDPK1 enzyme <i>in vitro</i>; (C) inhibition of parasite growth in HFF cells. Each data point in the dilution series is the average of two technical replicates. Control refers to no compound. Curves were fit using nonlinear regression analysis based on sigmoidal dose–response curves with variable slope.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of human kinase targets by <b>3a</b> based on a human kinome-wide screen (ThermoFischer). Compounds were tested in duplicate at 1 μM using ATP levels that matched the kinase <i>K</i><sub>m</sub> or using Lantha-Screen binding assays in the absence of ATP. Targets shown in red were inhibited by ∼50%. See <a href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf" class="ext-link">Table S1</a> for further details. The kinome tree was generated using KinMap,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and the image was reproduced courtesy of Cell Signaling Technology, Inc. (<a href="http://www.cellsignaling.com" class="extLink">www.cellsignaling.com</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <i>In vivo</i> pharmacokinetics and efficacy of compound <b>3a</b> in protecting against acute toxoplasmosis. (A) Model of experimental design. (B) PK analysis of escalating doses of <b>3a</b> delivered by oral gavage to adult female mice. Values plotted are free plasma levels based on estimation of % nonbound to serum proteins (<i>n</i> = 3 animals per group). For comparison the nonbound fractions equivalent to the EC<sub>50</sub>, 3 × EC<sub>50</sub>, and EC<sub>90</sub>, based on <i>in vitro</i> growth inhibition in HFF cells, are shown. (C) Groups of outbred female CD1 mice were infected with 3000 tachyzoites of the type 1 RH strain by ip inoculation, and compound <b>3a</b> was administered as shown by oral gavage for seven successive days beginning 24 h after infection (day 0). The control group had 9 animals and the treatment groups each had 12 animals. Expansion of parasite numbers and dissemination was monitored by bioluminescence imaging. Image shown is from 5 days postinfection. (D) Survival curves for animals inoculated and treated as described in (C). Control animals in (C) and (D) received vehicle only (0.5% CMC). (E) Surviving animals in (D) were sacrificed at day 15, and homogenates of lung and brain were injected into naïve recipient mice (1 recipient for each surviving animal) that were not further treated with compound. Survival curves of recipient mice are shown. Negative control animals were inoculated only with vehicle control (0.5% CMC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/medium/jm0c00419_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Efficacy of <b>3a</b> in protecting against reactivation of chronic infection in immunocompromised mice. (A) A mixture of male and female Ifngr1<sup>–/–</sup> mice was infected with five tissue cysts of the type II ME49 strain by oral gavage. Mice were given sulfadiazine (0.25 g/L in drinking water) from day 3 to day 22 to suppress tachyzoite growth and prevent death during the acute phase. At 48 h after removal of sulfadiazine, compound <b>3a</b> was administered by oral gavage at the doses indicated for 8 or 21 successive days. (B) PK of animals dosed orally with 60, 90, or 120 mg/kg BID (<i>n</i> = 3 animals per group). Free plasma levels are plotted relative to EC<sub>50</sub>, 3 × EC<sub>50</sub>, and EC<sub>90</sub> levels. (C) Weight loss following removal of sulfadiazine and administration of <b>3a</b>. (D) Survival curves for mice following removal of sulfadiazine and administration of <b>3a</b> at the indicated doses. Control animals received vehicle control (0.5% CMC, 0.1% Tween 80). For (C) and (D), 8 animals were used for the control and 6 animals each for the treatment groups. (E) Comparison of percent survival vs time and concentration of treatment with <b>3a</b> (<i>n</i> = 6 animals per group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00419/20200604/images/large/jm0c00419_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00419&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45116" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45116" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span> <i>Toxoplasmosis of Animals and Humans</i>; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>, <span class="NLM_year">2010</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">313</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=1-313&author=J.+P.+Dubey&title=Toxoplasmosis+of+Animals+and+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26btitle%3DToxoplasmosis%2520of%2520Animals%2520and%2520Humans%26pub%3DCRC%2520Press%26date%3D2010%26spage%3D1%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>, <span> </span><span class="NLM_article-title">The Life Cycle of <i>Toxoplasma gondii</i></span>. In  <i>Toxoplasma: Molecular and Cellular Biology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, J. W.</span>, <span class="NLM_string-name">Soldati, D.</span></span>, Eds.; <span class="NLM_publisher-name">Horizon Bioscience</span>: <span class="NLM_publisher-loc">Norfolk, U.K.</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">16</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2FB978-012369542-0%2F50003-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=3-16&author=J.+P.+Dubeyauthor=J.+W.+Ajioka&author=D.+Soldati&title=Toxoplasma%3A+Molecular+and+Cellular+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FB978-012369542-0%2F50003-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-012369542-0%252F50003-9%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520Life%2520Cycle%2520of%2520Toxoplasma%2520gondii%26btitle%3DToxoplasma%253A%2520Molecular%2520and%2520Cellular%2520Biology%26aulast%3DAjioka%26aufirst%3DJ.%2BW.%26pub%3DHorizon%2520Bioscience%26date%3D2007%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patwardhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinai, A. P.</span></span> <span> </span><span class="NLM_article-title">Novel approaches reveal that <i>Toxoplasma gondii</i> bradyzoites within tissue cysts are dynamic andreplicating entities in vivo</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e01155-15</span> <span class="refDoi"> DOI: 10.1128/mBio.01155-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FmBio.01155-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=26350965" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&issue=5&author=E.+Wattsauthor=Y.+Zhaoauthor=A.+Dharaauthor=B.+Ellerauthor=A.+Patwardhanauthor=A.+P.+Sinai&title=Novel+approaches+reveal+that+Toxoplasma+gondii+bradyzoites+within+tissue+cysts+are+dynamic+andreplicating+entities+in+vivo&doi=10.1128%2FmBio.01155-15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FmBio.01155-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01155-15%26sid%3Dliteratum%253Aachs%26aulast%3DWatts%26aufirst%3DE.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DDhara%26aufirst%3DA.%26aulast%3DEller%26aufirst%3DB.%26aulast%3DPatwardhan%26aufirst%3DA.%26aulast%3DSinai%26aufirst%3DA.%2BP.%26atitle%3DNovel%2520approaches%2520reveal%2520that%2520Toxoplasma%2520gondii%2520bradyzoites%2520within%2520tissue%2520cysts%2520are%2520dynamic%2520andreplicating%2520entities%2520in%2520vivo%26jtitle%3DmBio%26date%3D2015%26volume%3D6%26issue%3D5%26doi%3D10.1128%2FmBio.01155-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bhadra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobb, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span> <span> </span><span class="NLM_article-title">Donor CD8+ T cells prevent <i>Toxoplasma gondii</i> de-encystation but fail to rescue the exhausted endogenous CD8+ T cell population</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3414</span>– <span class="NLM_lpage">3425</span>, <span class="refDoi"> DOI: 10.1128/IAI.00784-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FIAI.00784-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=23817617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCmurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=3414-3425&issue=9&author=R.+Bhadraauthor=D.+A.+Cobbauthor=I.+A.+Khan&title=Donor+CD8%2B+T+cells+prevent+Toxoplasma+gondii+de-encystation+but+fail+to+rescue+the+exhausted+endogenous+CD8%2B+T+cell+population&doi=10.1128%2FIAI.00784-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Donor CD8+ T cells prevent Toxoplasma gondii de-encystation but fail to rescue the exhausted endogenous CD8+ T cell population</span></div><div class="casAuthors">Bhadra, Rajarshi; Cobb, Dustin A.; Khan, Imtiaz A.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3414-3425</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">1098-5522</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Functional exhaustion of CD8+ T cells due to increased expression of inhibitory mol. PD-1 (Programmed Death-1) causes reactivation of latent disease during later phases of chronic toxoplasmosis.  Onset of disease recrudescence results in decreased parasite cyst burden concomitant with parasites undergoing stage conversion from a primarily encysted, quiescent bradyzoite to a fast-replicating, highly motile tachyzoite.  Thus, reduced cyst burden is one of the early hallmarks of disease recrudescence.  This was further validated by depleting gamma interferon (IFN-γ), a cytokine known to control latent toxoplasmosis, in chronically infected prerecrudescent mice.  Since CD8+ T cells (an important source of IFN-γ) lose their functionality during the later phases of chronic toxoplasmosis, we next examd. if adoptive transfer of functional CD8+ T cells from acutely infected donors to the chronically infected prerecrudescent hosts could impede parasite de-encystation and rescue exhausted CD8+ T cells.  While the transfer of immune CD8+ T cells temporarily restricted the breakdown of cysts, the exhausted endogenous CD8+ T cell population was not rescued.  Over time, the donor population got deleted, resulting in parasite de-encystation and host mortality.  Considering that donor CD8+ T cells fail to become long-lived, one of the cardinal features of memory CD8+ T cells, it bears the implication that memory CD8 differentiation is impaired during chronic toxoplasmosis.  Moreover, our data strongly suggest that while adoptive immunotherapy can prevent parasite de-encystation transiently, reduced antigen burden in the chronic phase by itself is insufficient for rescue of exhausted CD8+ T cells.  The conclusions of this study have profound ramifications in designing immunotherapeutics against chronic toxoplasmosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpofhC0pfj1w7Vg90H21EOLACvtfcHk0lgw6HLdEvXg7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCmurzF&md5=7157a35ac31357280abfebcabd22d3bc</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1128%2FIAI.00784-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00784-12%26sid%3Dliteratum%253Aachs%26aulast%3DBhadra%26aufirst%3DR.%26aulast%3DCobb%26aufirst%3DD.%2BA.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26atitle%3DDonor%2520CD8%252B%2520T%2520cells%2520prevent%2520Toxoplasma%2520gondii%2520de-encystation%2520but%2520fail%2520to%2520rescue%2520the%2520exhausted%2520endogenous%2520CD8%252B%2520T%2520cell%2520population%26jtitle%3DInfect.%2520Immun.%26date%3D2013%26volume%3D81%26issue%3D9%26spage%3D3414%26epage%3D3425%26doi%3D10.1128%2FIAI.00784-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escajadillo, A.</span></span> <span> </span><span class="NLM_article-title">Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.4269/ajtmh.1987.36.517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.4269%2Fajtmh.1987.36.517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=3578650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADyaL2s3htVOqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1987&pages=517-522&author=J.+K.+Frenkelauthor=A.+Escajadillo&title=Cyst+rupture+as+a+pathogenic+mechanism+of+toxoplasmic+encephalitis&doi=10.4269%2Fajtmh.1987.36.517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis</span></div><div class="casAuthors">Frenkel J K; Escajadillo A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of tropical medicine and hygiene</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-22</span>
        ISSN:<span class="NLM_cas:issn">0002-9637</span>.
    </div><div class="casAbstract">Seemingly intact cysts and sequential stages of disintegrating cysts of Toxoplasma were identified immunohistologically within developing microglial nodules in a Panamanian night monkey (Aotus lemurinus).  This monkey had been successfully immunized and challenged 5 months earlier.  This supports the hypothesis that glial nodules unassociated with Toxoplasma tachyzoites may represent the tombstone of a Toxoplasma cyst.  Disintegration of cysts may give rise to clinical encephalitis in the presence of apparently adequate immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQr2YqyF9iY_oxhnOQkIHOxfW6udTcc2eYM_DmwBcNP7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s3htVOqsw%253D%253D&md5=0ba6191c6a21b744d44729ca198b4891</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.1987.36.517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.1987.36.517%26sid%3Dliteratum%253Aachs%26aulast%3DFrenkel%26aufirst%3DJ.%2BK.%26aulast%3DEscajadillo%26aufirst%3DA.%26atitle%3DCyst%2520rupture%2520as%2520a%2520pathogenic%2520mechanism%2520of%2520toxoplasmic%2520encephalitis%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D1987%26volume%3D36%26spage%3D517%26epage%3D522%26doi%3D10.4269%2Fajtmh.1987.36.517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, J. K.</span></span> <span> </span><span class="NLM_article-title">The <i>Toxoplasma gondii</i> oocyst from cat feces</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1084/jem.132.4.636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1084%2Fjem.132.4.636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=4927658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADyaE3MXivFajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=1970&pages=636-662&issue=4&author=J.+P.+Dubeyauthor=N.+L.+Millerauthor=J.+K.+Frenkel&title=The+Toxoplasma+gondii+oocyst+from+cat+feces&doi=10.1084%2Fjem.132.4.636"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii oocyst from cat feces</span></div><div class="casAuthors">Dubey, J. P.; Miller, Nancy L.; Frenkel, J. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">636-62</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    </div><div class="casAbstract">Coccidian oocysts resembling those of Isospora bigemina were excreted by cats fed Toxoplasma cysts, trophozoites, or oocysts.  Oocysts could not be sepd. from infectivity by filtration, by continuous particle electrophoresis, or by d. gradient centrifugation.  Excystation of oocysts was followed by an increase in titer of Toxoplasma infectivity.  Unsporulated oocysts in fresh cat feces were noninfectious to mince, but oocyst sporulation was assocd. quant. with the development of infectivity at different temps. and conditions of oxygenation; max. oocyst sporulation at 48 hr correlated with the development of max.  Toxoplasma infectivity.  H2SO4 (1-2%) and K2Cr2O7 (2.5%) were the best preservatives for sporulation of oocysts and for the development of Toxoplasma infectivity.  Low sporulation rates in 0.1% formalin, 20% EtOH, and water were assocd. with low infectivity in these reagents.  Oocysts, sporocysts, and sporozoites were stained specifically with Toxoplasma antibody in the indirect fluorescent antibody test.  Typical coccidian stages, schizonts and male and female gametocytes were found in the epithelium of the small intestine of kittens fed Toxoplasma cysts.  The classification of T. gondii is discussed in relation to that of other isosporan coccidia of cats and dogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonExDvHAtIj7Vg90H21EOLACvtfcHk0lgw6HLdEvXg7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXivFajsg%253D%253D&md5=db70ab7b71a52a32075ebe18633cf0bf</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1084%2Fjem.132.4.636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.132.4.636%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DMiller%26aufirst%3DN.%2BL.%26aulast%3DFrenkel%26aufirst%3DJ.%2BK.%26atitle%3DThe%2520Toxoplasma%2520gondii%2520oocyst%2520from%2520cat%2520feces%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1970%26volume%3D132%26issue%3D4%26spage%3D636%26epage%3D662%26doi%3D10.1084%2Fjem.132.4.636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. L.</span></span> <span> </span><span class="NLM_article-title"><i>Toxoplasma gondii</i> in cats: fecal stages identified as coccidian oocysts</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">896</span>, <span class="refDoi"> DOI: 10.1126/science.167.3919.893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1126%2Fscience.167.3919.893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=4903651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADyaE3c%252Fot1Kguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=1970&pages=893-896&author=J.+K.+Frenkelauthor=J.+P.+Dubeyauthor=N.+L.+Miller&title=Toxoplasma+gondii+in+cats%3A+fecal+stages+identified+as+coccidian+oocysts&doi=10.1126%2Fscience.167.3919.893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts</span></div><div class="casAuthors">Frenkel J K; Dubey J P; Miller N L</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">3919</span>),
    <span class="NLM_cas:pages">893-6</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Isospora-type oocysts were excreted by cats following the ingestion of Toxoplasma fromn infected mice.  Oocysts appeared 3 to 5 days after cyst. were ingested and 8 to 10 days after trophozoites were ingested, and also 21 to 24 days after the administration of infective fecal suspensions from cats.  A close quanititative and biologic correlation between oocysts and Toxoplasma infectivity of the feces was observed which could not be separated by density gradient centrifugation and filtration methods.  Toxoplasma is an intestinal coccidian of cats which is fecally spread.  It has evolved to multiply in brain and muscle and in other species, making it possible for carnivorism to become another means of transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE0mwzDXU9t3p3bfzSLaX5fW6udTcc2eYoMYGQ_GWUZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3c%252Fot1Kguw%253D%253D&md5=4c5e90c6ae2a1405bb1f0d199e8e86bf</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1126%2Fscience.167.3919.893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.167.3919.893%26sid%3Dliteratum%253Aachs%26aulast%3DFrenkel%26aufirst%3DJ.%2BK.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DMiller%26aufirst%3DN.%2BL.%26atitle%3DToxoplasma%2520gondii%2520in%2520cats%253A%2520fecal%2520stages%2520identified%2520as%2520coccidian%2520oocysts%26jtitle%3DScience%26date%3D1970%26volume%3D167%26spage%3D893%26epage%3D896%26doi%3D10.1126%2Fscience.167.3919.893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span> <span> </span><span class="NLM_article-title">Foodborne toxoplasmosis</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">845</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1093/cid/cis508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1093%2Fcid%2Fcis508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=22618566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADC%252BC38nlsVahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=845-851&author=J.+L.+Jonesauthor=J.+P.+Dubey&title=Foodborne+toxoplasmosis&doi=10.1093%2Fcid%2Fcis508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Foodborne toxoplasmosis</span></div><div class="casAuthors">Jones Jeffrey L; Dubey J P</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">845-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Toxoplasmosis can be due to congenital infection or acquired infection after birth and is one of the leading illnesses associated with foodborne hospitalizations and deaths.  Undercooked meat, especially pork, lamb, and wild game meat, and soil contaminated with cat feces on raw fruits and vegetables are the major sources of foodborne transmission for humans.  The new trend in the production of free-range organically raised meat could increase the risk of Toxoplasma gondii contamination of meat.  Foodborne transmission can be prevented by production practices that reduce T. gondii in meat, adequate cooking of meat, washing of raw fruits and vegetables, prevention of cross contamination in the kitchen, and measures that decrease spread of viable oocysts into the environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZHBKCRvyu4vEeosoOnpOLfW6udTcc2eYoMYGQ_GWUZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nlsVahsQ%253D%253D&md5=1cc4f6e240f27c8c02286f77039cac79</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcis508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcis508%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DJ.%2BL.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26atitle%3DFoodborne%2520toxoplasmosis%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26spage%3D845%26epage%3D851%26doi%3D10.1093%2Fcid%2Fcis508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span> <span> </span><span class="NLM_article-title">Waterborne toxoplasmosis--recent developments</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2009.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.exppara.2009.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=19324041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252FltlWitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2010&pages=10-25&issue=1&author=J.+L.+Jonesauthor=J.+P.+Dubey&title=Waterborne+toxoplasmosis%2D%2Drecent+developments&doi=10.1016%2Fj.exppara.2009.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Waterborne toxoplasmosis--recent developments</span></div><div class="casAuthors">Jones J L; Dubey J P</div><div class="citationInfo"><span class="NLM_cas:title">Experimental parasitology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Humans become infected with Toxoplasma gondii mainly by ingesting uncooked meat containing viable tissue cysts or by ingesting food or water contaminated with oocysts from the feces of infected cats.  Circumstantial evidence suggests that oocyst-induced infections in humans are clinically more severe than tissue cyst-acquired infections.  Until recently, waterborne transmission of T. gondii was considered uncommon, but a large human outbreak linked to contamination of a municipal water reservoir in Canada by wild felids and the widespread infection of marine mammals in the USA provided reasons to question this view.  The present paper examines the possible importance of T. gondii transmission by water.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8Al8ZjJ5UXo2y4bB4mnvYfW6udTcc2eYoMYGQ_GWUZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252FltlWitA%253D%253D&md5=4065ec5c0037bed3350aef8a21074502</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2009.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2009.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DJ.%2BL.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26atitle%3DWaterborne%2520toxoplasmosis--recent%2520developments%26jtitle%3DExp.%2520Parasitol.%26date%3D2010%26volume%3D124%26issue%3D1%26spage%3D10%26epage%3D25%26doi%3D10.1016%2Fj.exppara.2009.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liesenfeld, O.</span></span> <span> </span><span class="NLM_article-title">Toxoplasmosis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">1965</span>– <span class="NLM_lpage">1976</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(04)16412-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2FS0140-6736%2804%2916412-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=15194258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVemuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2004&pages=1965-1976&author=J.+G.+Montoyaauthor=O.+Liesenfeld&title=Toxoplasmosis&doi=10.1016%2FS0140-6736%2804%2916412-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasmosis</span></div><div class="casAuthors">Montoya, J. G.; Liesenfeld, O.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">9425</span>),
    <span class="NLM_cas:pages">1965-1976</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Toxoplasma gondii is a protozoan parasite that infects up to a third of the world's population.  Infection is mainly acquired by ingestion of food or water that is contaminated with oocysts shed by cats or by eating undercooked or raw meat contg. tissue cysts.  Primary infection is usually subclin. but in some patients cervical lymphadenopathy or ocular disease can be present.  Infection acquired during pregnancy may cause severe damage to the fetus.  In immunocompromised patients, reactivation of latent disease can cause life-threatening encephalitis.  Diagnosis of toxoplasmosis can be established by direct detection of the parasite or by serol. techniques.  The most commonly used therapeutic regimen, and probably the most effective, is the combination of pyrimethamine with sulfadiazine and folinic acid.  This Seminar provides an overview and update on management of patients with acute infection, pregnant women who acquire infection during gestation, fetuses or infants who are congenitally infected, those with ocular disease, and immunocompromised individuals.  Controversy about the effectiveness of primary and secondary prevention in pregnant women is discussed.  Important topics of current and future research are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjtqSI8fuY4rVg90H21EOLACvtfcHk0ljzBpPTAgNP8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVemuro%253D&md5=7fe37d0af87e4bbff2e087b416dcf5c0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2804%2916412-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252804%252916412-X%26sid%3Dliteratum%253Aachs%26aulast%3DMontoya%26aufirst%3DJ.%2BG.%26aulast%3DLiesenfeld%26aufirst%3DO.%26atitle%3DToxoplasmosis%26jtitle%3DLancet%26date%3D2004%26volume%3D363%26spage%3D1965%26epage%3D1976%26doi%3D10.1016%2FS0140-6736%2804%2916412-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Luft, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remington, J. S.</span></span> <span> </span><span class="NLM_article-title">Toxoplasmic encephalitis in AIDS</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1093/clinids/15.2.211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1093%2Fclinids%2F15.2.211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1520757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADyaK38zpt12ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1992&pages=211-222&author=B.+J.+Luftauthor=J.+S.+Remington&title=Toxoplasmic+encephalitis+in+AIDS&doi=10.1093%2Fclinids%2F15.2.211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasmic encephalitis in AIDS</span></div><div class="casAuthors">Luft B J; Remington J S</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-22</span>
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    </div><div class="casAbstract">Involvement of the central nervous system (CNS) is common in patients with advanced disease due to human immunodeficiency virus (HIV).  Symptoms range from lethargy and apathy to coma, incoordination and ataxia to hemiparesis, loss of memory to severe dementia, and focal to major motor seizures.  Involvement may be closely associated with HIV infection per se, as in the AIDS dementia complex, but is frequently caused by opportunistic pathogens such as Toxoplasma gondii and Cryptococcus neoformans or malignancies such as primary lymphoma of the CNS.  The clinical presentations of attendant and direct CNS involvement are remarkably non-specific and overlapping, yet a correct diagnosis is critical to successful intervention.  Toxoplasmic encephalitis is one of the most common and most treatable causes of AIDS-associated pathology of the CNS.  A great deal has been learned in the last 10 years about its unique presentation in the HIV-infected patient with advanced disease.  Drs.  Benjamin J.  Luft of the State University of New York at Stony Brook and Jack S.  Remington of the Stanford University School of Medicine and Palo Alto Medical Foundation's Research Institute have studied T. gondii for many years and are two of the leading experts in the field.  This commentary comprises an update of their initial review (J Infect Dis 1988;157:1-6) and a presentation of the current approaches to diagnosing and managing toxoplasmic encephalitis in HIV-infected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9-IOPR6i3Oc-crCu0nI_sfW6udTcc2ebGooLmvfaVZ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zpt12ntw%253D%253D&md5=a99d76ccc0406e74e81a3522f997cdb6</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1093%2Fclinids%2F15.2.211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fclinids%252F15.2.211%26sid%3Dliteratum%253Aachs%26aulast%3DLuft%26aufirst%3DB.%2BJ.%26aulast%3DRemington%26aufirst%3DJ.%2BS.%26atitle%3DToxoplasmic%2520encephalitis%2520in%2520AIDS%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D1992%26volume%3D15%26spage%3D211%26epage%3D222%26doi%3D10.1093%2Fclinids%2F15.2.211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Israelski, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remington, J. S.</span></span> <span> </span><span class="NLM_article-title">Toxoplasmosis in the non-AIDS immunocompromised host</span>. <i>Curr. Clin. Top. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=8397917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADyaK2c%252FgtVGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=322-356&author=D.+M.+Israelskiauthor=J.+S.+Remington&title=Toxoplasmosis+in+the+non-AIDS+immunocompromised+host"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasmosis in the non-AIDS immunocompromised host</span></div><div class="casAuthors">Israelski D M; Remington J S</div><div class="citationInfo"><span class="NLM_cas:title">Current clinical topics in infectious diseases</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">322-56</span>
        ISSN:<span class="NLM_cas:issn">0195-3842</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTywXsaUPD8jYMcDoIzZtNkfW6udTcc2ebGooLmvfaVZ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FgtVGjsQ%253D%253D&md5=3406defb6b29dc6140e9eb0a1ada956c</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsraelski%26aufirst%3DD.%2BM.%26aulast%3DRemington%26aufirst%3DJ.%2BS.%26atitle%3DToxoplasmosis%2520in%2520the%2520non-AIDS%2520immunocompromised%2520host%26jtitle%3DCurr.%2520Clin.%2520Top.%2520Infect.%2520Dis.%26date%3D1993%26volume%3D13%26spage%3D322%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunay, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajurel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhakal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liesenfeld, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, J. G.</span></span> <span> </span><span class="NLM_article-title">Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e00057-17</span> <span class="refDoi"> DOI: 10.1128/CMR.00057-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FCMR.00057-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=30209035" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&issue=4&author=I.+R.+Dunayauthor=K.+Gajurelauthor=R.+Dhakalauthor=O.+Liesenfeldauthor=J.+G.+Montoya&title=Treatment+of+toxoplasmosis%3A+historical+perspective%2C+animal+models%2C+and+current+clinical+practice&doi=10.1128%2FCMR.00057-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FCMR.00057-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00057-17%26sid%3Dliteratum%253Aachs%26aulast%3DDunay%26aufirst%3DI.%2BR.%26aulast%3DGajurel%26aufirst%3DK.%26aulast%3DDhakal%26aufirst%3DR.%26aulast%3DLiesenfeld%26aufirst%3DO.%26aulast%3DMontoya%26aufirst%3DJ.%2BG.%26atitle%3DTreatment%2520of%2520toxoplasmosis%253A%2520historical%2520perspective%252C%2520animal%2520models%252C%2520and%2520current%2520clinical%2520practice%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2018%26volume%3D31%26issue%3D4%26doi%3D10.1128%2FCMR.00057-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remington, J. S.</span></span> <span> </span><span class="NLM_article-title">The diagnosis and treatment of toxoplasmosis</span>. <i>Eur. J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1007/BF02001573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1007%2FBF02001573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=6861739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADyaL3s3jsVCgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1983&pages=95-104&author=R.+E.+McCabeauthor=J.+S.+Remington&title=The+diagnosis+and+treatment+of+toxoplasmosis&doi=10.1007%2FBF02001573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">The diagnosis and treatment of toxoplasmosis</span></div><div class="casAuthors">McCabe R E; Remington J S</div><div class="citationInfo"><span class="NLM_cas:title">European journal of clinical microbiology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-104</span>
        ISSN:<span class="NLM_cas:issn">0722-2211</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQl1NvOzTGOgwaK-_ZudimnfW6udTcc2eYy2BsDLsfMwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s3jsVCgsQ%253D%253D&md5=954c24a84e8327cf99ee0372443805fa</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1007%2FBF02001573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02001573%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DR.%2BE.%26aulast%3DRemington%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520diagnosis%2520and%2520treatment%2520of%2520toxoplasmosis%26jtitle%3DEur.%2520J.%2520Clin.%2520Microbiol.%26date%3D1983%26volume%3D2%26spage%3D95%26epage%3D104%26doi%3D10.1007%2FBF02001573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Harari, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casoy, J.</span></span> <span> </span><span class="NLM_article-title">Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: A systematic review</span>. <i>Drugs R&amp;D</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1007/s40268-017-0206-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1007%2Fs40268-017-0206-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=28879584" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=523-544&issue=4&author=R.+R.+Ben-Harariauthor=E.+Goodwinauthor=J.+Casoy&title=Adverse+event+profile+of+pyrimethamine-based+therapy+in+toxoplasmosis%3A+A+systematic+review&doi=10.1007%2Fs40268-017-0206-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1007%2Fs40268-017-0206-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40268-017-0206-8%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Harari%26aufirst%3DR.%2BR.%26aulast%3DGoodwin%26aufirst%3DE.%26aulast%3DCasoy%26aufirst%3DJ.%26atitle%3DAdverse%2520event%2520profile%2520of%2520pyrimethamine-based%2520therapy%2520in%2520toxoplasmosis%253A%2520A%2520systematic%2520review%26jtitle%3DDrugs%2520R%2526amp%253BD%26date%3D2017%26volume%3D17%26issue%3D4%26spage%3D523%26epage%3D544%26doi%3D10.1007%2Fs40268-017-0206-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Frenal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubremetz, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebrun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldati-Favre, D.</span></span> <span> </span><span class="NLM_article-title">Gliding motility powers invasion and egress in Apicomplexa</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1038/nrmicro.2017.86</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fnrmicro.2017.86" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=28867819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVekur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=645-660&issue=11&author=K.+Frenalauthor=J.+F.+Dubremetzauthor=M.+Lebrunauthor=D.+Soldati-Favre&title=Gliding+motility+powers+invasion+and+egress+in+Apicomplexa&doi=10.1038%2Fnrmicro.2017.86"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Gliding motility powers invasion and egress in Apicomplexa</span></div><div class="casAuthors">Frenal, Karine; Dubremetz, Jean-Francois; Lebrun, Maryse; Soldati-Favre, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">645-660</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Protozoan parasites have developed elaborate motility systems that facilitate infection and dissemination.  For example, amoebae use actin-rich membrane extensions called pseudopodia, whereas Kinetoplastida are propelled by microtubule-contg. flagella.  By contrast, the motile and invasive stages of the Apicomplexa - a phylum that contains the important human pathogens Plasmodium falciparum (which causes malaria) and Toxoplasma gondii (which causes toxoplasmosis) - have a unique machinery called the glideosome, which is composed of an actomyosin system that underlies the plasma membrane.  The glideosome promotes substrate-dependent gliding motility, which powers migration across biol. barriers, as well as active host cell entry and egress from infected cells.  In this Review, we discuss the discovery of the principles that govern gliding motility, the characterization of the mol. machinery involved, and its impact on parasite invasion and egress from infected cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0EoYvUAhbgrVg90H21EOLACvtfcHk0lgPXE0wKn8-MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVekur3O&md5=e0381f39faa4b2e88a2a59173ff839e6</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro.2017.86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro.2017.86%26sid%3Dliteratum%253Aachs%26aulast%3DFrenal%26aufirst%3DK.%26aulast%3DDubremetz%26aufirst%3DJ.%2BF.%26aulast%3DLebrun%26aufirst%3DM.%26aulast%3DSoldati-Favre%26aufirst%3DD.%26atitle%3DGliding%2520motility%2520powers%2520invasion%2520and%2520egress%2520in%2520Apicomplexa%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2017%26volume%3D15%26issue%3D11%26spage%3D645%26epage%3D660%26doi%3D10.1038%2Fnrmicro.2017.86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">How apicomplexan parasites move in and out of cells</span>. <i>Curr. Opin. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">592</span>– <span class="NLM_lpage">598</span>, <span class="refDoi"> DOI: 10.1016/j.copbio.2010.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.copbio.2010.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=20580218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1OmsrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=592-598&author=L.+D.+Sibley&title=How+apicomplexan+parasites+move+in+and+out+of+cells&doi=10.1016%2Fj.copbio.2010.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">How apicomplexan parasites move in and out of cells</span></div><div class="casAuthors">Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">592-598</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Apicomplexan parasites utilize a unique form of gliding motility' to traverse across substrates, migrate through tissues, and invade into and finally egress from their vertebrate host cells.  Parasite gliding relies on the treadmilling of surface adhesins linked to short actin filaments that are translocated rearward by stationary small myosin motors.  New details reveal mechanistic insight into the coordinated release and processing of adhesins, the complexity of adhesin-substrate interactions, the regulation of the actin-myosin motor complex, and the formation of a novel junction at the host-parasite interface.  These activities are carefully orchestrated to provide an efficient process for motility that is essential for parasite survival.  The parasite-specific nature of many of these steps reveals several essential points that may be targeted for intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYtFm2_k1IUrVg90H21EOLACvtfcHk0lgPXE0wKn8-MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1OmsrnP&md5=f2b346d747b1de86a1e6f614ff668bfc</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2010.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2010.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DHow%2520apicomplexan%2520parasites%2520move%2520in%2520and%2520out%2520of%2520cells%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2010%26volume%3D21%26spage%3D592%26epage%3D598%26doi%3D10.1016%2Fj.copbio.2010.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lourido, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>465</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1038/nature09022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fnature09022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=20485436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1Oisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=359-362&author=S.+Louridoauthor=J.+Shumanauthor=C.+Zhangauthor=K.+M.+Shokatauthor=R.+Huiauthor=L.+D.+Sibley&title=Calcium-dependent+protein+kinase+1+is+an+essential+regulator+of+exocytosis+in+Toxoplasma&doi=10.1038%2Fnature09022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma</span></div><div class="casAuthors">Lourido, Sebastian; Shuman, Joel; Zhang, Chao; Shokat, Kevan M.; Hui, Raymond; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7296</span>),
    <span class="NLM_cas:pages">359-362</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calcium-regulated exocytosis is a ubiquitous process in eukaryotes, whereby secretory vesicles fuse with the plasma membrane and release their contents in response to an intracellular calcium surge.  This process regulates various cellular functions such as plasma membrane repair in plants and animals, the discharge of defensive spikes in Paramecium, and the secretion of insulin from pancreatic cells, immune modulators from lymphocytes, and chem. transmitters from neurons.  In animal cells, serine/threonine kinases including cAMP-dependent protein kinase, protein kinase C and calmodulin kinases have been implicated in calcium-signal transduction leading to regulated secretion.  Although plants and protozoa also regulate secretion by means of intracellular calcium, the method by which these signals are relayed has not been explained.  Here we show that the Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) is an essential regulator of calcium-dependent exocytosis in this opportunistic human pathogen.  Conditional suppression of TgCDPK1 revealed that it controls calcium-dependent secretion of specialized organelles called micronemes, resulting in a block of essential phenotypes including parasite motility, host-cell invasion, and egress.  These phenotypes were recapitulated by using a chem. biol. approach in which pyrazolopyrimidine-derived compds. specifically inhibited TgCDPK1 and disrupted the parasite's life cycle at stages dependent on microneme secretion.  Inhibition was specific to TgCDPK1, because expression of a resistant mutant kinase reversed sensitivity to the inhibitor.  TgCDPK1 is conserved among apicomplexans and belongs to a family of kinases shared with plants and ciliates, suggesting that related CDPKs may have a function in calcium-regulated secretion in other organisms.  Because this kinase family is absent from mammalian hosts, it represents a validated target that may be exploitable for chemotherapy against T. gondii and related apicomplexans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5sWOGpkZQn7Vg90H21EOLACvtfcHk0lgPXE0wKn8-MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1Oisr0%253D&md5=750f6bf5c933759605574d4a2ab5accc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature09022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09022%26sid%3Dliteratum%253Aachs%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DShuman%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DHui%26aufirst%3DR.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DCalcium-dependent%2520protein%2520kinase%25201%2520is%2520an%2520essential%2520regulator%2520of%2520exocytosis%2520in%2520Toxoplasma%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D359%26epage%3D362%26doi%3D10.1038%2Fnature09022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keyloun, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castaneda, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRocher, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inampudi, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakaki, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napuli, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, C.</span></span> <span> </span><span class="NLM_article-title"><i>Toxoplasma gondii</i> calcium-dependent protein kinase 1 is a target for selective kinase inhibitors</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1038/nsmb.1818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fnsmb.1818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=20436472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVyiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=602-607&author=K.+K.+Ojoauthor=E.+T.+Larsonauthor=K.+R.+Keylounauthor=L.+J.+Castanedaauthor=A.+E.+DeRocherauthor=K.+K.+Inampudiauthor=J.+E.+Kimauthor=T.+L.+Arakakiauthor=R.+C.+Murphyauthor=L.+Zhangauthor=A.+J.+Napuliauthor=D.+J.+Malyauthor=C.+L.+M.+J.+Verlindeauthor=F.+S.+Bucknerauthor=M.+Parsonsauthor=W.+G.+J.+Holauthor=E.+A.+Merrittauthor=C.+Van+Voorhis&title=Toxoplasma+gondii+calcium-dependent+protein+kinase+1+is+a+target+for+selective+kinase+inhibitors&doi=10.1038%2Fnsmb.1818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors</span></div><div class="casAuthors">Ojo, Kayode K.; Larson, Eric T.; Keyloun, Katelyn R.; Castaneda, Lisa J.; De Rocher, Amy E.; Inampudi, Krishna K.; Kim, Jessica E.; Arakaki, Tracy L.; Murphy, Ryan C.; Zhang, Li; Napuli, Alberto J.; Maly, Dustin J.; Verlinde, Christophe L. M. J.; Buckner, Frederick S.; Parsons, Marilyn; Hol, Wim G. J.; Merritt, Ethan A.; Van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">602-607</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">New drugs are needed to treat toxoplasmosis.  Toxoplasma gondii calcium-dependent protein kinases (TgCDPKs) are attractive targets because they are absent in mammals.  We show that TgCDPK1 is inhibited by low nanomolar levels of bumped kinase inhibitors (BKIs), compds. inactive against mammalian kinases.  Cocrystal structures of TgCDPK1 with BKIs confirm that the structural basis for selectivity is due to the unique glycine gatekeeper residue in the ATP-binding site.  We show that BKIs interfere with an early step in T. gondii infection of human cells in culture.  Furthermore, we show that TgCDPK1 is the in vivo target of BKIs because T. gondii expressing a glycine to methionine gatekeeper mutant enzyme show significantly decreased sensitivity to BKIs.  Thus, design of selective TgCDPK1 inhibitors with low host toxicity may be achievable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiGhHqXpYi-7Vg90H21EOLACvtfcHk0lg5809xwnK2Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVyiurk%253D&md5=f1630eba0dd5dec19e8a095c041996b1</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1818%26sid%3Dliteratum%253Aachs%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DKeyloun%26aufirst%3DK.%2BR.%26aulast%3DCastaneda%26aufirst%3DL.%2BJ.%26aulast%3DDeRocher%26aufirst%3DA.%2BE.%26aulast%3DInampudi%26aufirst%3DK.%2BK.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DArakaki%26aufirst%3DT.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNapuli%26aufirst%3DA.%2BJ.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%2BM.%2BJ.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DVan%2BVoorhis%26aufirst%3DC.%26atitle%3DToxoplasma%2520gondii%2520calcium-dependent%2520protein%2520kinase%25201%2520is%2520a%2520target%2520for%2520selective%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D602%26epage%3D607%26doi%3D10.1038%2Fnsmb.1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wernimont, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finerty, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allali-Hassani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senisterra, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempel, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lourido, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, R.</span></span> <span> </span><span class="NLM_article-title">Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.1038/nsmb.1795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fnsmb.1795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=20436473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVyhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=596-601&author=A.+K.+Wernimontauthor=J.+D.+Artzauthor=P.+Finertyauthor=Y.+Linauthor=M.+Amaniauthor=A.+Allali-Hassaniauthor=G.+Senisterraauthor=M.+Vedadiauthor=W.+Tempelauthor=F.+Mackenzieauthor=I.+Chauauthor=S.+Louridoauthor=L.+D.+Sibleyauthor=R.+Hui&title=Structures+of+apicomplexan+calcium-dependent+protein+kinases+reveal+mechanism+of+activation+by+calcium&doi=10.1038%2Fnsmb.1795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium</span></div><div class="casAuthors">Wernimont, Amy K.; Artz, Jennifer D.; Finerty, Patrick, Jr.; Lin, Yu-Hui; Amani, Mehrnaz; Allali-Hassani, Abdellah; Senisterra, Guillermo; Vedadi, Masoud; Tempel, Wolfram; MacKenzie, Farrell; Chau, Irene; Lourido, Sebastian; Sibley, L. David; Hui, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calcium-dependent protein kinases (CDPKs) have pivotal roles in the calcium-signaling pathway in plants, ciliates and apicomplexan parasites and comprise a calmodulin-dependent kinase (CaMK)-like kinase domain regulated by a calcium-binding domain in the C terminus.  To understand this intramol. mechanism of activation, we solved the structures of the autoinhibited (apo) and activated (calcium-bound) conformations of CDPKs from the apicomplexan parasites Toxoplasma gondii and Cryptosporidium parvum.  In the apo form, the C-terminal CDPK activation domain (CAD) resembles a calmodulin protein with an unexpected long helix in the N terminus that inhibits the kinase domain in the same manner as CaMKII.  Calcium binding triggers the reorganization of the CAD into a highly intricate fold, leading to its relocation around the base of the kinase domain to a site remote from the substrate binding site.  This large conformational change constitutes a distinct mechanism in calcium signal-transduction pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPNbf5csvAT7Vg90H21EOLACvtfcHk0lg5809xwnK2Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVyhsr0%253D&md5=7e34915b35107e30227a6a786f397da7</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1795%26sid%3Dliteratum%253Aachs%26aulast%3DWernimont%26aufirst%3DA.%2BK.%26aulast%3DArtz%26aufirst%3DJ.%2BD.%26aulast%3DFinerty%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DAmani%26aufirst%3DM.%26aulast%3DAllali-Hassani%26aufirst%3DA.%26aulast%3DSenisterra%26aufirst%3DG.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DTempel%26aufirst%3DW.%26aulast%3DMackenzie%26aufirst%3DF.%26aulast%3DChau%26aufirst%3DI.%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26aulast%3DHui%26aufirst%3DR.%26atitle%3DStructures%2520of%2520apicomplexan%2520calcium-dependent%2520protein%2520kinases%2520reveal%2520mechanism%2520of%2520activation%2520by%2520calcium%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D596%26epage%3D601%26doi%3D10.1038%2Fnsmb.1795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubersax, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petsch, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matheos, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blethrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">A chemical switch for inhibitor-sensitive alleles of any protein kinase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>407</i></span> (<span class="NLM_issue">6802</span>),  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1038/35030148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2F35030148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=11014197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntF2ntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=395-401&issue=6802&author=A.+C.+Bishopauthor=J.+A.+Ubersaxauthor=D.+T.+Petschauthor=D.+P.+Matheosauthor=N.+S.+Grayauthor=J.+Blethrowauthor=E.+Shimizuauthor=J.+Z.+Tsienauthor=P.+G.+Schultzauthor=M.+D.+Roseauthor=J.+L.+Woodauthor=D.+O.+Morganauthor=K.+M.+Shokat&title=A+chemical+switch+for+inhibitor-sensitive+alleles+of+any+protein+kinase&doi=10.1038%2F35030148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical switch for inhibitor-sensitive alleles of any protein kinase</span></div><div class="casAuthors">Bishop, Anthony C.; Ubersax, Jeffrey A.; Petsch, Dejah T.; Matheos, Dina P.; Gray, Nathanael S.; Blethrow, Justin; Shimizu, Eiji; Tsien, Joe Z.; Schultz, Peter G.; Rose, Mark D.; Wood, John L.; Morgan, David O.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6802</span>),
    <span class="NLM_cas:pages">395-401</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein kinases have proved to be largely resistant to the design of highly specific inhibitors, even with the aid of combinatorial chem.  The lack of these reagents has complicated efforts to assign specific signaling roles to individual kinases.  Here we describe a chem. genetic strategy for sensitizing protein kinases to cell-permeable mols. that do not inhibit wild-type kinases.  From two inhibitor scaffolds, we have identified potent and selective inhibitors for sensitized kinases from five distinct subfamilies.  Tyrosine and serine/threonine kinases are equally amenable to this approach.  We have analyzed a budding yeast strain carrying an inhibitor-sensitive form of the cyclin-dependent kinase Cdc28 (CDK1) in place of the wild-type protein.  Specific inhibition of Cdc28 in vivo caused a pre-mitotic cell-cycle arrest that is distinct from the G1 arrest typically obsd. in temp.-sensitive cdc28 mutants.  The mutation that confers inhibitor-sensitivity is easily identifiable from primary sequence alignments.  Thus, this approach can be used to systematically generate conditional alleles of protein kinases, allowing for rapid functional characterization of members of this important gene family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqipYQXO52a6rVg90H21EOLACvtfcHk0lg5809xwnK2Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntF2ntL4%253D&md5=736782d1116a86dfc0dd6ab9a9aeec0a</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1038%2F35030148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35030148%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DA.%2BC.%26aulast%3DUbersax%26aufirst%3DJ.%2BA.%26aulast%3DPetsch%26aufirst%3DD.%2BT.%26aulast%3DMatheos%26aufirst%3DD.%2BP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DBlethrow%26aufirst%3DJ.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DTsien%26aufirst%3DJ.%2BZ.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DRose%26aufirst%3DM.%2BD.%26aulast%3DWood%26aufirst%3DJ.%2BL.%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520chemical%2520switch%2520for%2520inhibitor-sensitive%2520alleles%2520of%2520any%2520protein%2520kinase%26jtitle%3DNature%26date%3D2000%26volume%3D407%26issue%3D6802%26spage%3D395%26epage%3D401%26doi%3D10.1038%2F35030148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Acquisition of inhibitor-sensitive protein kinases through protein design</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1016/S0163-7258(98)00060-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2FS0163-7258%2898%2900060-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10454210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=337-346&issue=2%E2%80%933&author=A.+C.+Bishopauthor=K.+M.+Shokat&title=Acquisition+of+inhibitor-sensitive+protein+kinases+through+protein+design&doi=10.1016%2FS0163-7258%2898%2900060-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Acquisition of inhibitor-sensitive protein kinases through protein design</span></div><div class="casAuthors">Bishop, Anthony C.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">337-346</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with many refs.  Protein phosphorylation is the major post-translational modification used by eukaryotic cells to control cellular signaling.  Protein kinases have emerged as attractive drug targets because heightened protein kinase activity has been assocd. with several proliferative diseases, most notably cancer and restenosis.  Until now, it has been very difficult to confirm the utility of protein kinases as inhibitor targets because very few small mols. that selectively inhibit one particular kinase are known.  Discovery of highly specific kinase inhibitors has been slow because the protein family contains approx. 2000 members, all of which share a conserved active site fold.  Recent work in several labs. has sought to circumvent the problem of kinase structural degeneracy by engineering drug sensitivity into Src family tyrosine kinases and mitogen-activated protein kinases through site-directed mutagenesis.  By introducing a unique non-naturally occurring amino acid into a conserved region of the enzyme's binding site, a target protein kinase can be rapidly sensitized to a small mol.  Introduction of the engineered kinase into a cell line or animal model should greatly expedite the investigation of protein kinase inhibition as a viable drug treatment.  The purpose of this review is to summarize these recent advances in protein kinase drug sensitization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHyUn8jWhYxrVg90H21EOLACvtfcHk0ljkYkN65Lr59Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOhtb8%253D&md5=2b7a3a56e3cf5645d361c61d05224733</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900060-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900060-6%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DA.%2BC.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DAcquisition%2520of%2520inhibitor-sensitive%2520protein%2520kinases%2520through%2520protein%2520design%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D82%26issue%3D2%25E2%2580%25933%26spage%3D337%26epage%3D346%26doi%3D10.1016%2FS0163-7258%2898%2900060-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span> <span> </span><span class="NLM_article-title">Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2803</span>– <span class="NLM_lpage">2810</span>, <span class="refDoi"> DOI: 10.1021/jm201725v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201725v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2803-2810&issue=6&author=E.+T.+Larsonauthor=K.+K.+Ojoauthor=R.+C.+Murphyauthor=S.+M.+Johnsonauthor=Z.+Zhangauthor=J.+E.+Kimauthor=D.+J.+Leiblyauthor=A.+M.+Foxauthor=M.+C.+Reidauthor=E.+J.+Daleauthor=B.+G.+Pereraauthor=J.+Kimauthor=S.+N.+Hewittauthor=W.+G.+Holauthor=C.+L.+Verlindeauthor=E.+Fanauthor=W.+C.+Van+Voorhisauthor=D.+J.+Malyauthor=E.+A.+Merritt&title=Multiple+determinants+for+selective+inhibition+of+apicomplexan+calcium-dependent+protein+kinase+CDPK1&doi=10.1021%2Fjm201725v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Determinants for Selective Inhibition of Apicomplexan Calcium-Dependent Protein Kinase CDPK1</span></div><div class="casAuthors">Larson, Eric T.; Ojo, Kayode K.; Murphy, Ryan C.; Johnson, Steven M.; Zhang, Zhongsheng; Kim, Jessica E.; Leibly, David J.; Fox, Anna M. W.; Reid, Molly C.; Dale, Edward J.; Perera, B. Gayani K.; Kim, Jae; Hewitt, Stephen N.; Hol, Wim G. J.; Verlinde, Christophe L. M. J.; Fan, Erkang; Van Voorhis, Wesley C.; Maly, Dustin J.; Merritt, Ethan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2803-2810</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Diseases caused by the apicomplexan protozoans Toxoplasma gondii and Cryptosporidium parvum are a major health concern.  The life cycle of these parasites is regulated by a family of calcium-dependent protein kinases (CDPKs) that have no direct homologs in the human host.  Fortuitously, CDPK1 from both parasites contains a rare glycine gatekeeper residue adjacent to the ATP-binding pocket.  This has allowed creation of a series of C3-substituted pyrazolopyrimidine compds. that are potent inhibitors selective for CDPK1 over a panel of human kinases.  Here we demonstrate that selectivity is further enhanced by modification of the scaffold at the C1 position.  The explanation for this unexpected result is provided by crystal structures of the inhibitors bound to CDPK1 and the human kinase c-SRC.  Furthermore, the insight gained from these studies was applied to transform an alternative ATP-competitive scaffold lacking potency and selectivity for CDPK1 into a low nanomolar inhibitor of this enzyme with no activity against SRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxAUMMe3qUybVg90H21EOLACvtfcHk0ljkYkN65Lr59Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOgsLo%253D&md5=c8aae3a6d1811aaa2d1316eb98fa8251</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1021%2Fjm201725v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201725v%26sid%3Dliteratum%253Aachs%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DJohnson%26aufirst%3DS.%2BM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DLeibly%26aufirst%3DD.%2BJ.%26aulast%3DFox%26aufirst%3DA.%2BM.%26aulast%3DReid%26aufirst%3DM.%2BC.%26aulast%3DDale%26aufirst%3DE.%2BJ.%26aulast%3DPerera%26aufirst%3DB.%2BG.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHewitt%26aufirst%3DS.%2BN.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26atitle%3DMultiple%2520determinants%2520for%2520selective%2520inhibition%2520of%2520apicomplexan%2520calcium-dependent%2520protein%2520kinase%2520CDPK1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D6%26spage%3D2803%26epage%3D2810%26doi%3D10.1021%2Fjm201725v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellanos-Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keyloun, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhandari, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of calcium-dependent protein kinase 1 (CDPK1) from <i>C. parvum</i> and <i>T. gondii</i></span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1021/ml100096t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100096t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVWitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=331-335&issue=7&author=R.+C.+Murphyauthor=K.+K.+Ojoauthor=E.+T.+Larsonauthor=A.+Castellanos-Gonzalezauthor=B.+G.+Pereraauthor=K.+R.+Keylounauthor=J.+E.+Kimauthor=J.+G.+Bhandariauthor=N.+R.+Mullerauthor=C.+L.+Verlindeauthor=A.+C.+Whiteauthor=E.+A.+Merrittauthor=W.+C.+Van+Voorhisauthor=D.+J.+Maly&title=Discovery+of+potent+and+selective+inhibitors+of+calcium-dependent+protein+kinase+1+%28CDPK1%29+from+C.+parvum+and+T.+gondii&doi=10.1021%2Fml100096t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii</span></div><div class="casAuthors">Murphy, Ryan C.; Ojo, Kayode K.; Larson, Eric T.; Castellanos-Gonzalez, Alejandro; Perera, B. Gayani K.; Keyloun, Katelyn R.; Kim, Jessica E.; Bhandari, Janhavi G.; Muller, Natascha R.; Verlinde, Christophe L. M. J.; White, A. Clinton, Jr.; Merritt, Ethan A.; Van Voorhis, Wesley C.; Maly, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">331-335</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protozoans Cryptosporidium parvum and Toxoplasma gondii are parasites of major health concern to humans.  Both parasites contain a group of calcium-dependent protein kinases (CDPKs) which are found in plants and ciliates but not in humans or fungi.  Here, we describe a series of potent inhibitors that target CDPK1 in C. parvum (CpCDPK1) and T. gondii (TgCDPK1).  These inhibitors are highly selective for CpCDPK1 and TgCDPK1 over the mammalian kinases SRC and ABL.  Furthermore, they are able to block an early stage of C. parvum invasion of HCT-8 host cells, which is similar to their effects on T. gondii invasion of human fibroblasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotf_PwbMLWELVg90H21EOLACvtfcHk0ljkYkN65Lr59Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVWitbw%253D&md5=cace2277e9057a4895456006a12fb312</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fml100096t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100096t%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DCastellanos-Gonzalez%26aufirst%3DA.%26aulast%3DPerera%26aufirst%3DB.%2BG.%26aulast%3DKeyloun%26aufirst%3DK.%2BR.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DBhandari%26aufirst%3DJ.%2BG.%26aulast%3DMuller%26aufirst%3DN.%2BR.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DWhite%26aufirst%3DA.%2BC.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520calcium-dependent%2520protein%2520kinase%25201%2520%2528CDPK1%2529%2520from%2520C.%2520parvum%2520and%2520T.%2520gondii%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26issue%3D7%26spage%3D331%26epage%3D335%26doi%3D10.1021%2Fml100096t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lourido, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by <i>Toxoplasma gondii</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3068</span>– <span class="NLM_lpage">3077</span>, <span class="refDoi"> DOI: 10.1021/jm4001314</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001314" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslSgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3068-3077&author=S.+Louridoauthor=C.+Zhangauthor=M.+S.+Lopezauthor=K.+Tangauthor=J.+Barksauthor=Q.+Wangauthor=S.+A.+Wildmanauthor=K.+M.+Shokatauthor=L.+D.+Sibley&title=Optimizing+small+molecule+inhibitors+of+calcium-dependent+protein+kinase+1+to+prevent+infection+by+Toxoplasma+gondii&doi=10.1021%2Fjm4001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Small Molecule Inhibitors of Calcium-Dependent Protein Kinase 1 to Prevent Infection by Toxoplasma gondii</span></div><div class="casAuthors">Lourido, Sebastian; Zhang, Chao; Lopez, Michael S.; Tang, Keliang; Barks, Jennifer; Wang, Qiuling; Wildman, Scott A.; Shokat, Kevan M.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3068-3077</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toxoplasma gondii is sensitive to bulky pyrazolo [3,4-d] pyrimidine (PP) inhibitors due to the presence of a Gly gatekeeper in the essential calcium dependent protein kinase 1 (CDPK1).  Here we synthesized a no. of new derivs. of 3-methyl-benzyl-PP (3-MB-PP, or 1).  The potency of PP analogs in inhibiting CDPK1 enzyme activity in vitro (low nM IC50 values) and blocking parasite growth in host cell monolayers in vivo (low μM EC50 values) were highly correlated and occurred in a CDPK1-specific manner.  Chem. modification of the PP scaffold to increase half-life in the presence of microsomes in vitro led to identification of compds. with enhanced stability while retaining activity.  Several of these more potent compds. were able to prevent lethal infection with T. gondii in the mouse model.  Collectively, the strategies outlined here provide a route for development of more effective compds. for treatment of toxoplasmosis and perhaps related parasitic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBcv37M-6fobVg90H21EOLACvtfcHk0ljJ8FRBok_qtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslSgt78%253D&md5=352bb9e5b5304656aab52da763202b68</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1021%2Fjm4001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001314%26sid%3Dliteratum%253Aachs%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DTang%26aufirst%3DK.%26aulast%3DBarks%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DOptimizing%2520small%2520molecule%2520inhibitors%2520of%2520calcium-dependent%2520protein%2520kinase%25201%2520to%2520prevent%2520infection%2520by%2520Toxoplasma%2520gondii%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3068%26epage%3D3077%26doi%3D10.1021%2Fjm4001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vidadala, R. S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulverson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCloskey, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitman, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, S. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span> <span> </span><span class="NLM_article-title">7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-based inhibitors of calcium-dependent protein kinase 1 have distinct inhibitory and oral pharmacokinetic characteristics compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-based inhibitors</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.7b00224</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00224" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFWgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=516-522&issue=4&author=R.+S.+R.+Vidadalaauthor=M.+Golkowskiauthor=M.+A.+Hulversonauthor=R.+Choiauthor=M.+C.+McCloskeyauthor=G.+R.+Whitmanauthor=W.+Huangauthor=S.+L.+M.+Arnoldauthor=L.+K.+Barrettauthor=E.+Fanauthor=E.+A.+Merrittauthor=W.+C.+Van+Voorhisauthor=K.+K.+Ojoauthor=D.+J.+Maly&title=7+H-Pyrrolo%5B2%2C3-+d%5Dpyrimidin-4-amine-based+inhibitors+of+calcium-dependent+protein+kinase+1+have+distinct+inhibitory+and+oral+pharmacokinetic+characteristics+compared+with+1+H-Pyrazolo%5B3%2C4-+d%5Dpyrimidin-4-amine-based+inhibitors&doi=10.1021%2Facsinfecdis.7b00224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">7H-Pyrrolo[2,3-d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1H-Pyrazolo[3,4-d]pyrimidin-4-amine-Based Inhibitors</span></div><div class="casAuthors">Vidadala, Rama S. R.; Golkowski, Martin; Hulverson, Matthew A.; Choi, Ryan; McCloskey, Molly C.; Whitman, Grant R.; Huang, Wenlin; Arnold, Samuel L. M.; Barrett, Lynn K.; Fan, Erkang; Merritt, Ethan A.; Van Voorhis, Wesley C.; Ojo, Kayode K.; Maly, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">516-522</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibitors of Cryptosporidium calcium-dependent protein kinase 1 (CpCDPK1) based on the 1H-pyrazolo[3,4-d]pyrimidin-4-amine (pyrazolopyrimidine, PP) scaffold are effective in both in vitro and in vivo models of cryptosporidiosis.  However, the search for distinct safety and pharmacokinetic (PK) properties has motivated the exploration of alternative scaffolds.  Here, the authors describe a series of 7H-pyrrolo[2,3-d]pyrimidin-4-amine (pyrrolopyrimidine, PrP)-based analogs of PP CpCDPK1 inhibitors.  Most of the PrP-based inhibitors described potently inhibit the CpCDPK1 enzyme, demonstrate no toxicity against mammalian cells, and block proliferation of the C. parvum parasite in the low micromolar range.  Interestingly, certain substituents that show reduced CpCDPK1 potency when displayed from a PP scaffold provided notably enhanced efficacy in the context of a PrP scaffold.  PK studies on these paired compds. show that some PrP analogs have distinct physiochem. properties compared with their PP counterparts.  These results demonstrate that inhibitors based on a PrP scaffold are distinct therapeutic alternatives to previously developed PP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS1Vv28yqKuLVg90H21EOLACvtfcHk0ljJ8FRBok_qtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFWgsLo%253D&md5=ddd10343bf7e8144694b4df10325dbcf</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00224%26sid%3Dliteratum%253Aachs%26aulast%3DVidadala%26aufirst%3DR.%2BS.%2BR.%26aulast%3DGolkowski%26aufirst%3DM.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DChoi%26aufirst%3DR.%26aulast%3DMcCloskey%26aufirst%3DM.%2BC.%26aulast%3DWhitman%26aufirst%3DG.%2BR.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DArnold%26aufirst%3DS.%2BL.%2BM.%26aulast%3DBarrett%26aufirst%3DL.%2BK.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3D7%2520H-Pyrrolo%255B2%252C3-%2520d%255Dpyrimidin-4-amine-based%2520inhibitors%2520of%2520calcium-dependent%2520protein%2520kinase%25201%2520have%2520distinct%2520inhibitory%2520and%2520oral%2520pharmacokinetic%2520characteristics%2520compared%2520with%25201%2520H-Pyrazolo%255B3%252C4-%2520d%255Dpyrimidin-4-amine-based%2520inhibitors%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26issue%3D4%26spage%3D516%26epage%3D522%26doi%3D10.1021%2Facsinfecdis.7b00224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vidadala, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulverson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambriski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruzual, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRocher, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddaramaiah, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freiberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isoherranen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doggett, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span> <span> </span><span class="NLM_article-title">Development of an orally available and central nervous system (CNS) penetrant <i>Toxoplasma gondii</i> calcium-dependent protein kinase 1 (TgCDPK1) inhibitor with minimal human ether-a-go-go-related gene (hERG) activity for the treatment of toxoplasmosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6531</span>– <span class="NLM_lpage">6546</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00760</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSrsr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6531-6546&issue=13&author=R.+S.+Vidadalaauthor=K.+L.+Rivasauthor=K.+K.+Ojoauthor=M.+A.+Hulversonauthor=J.+A.+Zambriskiauthor=I.+Bruzualauthor=T.+L.+Schultzauthor=W.+Huangauthor=Z.+Zhangauthor=S.+Scheeleauthor=A.+E.+DeRocherauthor=R.+Choiauthor=L.+K.+Barrettauthor=L.+K.+Siddaramaiahauthor=W.+G.+Holauthor=E.+Fanauthor=E.+A.+Merrittauthor=M.+Parsonsauthor=G.+Freibergauthor=K.+Marshauthor=D.+J.+Kempfauthor=V.+B.+Carruthersauthor=N.+Isoherranenauthor=J.+S.+Doggettauthor=W.+C.+Van+Voorhisauthor=D.+J.+Maly&title=Development+of+an+orally+available+and+central+nervous+system+%28CNS%29+penetrant+Toxoplasma+gondii+calcium-dependent+protein+kinase+1+%28TgCDPK1%29+inhibitor+with+minimal+human+ether-a-go-go-related+gene+%28hERG%29+activity+for+the+treatment+of+toxoplasmosis&doi=10.1021%2Facs.jmedchem.6b00760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis</span></div><div class="casAuthors">Vidadala, Rama Subba Rao; Rivas, Kasey L.; Ojo, Kayode K.; Hulverson, Matthew A.; Zambriski, Jennifer A.; Bruzual, Igor; Schultz, Tracey L.; Huang, Wenlin; Zhang, Zhongsheng; Scheele, Suzanne; DeRocher, Amy E.; Choi, Ryan; Barrett, Lynn K.; Siddaramaiah, Latha Kallur; Hol, Wim G. J.; Fan, Erkang; Merritt, Ethan A.; Parsons, Marilyn; Freiberg, Gail; Marsh, Kennan; Kempf, Dale J.; Carruthers, Vern B.; Isoherranen, Nina; Doggett, J. Stone; Van Voorhis, Wesley C.; Maly, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6531-6546</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New therapies are needed for the treatment of toxoplasmosis, which is a disease caused by the protozoan parasite Toxoplasma gondii.  To this end, we previously developed a potent and selective inhibitor (compd. 1) of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) that possesses antitoxoplasmosis activity in vitro and in vivo.  Unfortunately, 1 has potent human ether-a-go-go-related gene (hERG) inhibitory activity, assocd. with long Q-T syndrome, and consequently presents a cardiotoxicity risk.  Here, we describe the identification of an optimized TgCDPK1 inhibitor 32, which does not have a hERG liability and possesses a favorable pharmacokinetic profile in small and large animals. 32(I) is CNS-penetrant and highly effective in acute and latent mouse models of T. gondii infection, significantly reducing the amt. of parasite in the brain, spleen, and peritoneal fluid and reducing brain cysts by >85%.  These properties make 32 a promising lead for the development of a new antitoxoplasmosis therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps5haum1lCNbVg90H21EOLACvtfcHk0ljCLTSSbg9hKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSrsr%252FM&md5=8eb12f3703985ad69b921f1495858081</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00760%26sid%3Dliteratum%253Aachs%26aulast%3DVidadala%26aufirst%3DR.%2BS.%26aulast%3DRivas%26aufirst%3DK.%2BL.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DZambriski%26aufirst%3DJ.%2BA.%26aulast%3DBruzual%26aufirst%3DI.%26aulast%3DSchultz%26aufirst%3DT.%2BL.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DScheele%26aufirst%3DS.%26aulast%3DDeRocher%26aufirst%3DA.%2BE.%26aulast%3DChoi%26aufirst%3DR.%26aulast%3DBarrett%26aufirst%3DL.%2BK.%26aulast%3DSiddaramaiah%26aufirst%3DL.%2BK.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DFreiberg%26aufirst%3DG.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DCarruthers%26aufirst%3DV.%2BB.%26aulast%3DIsoherranen%26aufirst%3DN.%26aulast%3DDoggett%26aufirst%3DJ.%2BS.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3DDevelopment%2520of%2520an%2520orally%2520available%2520and%2520central%2520nervous%2520system%2520%2528CNS%2529%2520penetrant%2520Toxoplasma%2520gondii%2520calcium-dependent%2520protein%2520kinase%25201%2520%2528TgCDPK1%2529%2520inhibitor%2520with%2520minimal%2520human%2520ether-a-go-go-related%2520gene%2520%2528hERG%2529%2520activity%2520for%2520the%2520treatment%2520of%2520toxoplasmosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D13%26spage%3D6531%26epage%3D6546%26doi%3D10.1021%2Facs.jmedchem.6b00760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRocher, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span> <span> </span><span class="NLM_article-title">Development of <i>Toxoplasma gondii</i> calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2416</span>– <span class="NLM_lpage">2426</span>, <span class="refDoi"> DOI: 10.1021/jm201713h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201713h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVeksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2416-2426&issue=5&author=S.+M.+Johnsonauthor=R.+C.+Murphyauthor=J.+A.+Geigerauthor=A.+E.+DeRocherauthor=Z.+Zhangauthor=K.+K.+Ojoauthor=E.+T.+Larsonauthor=B.+G.+Pereraauthor=E.+J.+Daleauthor=P.+Heauthor=M.+C.+Reidauthor=A.+M.+Foxauthor=N.+R.+Muellerauthor=E.+A.+Merrittauthor=E.+Fanauthor=M.+Parsonsauthor=W.+C.+Van+Voorhisauthor=D.+J.+Maly&title=Development+of+Toxoplasma+gondii+calcium-dependent+protein+kinase+1+%28TgCDPK1%29+inhibitors+with+potent+anti-toxoplasma+activity&doi=10.1021%2Fjm201713h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitors with Potent Anti-Toxoplasma Activity</span></div><div class="casAuthors">Johnson, Steven M.; Murphy, Ryan C.; Geiger, Jennifer A.; DeRocher, Amy E.; Zhang, Zhongsheng; Ojo, Kayode K.; Larson, Eric T.; Perera, B. Gayani K.; Dale, Edward J.; He, Panqing; Reid, Molly C.; Fox, Anna M. W.; Mueller, Natascha R.; Merritt, Ethan A.; Fan, Erkang; Parsons, Marilyn; Van Voorhis, Wesley C.; Maly, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2416-2426</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toxoplasmosis is a disease of prominent health concern that is caused by the protozoan parasite Toxoplasma gondii.  Proliferation of T. gondii is dependent on its ability to invade host cells, which is mediated in part by calcium-dependent protein kinase 1 (CDPK1).  We have developed ATP competitive inhibitors of TgCDPK1 that block invasion of parasites into host cells, preventing their proliferation.  The presence of a unique glycine gatekeeper residue in TgCDPK1 permits selective inhibition of the parasite enzyme over human kinases.  These potent TgCDPK1 inhibitors do not inhibit the growth of human cell lines and represent promising candidates as toxoplasmosis therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxuYszPit90rVg90H21EOLACvtfcHk0ljCLTSSbg9hKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVeksb8%253D&md5=862ac0e5066f60d7eeaccc723c2c4e75</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fjm201713h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201713h%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BM.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DGeiger%26aufirst%3DJ.%2BA.%26aulast%3DDeRocher%26aufirst%3DA.%2BE.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DPerera%26aufirst%3DB.%2BG.%26aulast%3DDale%26aufirst%3DE.%2BJ.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DReid%26aufirst%3DM.%2BC.%26aulast%3DFox%26aufirst%3DA.%2BM.%26aulast%3DMueller%26aufirst%3DN.%2BR.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3DDevelopment%2520of%2520Toxoplasma%2520gondii%2520calcium-dependent%2520protein%2520kinase%25201%2520%2528TgCDPK1%2529%2520inhibitors%2520with%2520potent%2520anti-toxoplasma%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D5%26spage%3D2416%26epage%3D2426%26doi%3D10.1021%2Fjm201713h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Bakkouri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">452</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2015.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.tips.2015.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=26002073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVWitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=452-460&issue=7&author=R.+Huiauthor=M.+El+Bakkouriauthor=L.+D.+Sibley&title=Designing+selective+inhibitors+for+calcium-dependent+protein+kinases+in+apicomplexans&doi=10.1016%2Fj.tips.2015.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans</span></div><div class="casAuthors">Hui, Raymond; El Bakkouri, Majida; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">452-460</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Apicomplexan parasites cause some of the most severe human diseases, including malaria (caused by Plasmodium), toxoplasmosis, and cryptosporidiosis.  Treatments are limited by the lack of effective drugs and development of resistance to available agents.  By exploiting novel features of protein kinases in these parasites, it may be possible to develop new treatments.  We summarize here recent advances in identifying small mol. inhibitors against a novel family of plant-like, calcium-dependent kinases that are uniquely expanded in apicomplexan parasites.  Anal. of the 3D structure, activation mechanism, and sensitivity to small mols. had identified several attractive chem. scaffolds that are potent and selective inhibitors of these parasite kinases.  Further optimization of these leads may yield promising new drugs for treatment of these parasitic infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-4M4FEBeFQrVg90H21EOLACvtfcHk0liGUWAAur5ufQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVWitLk%253D&md5=0081edfce5d381c6a34c396b011c24b8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DR.%26aulast%3DEl%2BBakkouri%26aufirst%3DM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DDesigning%2520selective%2520inhibitors%2520for%2520calcium-dependent%2520protein%2520kinases%2520in%2520apicomplexans%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26issue%3D7%26spage%3D452%26epage%3D460%26doi%3D10.1016%2Fj.tips.2015.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doggett, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulverson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, S. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggs, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemphill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mealey, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A. O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span> <span> </span><span class="NLM_article-title">Extended-spectrum antiprotozoal bumped kinase inhibitors: A review</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2017.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.exppara.2017.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=28065755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2017&pages=71-83&author=W.+C.+Van%0AVoorhisauthor=J.+S.+Doggettauthor=M.+Parsonsauthor=M.+A.+Hulversonauthor=R.+Choiauthor=S.+L.+M.+Arnoldauthor=M.+W.+Riggsauthor=A.+Hemphillauthor=D.+K.+Howeauthor=R.+H.+Mealeyauthor=A.+O.+T.+Lauauthor=E.+A.+Merrittauthor=D.+J.+Malyauthor=E.+Fanauthor=K.+K.+Ojo&title=Extended-spectrum+antiprotozoal+bumped+kinase+inhibitors%3A+A+review&doi=10.1016%2Fj.exppara.2017.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-spectrum antiprotozoal bumped kinase inhibitors: A review</span></div><div class="casAuthors">Van Voorhis, Wesley C.; Doggett, J. Stone; Parsons, Marilyn; Hulverson, Matthew A.; Choi, Ryan; Arnold, Samuel; Riggs, Michael W.; Hemphill, Andrew; Howe, Daniel K.; Mealey, Robert H.; Lau, Audrey O. T.; Merritt, Ethan A.; Maly, Dustin J.; Fan, Erkang; Ojo, Kayode K.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71-83</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Many life-cycle processes in parasites are regulated by protein phosphorylation.  Hence, disruption of essential protein kinase function has been explored for therapy of parasitic diseases.  However, the difficulty of inhibiting parasite protein kinases to the exclusion of host orthologues poses a practical challenge.  A possible path around this difficulty is the use of bumped kinase inhibitors for targeting calcium dependent protein kinases that contain atypically small gatekeeper residues and are crucial for pathogenic apicomplexan parasites' survival and proliferation.  In this review, we review efficacy against the kinase target, the parasite growth in vitro, and in animal infection models, as well as the relevant pharmacokinetic and safety parameters of bumped-kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryqXFGOQxay7Vg90H21EOLACvtfcHk0liGUWAAur5ufQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KhsLw%253D&md5=cb59a64078058058bacae1e4f9948303</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2017.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2017.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DDoggett%26aufirst%3DJ.%2BS.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DChoi%26aufirst%3DR.%26aulast%3DArnold%26aufirst%3DS.%2BL.%2BM.%26aulast%3DRiggs%26aufirst%3DM.%2BW.%26aulast%3DHemphill%26aufirst%3DA.%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DMealey%26aufirst%3DR.%2BH.%26aulast%3DLau%26aufirst%3DA.%2BO.%2BT.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26atitle%3DExtended-spectrum%2520antiprotozoal%2520bumped%2520kinase%2520inhibitors%253A%2520A%2520review%26jtitle%3DExp.%2520Parasitol.%26date%3D2017%26volume%3D180%26spage%3D71%26epage%3D83%26doi%3D10.1016%2Fj.exppara.2017.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doggett, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span> <span> </span><span class="NLM_article-title">Bumped kinase inhibitor 1294 treats established <i>Toxoplasma gondii</i> infection</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3547</span>– <span class="NLM_lpage">3549</span>, <span class="refDoi"> DOI: 10.1128/AAC.01823-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FAAC.01823-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=24687502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADC%252BC2crptV2ktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=3547-3549&issue=6&author=J.+S.+Doggettauthor=K.+K.+Ojoauthor=E.+Fanauthor=D.+J.+Malyauthor=W.+C.+Van+Voorhis&title=Bumped+kinase+inhibitor+1294+treats+established+Toxoplasma+gondii+infection&doi=10.1128%2FAAC.01823-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection</span></div><div class="casAuthors">Doggett J Stone; Ojo Kayode K; Van Voorhis Wesley C; Fan Erkang; Maly Dustin J</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial agents and chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3547-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Toxoplasma gondii is a unicellular parasite that causes severe brain and eye disease.  Current drugs for T. gondii are limited by toxicity.  Bumped kinase inhibitors (BKIs) selectively inhibit calcium-dependent protein kinases of the apicomplexan pathogens T. gondii, cryptosporidia, and plasmodia.  A lead anti-Toxoplasma BKI, 1294, has been developed to be metabolically stable and orally bioavailable.  Herein, we demonstrate the oral efficacy of 1294 against toxoplasmosis in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOnucFrtFbhz0O18WR3iAofW6udTcc2eb_iYTYDirbbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crptV2ktA%253D%253D&md5=17e39dbc0043221abd603d23ad7176b5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.01823-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01823-13%26sid%3Dliteratum%253Aachs%26aulast%3DDoggett%26aufirst%3DJ.%2BS.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DBumped%2520kinase%2520inhibitor%25201294%2520treats%2520established%2520Toxoplasma%2520gondii%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D6%26spage%3D3547%26epage%3D3549%26doi%3D10.1128%2FAAC.01823-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutaganira, F. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhason, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radke, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddirala, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Bakkouri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of calcium dependent protein kinase 1 (CDPK1) by pyrazolopyrimidine analogs decreases establishment and reoccurrence of central nervous system disease by <i>Toxoplasma gondii</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">9976</span>– <span class="NLM_lpage">9989</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01192</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01192" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFensbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9976-9989&issue=24&author=F.+U.+Rutaganiraauthor=J.+Barksauthor=M.+S.+Dhasonauthor=Q.+Wangauthor=M.+S.+Lopezauthor=S.+Longauthor=J.+B.+Radkeauthor=N.+G.+Jonesauthor=A.+R.+Maddiralaauthor=J.+W.+Janetkaauthor=M.+El+Bakkouriauthor=R.+Huiauthor=K.+M.+Shokatauthor=L.+D.+Sibley&title=Inhibition+of+calcium+dependent+protein+kinase+1+%28CDPK1%29+by+pyrazolopyrimidine+analogs+decreases+establishment+and+reoccurrence+of+central+nervous+system+disease+by+Toxoplasma+gondii&doi=10.1021%2Facs.jmedchem.7b01192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii</span></div><div class="casAuthors">Rutaganira, Florentine U.; Barks, Jennifer; Dhason, Mary Savari; Wang, Qiuling; Lopez, Michael S.; Long, Shaojun; Radke, Joshua B.; Jones, Nathaniel G.; Maddirala, Amarendar R.; Janetka, James W.; El Bakkouri, Majida; Hui, Raymond; Shokat, Kevan M.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9976-9989</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Calcium dependent protein kinase 1 (CDPK1) is an essential enzyme in the opportunistic pathogen Toxoplasma gondii.  CDPK1 controls multiple processes that are crit. to the intracellular replicative cycle of T. gondii including secretion of adhesins, motility, invasion, and egress.  Remarkably, CDPK1 contains a small glycine gatekeeper residue in the ATP binding pocket making it sensitive to ATP-competitive inhibitors with bulky substituents that complement this expanded binding pocket.  Here the authors explored structure-activity relationships of a series of pyrazolopyrimidine inhibitors of CDPK1 with the goal of increasing selectivity over host enzymes, improving antiparasite potency, and improving metabolic stability.  The resulting lead compd. 24 exhibited excellent enzyme inhibition and selectivity for CDPK1 and potently inhibited parasite growth in vitro.  Compd. 24 was also effective at treating acute toxoplasmosis in the mouse, reducing dissemination to the central nervous system, and decreasing reactivation of chronic infection in severely immunocompromised mice.  These findings provide proof of concept for the development of small mol. inhibitors of CDPK1 for treatment of CNS toxoplasmosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR_eZs2pZPQ7Vg90H21EOLACvtfcHk0ljWqcq7kesj5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFensbzO&md5=27908eedbcadb1132f254fda63336842</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01192%26sid%3Dliteratum%253Aachs%26aulast%3DRutaganira%26aufirst%3DF.%2BU.%26aulast%3DBarks%26aufirst%3DJ.%26aulast%3DDhason%26aufirst%3DM.%2BS.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DLong%26aufirst%3DS.%26aulast%3DRadke%26aufirst%3DJ.%2BB.%26aulast%3DJones%26aufirst%3DN.%2BG.%26aulast%3DMaddirala%26aufirst%3DA.%2BR.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DEl%2BBakkouri%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DR.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DInhibition%2520of%2520calcium%2520dependent%2520protein%2520kinase%25201%2520%2528CDPK1%2529%2520by%2520pyrazolopyrimidine%2520analogs%2520decreases%2520establishment%2520and%2520reoccurrence%2520of%2520central%2520nervous%2520system%2520disease%2520by%2520Toxoplasma%2520gondii%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D24%26spage%3D9976%26epage%3D9989%26doi%3D10.1021%2Facs.jmedchem.7b01192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidadala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulverson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isoherranen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comess, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span> <span> </span><span class="NLM_article-title">A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>209</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1093/infdis/jit522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1093%2Finfdis%2Fjit522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=24123773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2cXit1Smtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2014&pages=275-284&issue=2&author=K.+K.+Ojoauthor=R.+T.+Eastmanauthor=R.+Vidadalaauthor=Z.+Zhangauthor=K.+L.+Rivasauthor=R.+Choiauthor=J.+D.+Lutzauthor=M.+C.+Reidauthor=A.+M.+Foxauthor=M.+A.+Hulversonauthor=M.+Kennedyauthor=N.+Isoherranenauthor=L.+M.+Kimauthor=K.+M.+Comessauthor=D.+J.+Kempfauthor=C.+L.+Verlindeauthor=X.+Z.+Suauthor=S.+H.+Kappeauthor=D.+J.+Malyauthor=E.+Fanauthor=W.+C.+Van+Voorhis&title=A+specific+inhibitor+of+PfCDPK4+blocks+malaria+transmission%3A+chemical-genetic+validation&doi=10.1093%2Finfdis%2Fjit522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A Specific Inhibitor of PfCDPK4 Blocks Malaria Transmission: Chemical-genetic Validation</span></div><div class="casAuthors">Ojo, Kayode K.; Eastman, Richard T.; Vidadala, Rama Subba Rao; Zhang, Zhongsheng; Rivas, Kasey L.; Choi, Ryan; Lutz, Justin D.; Reid, Molly C.; Fox, Anna M. W.; Hulverson, Matthew A.; Kennedy, Mark; Isoherranen, Nina; Kim, Laura M.; Comess, Kenneth M.; Kempf, Dale J.; Verlinde, Christophe L. M. J.; Su, Xin-zhuan; Kappe, Stefan H. I.; Maly, Dustin J.; Fan, Erkang; Van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-284</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Malaria parasites are transmitted by mosquitoes, and blocking parasite transmission is crit. in reducing or eliminating malaria in endemic regions.  Here, we report the pharmacol. characterization of a new class of malaria transmission-blocking compds. that acts via the inhibition of Plasmodia CDPK4 enzyme.  We demonstrate that these compds. achieved selectivity over mammalian kinases by capitalizing on a small serine gatekeeper residue in the active site of the Plasmodium CDPK4 enzyme.  To directly confirm the mechanism of action of these compds., we generated P. falciparum parasites that express a drug-resistant methionine gatekeeper (S147M) CDPK4 mutant.  Mutant parasites showed a shift in exflagellation EC50 relative to the wild-type strains in the presence of compd. 1294, providing chem.-genetic evidence that CDPK4 is the target of the compd.  Pharmacokinetic analyses suggest that coformulation of this transmission-blocking agent with asexual stage antimalarials such as artemisinin combination therapy (ACT) is a promising option for drug delivery that may reduce transmission of malaria including drug-resistant strains.  Ongoing studies include refining the compds. to improve efficacy and toxicol. properties for efficient blocking of malaria transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4SsoTjMi12LVg90H21EOLACvtfcHk0ljWqcq7kesj5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXit1Smtg%253D%253D&md5=cc5499eca2d177bfa8cb1c523eb54525</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjit522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjit522%26sid%3Dliteratum%253Aachs%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DEastman%26aufirst%3DR.%2BT.%26aulast%3DVidadala%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRivas%26aufirst%3DK.%2BL.%26aulast%3DChoi%26aufirst%3DR.%26aulast%3DLutz%26aufirst%3DJ.%2BD.%26aulast%3DReid%26aufirst%3DM.%2BC.%26aulast%3DFox%26aufirst%3DA.%2BM.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DKennedy%26aufirst%3DM.%26aulast%3DIsoherranen%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DL.%2BM.%26aulast%3DComess%26aufirst%3DK.%2BM.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DSu%26aufirst%3DX.%2BZ.%26aulast%3DKappe%26aufirst%3DS.%2BH.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520PfCDPK4%2520blocks%2520malaria%2520transmission%253A%2520chemical-genetic%2520validation%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2014%26volume%3D209%26issue%3D2%26spage%3D275%26epage%3D284%26doi%3D10.1093%2Finfdis%2Fjit522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dobrowolski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">933</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81071-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2FS0092-8674%2800%2981071-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=8601316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADyaK28XhvFKjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1996&pages=933-939&issue=6&author=J.+M.+Dobrowolskiauthor=L.+D.+Sibley&title=Toxoplasma+invasion+of+mammalian+cells+is+powered+by+the+actin+cytoskeleton+of+the+parasite&doi=10.1016%2FS0092-8674%2800%2981071-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite</span></div><div class="casAuthors">Dobrowolski, Janice M.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">933-9</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Toxoplasma gondii is an obligate intracellular parasite that invades a wide range of vertebrate host cells.  The authors demonstrate that invasion is crit. dependent on actin filaments in the parasite, but not the host cell.  Invasion into cytochalasin D (CD)-resistant host cells was blocked by CD, whereas parasite mutants invaded wild-type host cells in the presence of drug.  CD resistance in Toxoplasma was mediated by a point mutation in the single-copy actin gene ACT1.  Transfection of the mutant act1 allele into wild-type Toxoplasma conferred motility and invasion in the presence of CD.  Thus, host cell invasion by Toxoplasma, and likely by related Apicomplexans, is actively powered by an actin-based contractile system in the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBjrv4y6LxarVg90H21EOLACvtfcHk0lhC7Vp8wKaWjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvFKjs70%253D&md5=55242bdb0bb9ce4a0128139630de7085</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981071-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981071-5%26sid%3Dliteratum%253Aachs%26aulast%3DDobrowolski%26aufirst%3DJ.%2BM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DToxoplasma%2520invasion%2520of%2520mammalian%2520cells%2520is%2520powered%2520by%2520the%2520actin%2520cytoskeleton%2520of%2520the%2520parasite%26jtitle%3DCell%26date%3D1996%26volume%3D84%26issue%3D6%26spage%3D933%26epage%3D939%26doi%3D10.1016%2FS0092-8674%2800%2981071-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, Y.</span></span> <span> </span><span class="NLM_article-title">Efficient synthesis of cyclopropylhydrazine salts</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">30</span>),  <span class="NLM_fpage">4102</span>– <span class="NLM_lpage">4104</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2014.05.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.tetlet.2014.05.098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCqtrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=4102-4104&issue=30&author=T.+Shibueauthor=Y.+Fukuda&title=Efficient+synthesis+of+cyclopropylhydrazine+salts&doi=10.1016%2Fj.tetlet.2014.05.098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis of cyclopropylhydrazine salts</span></div><div class="casAuthors">Shibue, Taku; Fukuda, Yasumichi</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4102-4104</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">An efficient procedure for the synthesis of cyclopropylhydrazine in salt form is reported.  Copper-catalyzed addn. of cyclopropylboronic acid to the azo group of di-tert-Bu azodicarboxylate and subsequent deprotection gave the cyclopropylhydrazine salts in high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmYCON6GrI-rVg90H21EOLACvtfcHk0lhC7Vp8wKaWjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqtrbO&md5=21f0f0be3454dbef4ed5a4fe10542e9d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2014.05.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2014.05.098%26sid%3Dliteratum%253Aachs%26aulast%3DShibue%26aufirst%3DT.%26aulast%3DFukuda%26aufirst%3DY.%26atitle%3DEfficient%2520synthesis%2520of%2520cyclopropylhydrazine%2520salts%26jtitle%3DTetrahedron%2520Lett.%26date%3D2014%26volume%3D55%26issue%3D30%26spage%3D4102%26epage%3D4104%26doi%3D10.1016%2Fj.tetlet.2014.05.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neidlein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikelj, D.</span></span> <span> </span><span class="NLM_article-title">A facilesynthesis of dialkoxycarbonylketene-ethylene, dicyanoketene-ethylene, and alkoxycarbonyl(cyano)ketene-ethylene acetals</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>1988</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">983</span>, <span class="refDoi"> DOI: 10.1055/s-1988-27775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1055%2Fs-1988-27775" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1988&publication_year=1988&pages=981-983&issue=12&author=R.+Neidleinauthor=D.+Kikelj&title=A+facilesynthesis+of+dialkoxycarbonylketene-ethylene%2C+dicyanoketene-ethylene%2C+and+alkoxycarbonyl%28cyano%29ketene-ethylene+acetals&doi=10.1055%2Fs-1988-27775"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1055%2Fs-1988-27775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1988-27775%26sid%3Dliteratum%253Aachs%26aulast%3DNeidlein%26aufirst%3DR.%26aulast%3DKikelj%26aufirst%3DD.%26atitle%3DA%2520facilesynthesis%2520of%2520dialkoxycarbonylketene-ethylene%252C%2520dicyanoketene-ethylene%252C%2520and%2520alkoxycarbonyl%2528cyano%2529ketene-ethylene%2520acetals%26jtitle%3DSynthesis%26date%3D1988%26volume%3D1988%26issue%3D12%26spage%3D981%26epage%3D983%26doi%3D10.1055%2Fs-1988-27775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miah, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champigny, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percy, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Procopiou, P. A.</span></span> <span> </span><span class="NLM_article-title">Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">5327</span>– <span class="NLM_lpage">5340</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.bmc.2017.07.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=28801066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSiur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=5327-5340&issue=20&author=A.+H.+Miahauthor=A.+C.+Champignyauthor=R.+H.+Gravesauthor=S.+T.+Hodgsonauthor=J.+M.+Percyauthor=P.+A.+Procopiou&title=Identification+of+pyrazolopyrimidine+arylsulfonamides+as+CC-chemokine+receptor+4+%28CCR4%29+antagonists&doi=10.1016%2Fj.bmc.2017.07.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists</span></div><div class="casAuthors">Miah, Afjal H.; Champigny, Aurelie C.; Graves, Rebecca H.; Hodgson, Simon T.; Percy, Jonathan M.; Procopiou, Panayiotis A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5327-5340</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel 4-aminoindazole sulfonamide hit (13) was identified as a human CCR4 antagonists from testing a focussed library of compds. in the primary GTPγS assay.  Replacing the indazole core with a pyrazolopyrimidine, and introduction of a methoxy group adjacent to the sulfonamide substituent, resulted in the identification of pyrazolopyrimidine 37a, which exhibited good binding affinity in the GTPγS assay (pIC50 = 7.2), low lipophilicity (c log P = 2.2, chromlog D7.4 = 2.4), high LE (0.41), high soly. (CLND soly. ≥581 μM), and an excellent PK profile in both the rat (F = 62%) and the dog (F = 100%).  Further SAR investigation of the pyrazolopyrimidine suggested that substitution at N1 is tolerated, providing a suitable vector to modulate the properties, and increase the potency in a lead optimization campaign.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-B5cBac9FfrVg90H21EOLACvtfcHk0lhC7Vp8wKaWjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSiur3F&md5=70d9ea63989eb24ce0bff5745751f846</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DMiah%26aufirst%3DA.%2BH.%26aulast%3DChampigny%26aufirst%3DA.%2BC.%26aulast%3DGraves%26aufirst%3DR.%2BH.%26aulast%3DHodgson%26aufirst%3DS.%2BT.%26aulast%3DPercy%26aufirst%3DJ.%2BM.%26aulast%3DProcopiou%26aufirst%3DP.%2BA.%26atitle%3DIdentification%2520of%2520pyrazolopyrimidine%2520arylsulfonamides%2520as%2520CC-chemokine%2520receptor%25204%2520%2528CCR4%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26issue%3D20%26spage%3D5327%26epage%3D5340%26doi%3D10.1016%2Fj.bmc.2017.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winzer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguado-Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manser, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Mora, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojo, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemphill, A.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans <i>Toxoplasma gondii</i> and <i>Neospora caninum</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">6361</span>– <span class="NLM_lpage">6374</span>, <span class="refDoi"> DOI: 10.1128/AAC.01236-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FAAC.01236-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=26248379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=6361-6374&issue=10&author=P.+Winzerauthor=J.+Mullerauthor=A.+Aguado-Martinezauthor=M.+Rahmanauthor=V.+Balmerauthor=V.+Manserauthor=L.+M.+Ortega-Moraauthor=K.+K.+Ojoauthor=E.+Fanauthor=D.+J.+Malyauthor=W.+C.+Van+Voorhisauthor=A.+Hemphill&title=In+vitro+and+in+vivo+effects+of+the+bumped+kinase+inhibitor+1294+in+the+related+cyst-forming+apicomplexans+Toxoplasma+gondii+and+Neospora+caninum&doi=10.1128%2FAAC.01236-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro and In Vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans toxoplasma gondii and Neospora caninum</span></div><div class="casAuthors">Winzer, Pablo; Muller, Joachim; Aguado-Martinez, Adriana; Rahman, Mahbubur; Balmer, Vreni; Manser, Vera; Miguel, Ortega-Mora Luis; Ojo, Kayode K.; Fan, Erkang; Maly, Dustin J.; C. Van Voorhis, Wesley; Hemphill, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6361-6374</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report on the in vitro effects of the bumped kinase inhibitor 1294 (BKI-1294) in cultures of virulent Neospora caninum isolates Nc-Liverpool (Nc-Liv) and Nc-Spain7 and in two strains of Toxoplasma gondii (RH and ME49), all grown in human foreskin fibroblasts.  In these parasites, BKI-1294 acted with 50% inhibitory concns. (IC50s) ranging from 20 nM (T. gondii RH) to 360 nM (N. caninum Nc-Liv), and exposure of intracellular stages to 1294 led to the nondisjunction of newly formed tachyzoites, resulting in the formation of multinucleated complexes similar to complexes previously obsd. in BKI-1294- treated N. caninum beta-galactosidase-expressing parasites.  However, such complexes were not seen in a transgenic T. gondii strain that expressed CDPK1 harboring a mutation (G to M) in the gatekeeper residue.  In T. gondii ME49 and N. caninum Nc-Liv, exposure of cultures to BKI-1294 resulted in the elevated expression of mRNA coding for the bradyzoite marker BAG1.  Unlike in bradyzoites, SAG1 expression was not repressed.  Immunofluorescence also showed that these multinucleated complexes expressed SAG1 and BAG1 and the monoclonal antibody CC2, which binds to a yet unidentified bradyzoite antigen, also exhibited increased labeling.  In a pregnant mouse model, BKI-1294 efficiently inhibited vertical transmission in BALB/c mice exptl. infected with one of the two virulent isolates Nc-Liv or Nc-Spain7, demonstrating proof of concept that this compd. protected offspring from vertical transmission and disease.  The obsd. deregulated antigen expression effect may enhance the immune response during BKI-1294 therapy and will be the subject of future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv-Uw_Y4GsNLVg90H21EOLACvtfcHk0lijJQDZTRB0hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWqtL0%253D&md5=e17f0f2cd7e095e95d6df945f6bf3d49</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.01236-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01236-15%26sid%3Dliteratum%253Aachs%26aulast%3DWinzer%26aufirst%3DP.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DAguado-Martinez%26aufirst%3DA.%26aulast%3DRahman%26aufirst%3DM.%26aulast%3DBalmer%26aufirst%3DV.%26aulast%3DManser%26aufirst%3DV.%26aulast%3DOrtega-Mora%26aufirst%3DL.%2BM.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DHemphill%26aufirst%3DA.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520effects%2520of%2520the%2520bumped%2520kinase%2520inhibitor%25201294%2520in%2520the%2520related%2520cyst-forming%2520apicomplexans%2520Toxoplasma%2520gondii%2520and%2520Neospora%2520caninum%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26issue%3D10%26spage%3D6361%26epage%3D6374%26doi%3D10.1128%2FAAC.01236-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemae, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiwa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakoshi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recuenco, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwanaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span> <span> </span><span class="NLM_article-title">Identification of mutations in TgMAPK1 of <i>Toxoplasma gondii</i> conferring resistance to 1NM-PP1</span>. <i>Int. J. Parasitol.: Drugs Drug Resist.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.ijpddr.2013.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2Fj.ijpddr.2013.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=24533298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADC%252BC2cvls1ensg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=93-101&author=T.+Sugiauthor=K.+Kobayashiauthor=H.+Takemaeauthor=H.+Gongauthor=A.+Ishiwaauthor=F.+Murakoshiauthor=F.+C.+Recuencoauthor=T.+Iwanagaauthor=T.+Horimotoauthor=H.+Akashiauthor=K.+Kato&title=Identification+of+mutations+in+TgMAPK1+of+Toxoplasma+gondii+conferring+resistance+to+1NM-PP1&doi=10.1016%2Fj.ijpddr.2013.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of mutations in TgMAPK1 of Toxoplasma gondii conferring resistance to 1NM-PP1</span></div><div class="casAuthors">Sugi Tatsuki; Takemae Hitoshi; Gong Haiyan; Ishiwa Akiko; Murakoshi Fumi; Recuenco Frances C; Iwanaga Tatsuya; Horimoto Taisuke; Akashi Hiroomi; Kobayashi Kyousuke; Kato Kentaro</div><div class="citationInfo"><span class="NLM_cas:title">International journal for parasitology. Drugs and drug resistance</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-101</span>
        ISSN:<span class="NLM_cas:issn">2211-3207</span>.
    </div><div class="casAbstract">Toxoplasma gondii is an important food and waterborne pathogen that causes severe disease in immunocompromised patients.  Bumped kinase inhibitors (BKIs) have an antiparasitic effect on T. gondii tachyzoite growth by targeting T. gondii calmodulin-domain protein kinase 1 (TgCDPK1).  To identify mutations that confer resistance to BKIs, chemical mutagenesis was performed, followed by selection in media containing either 250 or 1000 nM 1NM-PP1.  Whole-genome sequence analysis of resistant clones revealed single nucleotide mutations in T. gondii mitogen-activated protein kinase 1 (TgMAPK1) at amino acids 162 (L162Q) and 171 (I171N).  Plasmid constructs having the TgMAPK1 L162Q mutant sequence successfully replaced native TgMAPK1 genome locus in the presence of 1000 nM 1NM-PP1.  The inhibitory effect of 1NM-PP1 on cell division observed in the parent clone was decreased in 1NM-PP1-resistant clones; however, effects on parasite invasion and calcium-induced egress were similar in both parent and resistant clones.  A plasmid construct expressing the full length TgMAPK1 splicing isoform with L162Q mutation successfully complemented TgMAPK1 function in the pressure of 250 nM 1NM-PP1 in plaque assay. 1NM-PP1-resistant clones showed resistance to other BKIs (3MB-PP1 and 3BrB-PP1) with different levels.  Here we identify TgMAPK1 as a novel target for 1NM-PP1 activity.  This inhibitory effect is mediated through inhibition of tachyzoite cell division, and can be overcome through mutations at multiple residues in TgMAPK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0kT6fDiRpcRjv2lLSLOxFfW6udTcc2eZ8CgxIKKgUlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvls1ensg%253D%253D&md5=7835bea69c668c29fee552ac0b59afb2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpddr.2013.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpddr.2013.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DSugi%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DTakemae%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DH.%26aulast%3DIshiwa%26aufirst%3DA.%26aulast%3DMurakoshi%26aufirst%3DF.%26aulast%3DRecuenco%26aufirst%3DF.%2BC.%26aulast%3DIwanaga%26aufirst%3DT.%26aulast%3DHorimoto%26aufirst%3DT.%26aulast%3DAkashi%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520mutations%2520in%2520TgMAPK1%2520of%2520Toxoplasma%2520gondii%2520conferring%2520resistance%2520to%25201NM-PP1%26jtitle%3DInt.%2520J.%2520Parasitol.%253A%2520Drugs%2520Drug%2520Resist.%26date%3D2013%26volume%3D3%26spage%3D93%26epage%3D101%26doi%3D10.1016%2Fj.ijpddr.2013.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witucki, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraybill, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubersax, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blethrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Structural basis for selective inhibition of Src family kinases by PP1</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">678</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(99)80118-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1016%2FS1074-5521%2899%2980118-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10467133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFaqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=671-678&issue=9&author=Y.+Liuauthor=A.+Bishopauthor=L.+Wituckiauthor=B.+Kraybillauthor=E.+Shimizuauthor=J.+Tsienauthor=J.+Ubersaxauthor=J.+Blethrowauthor=D.+O.+Morganauthor=K.+M.+Shokat&title=Structural+basis+for+selective+inhibition+of+Src+family+kinases+by+PP1&doi=10.1016%2FS1074-5521%2899%2980118-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for selective inhibition of Src family kinases by PP1</span></div><div class="casAuthors">Liu, Yi; Bishop, Anthony; Witucki, Laurie; Kraybill, Brian; Shimizu, Eiji; Tsien, Joe; Ubersax, Jeff; Blethrow, Justin; Morgan, David O.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">671-678</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that can target individual kinases are powerful tools for use in signal transduction research.  It is difficult to find such compds. because of the enormous no. of protein kinases and the highly conserved nature of their catalytic domains.  Recently, a novel, potent, Src family selective tyrosine kinase inhibitor was reported (PP1).  Here, we study the structural basis for this inhibitor's specificity for Src family kinases.  A single residue corresponding to Ile338 (v-Src numbering; Thr338 in c-Src) in Src family tyrosine kinases largely controls PP1's ability to inhibit protein kinases.  Mutation of Ile338 to a larger residue such as methionine or phenylalanine in v-Src makes this inhibitor less potent.  Conversely, mutation of Ile338 to alanine or glycine increases PP1's potency.  PP1 can inhibit Ser/Thr kinases if the residue corresponding to Ile338 in v-Src is mutated to glycine.  We have accurately predicted several non-Src family kinases that are moderately (IC50 ∼1 μM) inhibited by PP1, including c-Abl and the MAP kinase p38.  Our mutagenesis studies of the ATP-binding site in both tyrosine kinases and Ser/Thr kinases explain why PP1 is a specific inhibitor of Src family tyrosine kinases.  Detn. of the structural basis of inhibitor specificity will aid in the design of more potent and more selective protein kinase inhibitors.  The ability to desensitize a particular kinase to PP1 inhibition of residue 338 or conversely to sensitize a kinase to PP1 inhibition by mutation should provide a useful basis for chem. genetic studies of kinase signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC8HNYPVy4RLVg90H21EOLACvtfcHk0lijJQDZTRB0hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFaqur4%253D&md5=4d09cc5fb95c2ed5d538c02f356c0842</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980118-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980118-5%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DBishop%26aufirst%3DA.%26aulast%3DWitucki%26aufirst%3DL.%26aulast%3DKraybill%26aufirst%3DB.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DTsien%26aufirst%3DJ.%26aulast%3DUbersax%26aufirst%3DJ.%26aulast%3DBlethrow%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DStructural%2520basis%2520for%2520selective%2520inhibition%2520of%2520Src%2520family%2520kinases%2520by%2520PP1%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26issue%3D9%26spage%3D671%26epage%3D678%26doi%3D10.1016%2FS1074-5521%2899%2980118-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swapna, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjithomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karamycheva, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunk, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothroyd, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darde, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Miranda, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gennari, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeij, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grigg, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissinger, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roos, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic <i>Toxoplasma gondii</i> genomes</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">10147</span>, <span class="refDoi"> DOI: 10.1038/ncomms10147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fncomms10147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=26738725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=10147&author=H.+Lorenziauthor=A.+Khanauthor=M.+S.+Behnkeauthor=S.+Namasivayamauthor=L.+S.+Swapnaauthor=M.+Hadjithomasauthor=S.+Karamychevaauthor=D.+Pinneyauthor=B.+P.+Brunkauthor=J.+W.+Ajiokaauthor=D.+Ajzenbergauthor=J.+C.+Boothroydauthor=J.+P.+Boyleauthor=M.+L.+Dardeauthor=M.+A.+Diaz-Mirandaauthor=J.+P.+Dubeyauthor=H.+M.+Fritzauthor=S.+M.+Gennariauthor=B.+D.+Gregoryauthor=K.+Kimauthor=J.+P.+Saeijauthor=C.+Suauthor=M.+W.+Whiteauthor=X.+Q.+Zhuauthor=D.+K.+Howeauthor=B.+M.+Rosenthalauthor=M.+E.+Griggauthor=J.+Parkinsonauthor=L.+Liuauthor=J.+C.+Kissingerauthor=D.+S.+Roosauthor=L.+D.+Sibley&title=Local+admixture+of+amplified+and+diversified+secreted+pathogenesis+determinants+shapes+mosaic+Toxoplasma+gondii+genomes&doi=10.1038%2Fncomms10147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes</span></div><div class="casAuthors">Lorenzi, Hernan; Khan, Asis; Behnke, Michael S.; Namasivayam, Sivaranjani; Swapna, Lakshmipuram S.; Hadjithomas, Michalis; Karamycheva, Svetlana; Pinney, Deborah; Brunk, Brian P.; Ajioka, James W.; Ajzenberg, Daniel; Boothroyd, John C.; Boyle, Jon P.; Darde, Marie L.; Diaz-Miranda, Maria A.; Dubey, Jitender P.; Fritz, Heather M.; Gennari, Solange M.; Gregory, Brian D.; Kim, Kami; Saeij, Jeroen P. J.; Su, Chunlei; White, Michael W.; Zhu, Xing-Quan; Howe, Daniel K.; Rosenthal, Benjamin M.; Grigg, Michael E.; Parkinson, John; Liu, Liang; Kissinger, Jessica C.; Roos, David S.; David Sibley, L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10147</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Toxoplasma gondii is among the most prevalent parasites worldwide, infecting many wild and domestic animals and causing zoonotic infections in humans.  T. gondii differs substantially in its broad distribution from closely related parasites that typically have narrow, specialized host ranges.  To elucidate the genetic basis for these differences, we compared the genomes of 62 globally distributed T. gondii isolates to several closely related coccidian parasites.  Our findings reveal that tandem amplification and diversification of secretory pathogenesis determinants is the primary feature that distinguishes the closely related genomes of these biol. diverse parasites.  We further show that the unusual population structure of T. gondii is characterized by clade-specific inheritance of large conserved haploblocks that are significantly enriched in tandemly clustered secretory pathogenesis determinants.  The shared inheritance of these conserved haploblocks, which show a different ancestry than the genome as a whole, may thus influence transmission, host range, and pathogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdDKqaMZXy87Vg90H21EOLACvtfcHk0ljvkVAOx_zEGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFOrsw%253D%253D&md5=1952e8e223c43abfde12aa2f61a64cf3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fncomms10147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10147%26sid%3Dliteratum%253Aachs%26aulast%3DLorenzi%26aufirst%3DH.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DBehnke%26aufirst%3DM.%2BS.%26aulast%3DNamasivayam%26aufirst%3DS.%26aulast%3DSwapna%26aufirst%3DL.%2BS.%26aulast%3DHadjithomas%26aufirst%3DM.%26aulast%3DKaramycheva%26aufirst%3DS.%26aulast%3DPinney%26aufirst%3DD.%26aulast%3DBrunk%26aufirst%3DB.%2BP.%26aulast%3DAjioka%26aufirst%3DJ.%2BW.%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DBoothroyd%26aufirst%3DJ.%2BC.%26aulast%3DBoyle%26aufirst%3DJ.%2BP.%26aulast%3DDarde%26aufirst%3DM.%2BL.%26aulast%3DDiaz-Miranda%26aufirst%3DM.%2BA.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DFritz%26aufirst%3DH.%2BM.%26aulast%3DGennari%26aufirst%3DS.%2BM.%26aulast%3DGregory%26aufirst%3DB.%2BD.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DSaeij%26aufirst%3DJ.%2BP.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DM.%2BW.%26aulast%3DZhu%26aufirst%3DX.%2BQ.%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DRosenthal%26aufirst%3DB.%2BM.%26aulast%3DGrigg%26aufirst%3DM.%2BE.%26aulast%3DParkinson%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKissinger%26aufirst%3DJ.%2BC.%26aulast%3DRoos%26aufirst%3DD.%2BS.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DLocal%2520admixture%2520of%2520amplified%2520and%2520diversified%2520secreted%2520pathogenesis%2520determinants%2520shapes%2520mosaic%2520Toxoplasma%2520gondii%2520genomes%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D10147%26doi%3D10.1038%2Fncomms10147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, M.</span></span> <span> </span><span class="NLM_article-title">The role of aldehyde oxidase in drug metabolism</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1517/17425255.2012.663352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1517%2F17425255.2012.663352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=22335465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVOrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=487-503&issue=4&author=E.+Garattiniauthor=M.+Terao&title=The+role+of+aldehyde+oxidase+in+drug+metabolism&doi=10.1517%2F17425255.2012.663352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The role of aldehyde oxidase in drug metabolism</span></div><div class="casAuthors">Garattini, Enrico; Terao, Mineko</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">487-503</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Aldehyde oxidases (AOXs) are molybdo-flavoenzymes with complex evolutionary profiles, as the no. and types of active AOX genes vary according to the animal species considered.  Humans and higher primates have a single functional AOX1 gene, while rodents are endowed with four AOXs.  Along with the endoplasmic cytochrome P 450 system (CYP450), cytoplasmic AOX1 is the major enzyme involved in the hepatic phase I metab. of numerous xenobiotics.Areas covered: The authors review literature to highlight the fact that aldehydes are not the only AOX substrates, as aza- and oxo-heterocycles, that represent the scaffold of many drugs, are also oxidized efficiently by these enzymes.  Addnl., the ndefine the different complements of AOX isoenzymes expressed in humans and animal models used in drug metab. studies and discuss the implications.  Furthermore, the authors report on human AOX1 allelic variants that alter the activity of this enzyme.  Finally, they discuss the factors of potential importance in controlling the functional activity of AOX1.Expert opinion: There is evidence for an increasing relevance of AOX1 in the metab. and clearance of new drugs, as measures aiming at controlling CYP450-dependent metab. of prospective therapeutic agents are becoming routine.  This calls for investigations into the biol., catalytic properties and substrate specificity of human AOX1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCgeYumc6Up7Vg90H21EOLACvtfcHk0ljvkVAOx_zEGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVOrsLg%253D&md5=b7e5d6a1f1164ccd14a042aefded8a66</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1517%2F17425255.2012.663352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2012.663352%26sid%3Dliteratum%253Aachs%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520aldehyde%2520oxidase%2520in%2520drug%2520metabolism%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2012%26volume%3D8%26issue%3D4%26spage%3D487%26epage%3D503%26doi%3D10.1517%2F17425255.2012.663352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span> <span> </span><span class="NLM_article-title">Adenosine receptors as drug targets--what are the challenges?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1038/nrd3955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fnrd3955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=23535933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC3sXks1Glsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=265-286&issue=4&author=J.+F.+Chenauthor=H.+K.+Eltzschigauthor=B.+B.+Fredholm&title=Adenosine+receptors+as+drug+targets%2D%2Dwhat+are+the+challenges%3F&doi=10.1038%2Fnrd3955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors as drug targets - what are the challenges?</span></div><div class="casAuthors">Chen, Jiang-Fan; Eltzschig, Holger K.; Fredholm, Bertil B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">265-286</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Adenosine signalling has long been a target for drug development, with adenosine itself or its derivs. being used clin. since the 1940s.  In addn., methylxanthines such as caffeine have profound biol. effects as antagonists at adenosine receptors.  Moreover, drugs such as dipyridamole and methotrexate act by enhancing the activation of adenosine receptors.  There is strong evidence that adenosine has a functional role in many diseases, and several pharmacol. compds. specifically targeting individual adenosine receptors - either directly or indirectly - have now entered the clinic.  However, only one adenosine receptor-specific agent - the adenosine A2A receptor agonist regadenoson (Lexiscan; Astellas Pharma) - has so far gained approval from the US Food and Drug Administration (FDA).  Here, we focus on the biol. of adenosine signalling to identify hurdles in the development of addnl. pharmacol. compds. targeting adenosine receptors and discuss strategies to overcome these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqhEzWXi1WS7Vg90H21EOLACvtfcHk0ljvkVAOx_zEGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXks1Glsrs%253D&md5=898fee7a68273ebfbd5a1d3dca307dc5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnrd3955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3955%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DAdenosine%2520receptors%2520as%2520drug%2520targets--what%2520are%2520the%2520challenges%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D4%26spage%3D265%26epage%3D286%26doi%3D10.1038%2Fnrd3955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberg, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span> <span> </span><span class="NLM_article-title">hERG K(+) channels: structure, function, and clinical significance</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1393</span>– <span class="NLM_lpage">1478</span>, <span class="refDoi"> DOI: 10.1152/physrev.00036.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1152%2Fphysrev.00036.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=22988594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KmtbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2012&pages=1393-1478&issue=3&author=J.+I.+Vandenbergauthor=M.+D.+Perryauthor=M.+J.+Perrinauthor=S.+A.+Mannauthor=Y.+Keauthor=A.+P.+Hill&title=hERG+K%28%2B%29+channels%3A+structure%2C+function%2C+and+clinical+significance&doi=10.1152%2Fphysrev.00036.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">HERG K+ channels: structure, function, and clinical significance</span></div><div class="casAuthors">Vandenberg, Jamie I.; Perry, Matthew D.; Perrin, Mark J.; Mann, Stefan A.; Ke, Ying; Hill, Adam P.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1393-1478</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The human ether-a-go-go related gene (hERG) encodes the pore-forming subunit of the rapid component of the delayed rectifier K+ channel, Kv11.1, which are expressed in the heart, various brain regions, smooth muscle cells, endocrine cells, and a wide range of tumor cell lines.  However, it is the role that Kv11.1 channels play in the heart that has been best characterized, for two main reasons.  First, it is the gene product involved in chromosome 7-assocd. long QT syndrome (LOTS), an inherited disorder assocd. with a markedly increased risk of ventricular arrhythmias and sudden cardiac death.  Second, blockade of Kv11.1, by a wide range of prescription medications, causes drug-induced QT prolongation with an increase in risk of sudden cardiac arrest.  In the first part of this review, the properties of Kv11.1 channels, including biogenesis, trafficking, gating, and pharmacol. are discussed, while the second part focuses on the pathophysiol. of Kv11.1 channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7aFPdwhDHVLVg90H21EOLACvtfcHk0ljtykdCVctzKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KmtbbM&md5=0a51ed516e2e5599c5acf31b8444ae6a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00036.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00036.2011%26sid%3Dliteratum%253Aachs%26aulast%3DVandenberg%26aufirst%3DJ.%2BI.%26aulast%3DPerry%26aufirst%3DM.%2BD.%26aulast%3DPerrin%26aufirst%3DM.%2BJ.%26aulast%3DMann%26aufirst%3DS.%2BA.%26aulast%3DKe%26aufirst%3DY.%26aulast%3DHill%26aufirst%3DA.%2BP.%26atitle%3DhERG%2520K%2528%252B%2529%2520channels%253A%2520structure%252C%2520function%252C%2520and%2520clinical%2520significance%26jtitle%3DPhysiol.%2520Rev.%26date%3D2012%26volume%3D92%26issue%3D3%26spage%3D1393%26epage%3D1478%26doi%3D10.1152%2Fphysrev.00036.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, A.</span></span> <span> </span><span class="NLM_article-title">The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects</span>. <i>Am. Fam. Physician</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=17708140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A280%3ADC%252BD2svovFGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=391-396&issue=3&author=T.+Lynchauthor=A.+Price&title=The+effect+of+cytochrome+P450+metabolism+on+drug+response%2C+interactions%2C+and+adverse+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects</span></div><div class="casAuthors">Lynch Tom; Price Amy</div><div class="citationInfo"><span class="NLM_cas:title">American family physician</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">391-6</span>
        ISSN:<span class="NLM_cas:issn">0002-838X</span>.
    </div><div class="casAbstract">Cytochrome P450 enzymes are essential for the metabolism of many medications.  Although this class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most significant enzymes being CYP3A4 and CYP2D6.  Genetic variability (polymorphism) in these enzymes may influence a patient's response to commonly prescribed drug classes, including beta blockers and antidepressants.  Cytochrome P450 enzymes can be inhibited or induced by drugs, resulting in clinically significant drug-drug interactions that can cause unanticipated adverse reactions or therapeutic failures.  Interactions with warfarin, antidepressants, antiepileptic drugs, and statins often involve the cytochrome P450 enzymes.  Knowledge of the most important drugs metabolized by cytochrome P450 enzymes, as well as the most potent inhibiting and inducing drugs, can help minimize the possibility of adverse drug reactions and interactions.  Although genotype tests can determine if a patient has a specific enzyme polymorphism, it has not been determined if routine use of these tests will improve outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQE6VB-Pf2cThe4jJGKT5N0fW6udTcc2eaknC9D8ZeQMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svovFGhtQ%253D%253D&md5=68832276c56c8fb5f2818fc25bcc637f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DT.%26aulast%3DPrice%26aufirst%3DA.%26atitle%3DThe%2520effect%2520of%2520cytochrome%2520P450%2520metabolism%2520on%2520drug%2520response%252C%2520interactions%252C%2520and%2520adverse%2520effects%26jtitle%3DAm.%2520Fam.%2520Physician%26date%3D2007%26volume%3D76%26issue%3D3%26spage%3D391%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothroyd, J. C.</span></span> <span> </span><span class="NLM_article-title">Virulent strains of <i>Toxoplasma gondii</i> comprise a single clonal lineage</span>. <i>Nature (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1038/359082a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2F359082a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1992&pages=82-85&author=L.+D.+Sibleyauthor=J.+C.+Boothroyd&title=Virulent+strains+of+Toxoplasma+gondii+comprise+a+single+clonal+lineage&doi=10.1038%2F359082a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1038%2F359082a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F359082a0%26sid%3Dliteratum%253Aachs%26aulast%3DSibley%26aufirst%3DL.%2BD.%26aulast%3DBoothroyd%26aufirst%3DJ.%2BC.%26atitle%3DVirulent%2520strains%2520of%2520Toxoplasma%2520gondii%2520comprise%2520a%2520single%2520clonal%2520lineage%26jtitle%3DNature%2520%2528London%252C%2520U.%2520K.%2529%26date%3D1992%26volume%3D359%26spage%3D82%26epage%3D85%26doi%3D10.1038%2F359082a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Identification of quantitative trait loci controlling acute virulence in <i>Toxoplasma gondii</i></span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">10753</span>– <span class="NLM_lpage">10758</span>, <span class="refDoi"> DOI: 10.1073/pnas.172117099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1073%2Fpnas.172117099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=12149482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1Cht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=10753-10758&author=C.+Suauthor=D.+K.+Howeauthor=J.+P.+Dubeyauthor=J.+W.+Ajiokaauthor=L.+D.+Sibley&title=Identification+of+quantitative+trait+loci+controlling+acute+virulence+in+Toxoplasma+gondii&doi=10.1073%2Fpnas.172117099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii</span></div><div class="casAuthors">Su, Chunlei; Howe, Daniel K.; Dubey, J. P.; Ajioka, James W.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">10753-10758</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Strains of Toxoplasma gondii can be grouped into three predominant clonal lineages with members of the type I group being uniformly lethal in mice.  To elucidate the basis of this extreme virulence, a genetic cross was performed between a highly virulent type I strain (GT-1) and a less-virulent type III strain (CTG), and the phenotypes of resulting progeny were analyzed by genetic linkage mapping.  Anal. of independent recombinant progeny identified several quant. trait loci that contributed to acute virulence.  A major quant. trait locus located on chromosome VII accounted for ≈50% of the virulence phenotype, whereas a minor locus on chromosome IV, linked to the ROP1 gene, accounted for ≈10%.  These loci are conserved in other type I strains, indicating that acute virulence is controlled by discrete genes common to the type I lineage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaGd1mv6I_YbVg90H21EOLACvtfcHk0ljtykdCVctzKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1Cht7o%253D&md5=7677a36353d5f0e37eab2cb01a8fee1a</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.172117099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.172117099%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DC.%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DAjioka%26aufirst%3DJ.%2BW.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DIdentification%2520of%2520quantitative%2520trait%2520loci%2520controlling%2520acute%2520virulence%2520in%2520Toxoplasma%2520gondii%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D10753%26epage%3D10758%26doi%3D10.1073%2Fpnas.172117099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fentress, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashayekhi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">The polymorphic pseudokinase ROP5 controls virulence in <i>Toxoplasma gondii</i> by regulating the active kinase ROP18</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e1002992</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1002992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1371%2Fjournal.ppat.1002992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=23144612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCis7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&author=M.+S.+Behnkeauthor=S.+J.+Fentressauthor=M.+Mashayekhiauthor=L.+L.+Liauthor=G.+A.+Taylorauthor=L.+D.+Sibley&title=The+polymorphic+pseudokinase+ROP5+controls+virulence+in+Toxoplasma+gondii+by+regulating+the+active+kinase+ROP18&doi=10.1371%2Fjournal.ppat.1002992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18</span></div><div class="casAuthors">Behnke, Michael S.; Fentress, Sarah J.; Mashayekhi, Mona; Li, Lucy X.; Taylor, Gregory A.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e1002992</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Secretory polymorphic serine/threonine kinases control pathogenesis of Toxoplasma gondii in the mouse.  Genetic studies show that the pseudokinase ROP5 is essential for acute virulence, but do not reveal its mechanism of action.  Here we demonstrate that ROP5 controls virulence by blocking IFN-γ mediated clearance in activated macrophages.  ROP5 was required for the catalytic activity of the active S/T kinase ROP18, which phosphorylates host immunity related GTPases (IRGs) and protects the parasite from clearance.  ROP5 directly regulated activity of ROP18 in vitro, and both proteins were necessary to avoid IRG recruitment and clearance in macrophages.  Clearance of both the Δrop5 and Δrop18 mutants was reversed in macrophages lacking Irgm3, which is required for IRG function, and the virulence defect was fully restored in Irgm3-/- mice.  Our findings establish that the pseudokinase ROP5 controls the activity of ROP18, thereby blocking IRG mediated clearance in macrophages.  Addnl., ROP5 has other functions that are also Irgm3 and IFN-γ dependent, indicting it plays a general role in governing virulence factors that block immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovOrvMpFAA67Vg90H21EOLACvtfcHk0liLLvIhINxW-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCis7vP&md5=4600462dbd8bc9d56720b8af2a92354b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002992%26sid%3Dliteratum%253Aachs%26aulast%3DBehnke%26aufirst%3DM.%2BS.%26aulast%3DFentress%26aufirst%3DS.%2BJ.%26aulast%3DMashayekhi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%2BL.%26aulast%3DTaylor%26aufirst%3DG.%2BA.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DThe%2520polymorphic%2520pseudokinase%2520ROP5%2520controls%2520virulence%2520in%2520Toxoplasma%2520gondii%2520by%2520regulating%2520the%2520active%2520kinase%2520ROP18%26jtitle%3DPLoS%2520Pathog.%26date%3D2012%26volume%3D8%26doi%3D10.1371%2Fjournal.ppat.1002992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quezado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nath, A.</span></span> <span> </span><span class="NLM_article-title">HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">662</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2016.149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1038%2Fnrneurol.2016.149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=27786246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqs7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=662-674&issue=11&author=L.+N.+Bowenauthor=B.+Smithauthor=D.+Reichauthor=M.+Quezadoauthor=A.+Nath&title=HIV-associated+opportunistic+CNS+infections%3A+pathophysiology%2C+diagnosis+and+treatment&doi=10.1038%2Fnrneurol.2016.149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment</span></div><div class="casAuthors">Bowen, Lauren N.; Smith, Bryan; Reich, Daniel; Quezado, Martha; Nath, Avindra</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">662-674</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nearly 30 years after the advent of antiretroviral therapy (ART), CNS opportunistic infections remain a major cause of morbidity and mortality in HIV-pos. individuals.  Unknown HIV-pos. disease status, antiretroviral drug resistance, poor drug compliance, and recreational drug abuse are factors that continue to influence the morbidity and mortality of infections.  The clin. and radiog. pattern of CNS opportunistic infections is unique in the setting of HIV infection: opportunistic infections in HIV-pos. patients often have characteristic clin. and radiol. presentations that can differ from the presentation of opportunistic infections in immunocompetent patients and are often sufficient to establish the diagnosis.  ART in the setting of these opportunistic infections can lead to a paradoxical worsening caused by an immune reconstitution inflammatory syndrome (IRIS).  In this Review, we discuss several of the most common CNS opportunistic infections: cerebral toxoplasmosis, progressive multifocal leukoencephalopathy (PML), tuberculous meningitis, cryptococcal meningitis and cytomegalovirus infection, with an emphasis on clin. pearls, pathol. findings, MRI findings and treatment.  Moreover, we discuss the risk factors, pathophysiol. and management of IRIS.  We also summarize the challenges that remain in management of CNS opportunistic infections, which includes the lack of phase II and III clin. trials, absence of antimicrobials for infections such as PML, and controversy regarding the use of corticosteroids for treatment of IRIS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDjBQM53c5lLVg90H21EOLACvtfcHk0liLLvIhINxW-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqs7nN&md5=e1ab369550e394f982d573c6c33e14d5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2016.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2016.149%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DL.%2BN.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DReich%26aufirst%3DD.%26aulast%3DQuezado%26aufirst%3DM.%26aulast%3DNath%26aufirst%3DA.%26atitle%3DHIV-associated%2520opportunistic%2520CNS%2520infections%253A%2520pathophysiology%252C%2520diagnosis%2520and%2520treatment%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2016%26volume%3D12%26issue%3D11%26spage%3D662%26epage%3D674%26doi%3D10.1038%2Fnrneurol.2016.149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, R. E.</span></span> <span> </span><span class="NLM_article-title">Antitoxoplasma Chemotherapy</span>. In  <i>Toxoplasmosis: A Comprehensive Clinical Guide</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joynson, D. H. M.</span>, <span class="NLM_string-name">Wreghitt, T. G.</span></span>, Eds.; <span class="NLM_publisher-name">Cambridge University Press</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2001</span>; pp  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">359</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1017%2FCBO9780511527005.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=319-359&author=R.+E.+McCabeauthor=D.+H.+M.+Joynson&author=T.+G.+Wreghitt&title=Toxoplasmosis%3A+A+Comprehensive+Clinical+Guide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1017%2FCBO9780511527005.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1017%252FCBO9780511527005.015%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DR.%2BE.%26atitle%3DAntitoxoplasma%2520Chemotherapy%26btitle%3DToxoplasmosis%253A%2520A%2520Comprehensive%2520Clinical%2520Guide%26aulast%3DJoynson%26aufirst%3DD.%2BH.%2BM.%26pub%3DCambridge%2520University%2520Press%26date%3D2001%26spage%3D319%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, L. J.</span></span> <span> </span><span class="NLM_article-title">A patatin-like protein protects <i>Toxoplasma gondii</i> from degradation in a nitric oxide-dependent manner</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1128/IAI.05543-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FIAI.05543-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=22006568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=55-61&issue=1&author=C.+M.+Tobinauthor=L.+J.+Knoll&title=A+patatin-like+protein+protects+Toxoplasma+gondii+from+degradation+in+a+nitric+oxide-dependent+manner&doi=10.1128%2FIAI.05543-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner</span></div><div class="casAuthors">Tobin, Crystal M.; Knoll, Laura J.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toxoplasma gondii is an obligate intracellular parasite that uses immune cells to disseminate throughout its host.  T. gondii can persist and even slowly replicate in activated host macrophages by reducing the antimicrobial effects of mols. such as nitric oxide (NO).  A T. gondii patatin-like protein called TgPL1 was previously shown to be important for survival in activated macrophages.  Here we show that a T. gondii mutant with a deletion of the TgPL1 gene (ΔTgPL1) is degraded in activated macrophages.  This degrdn. phenotype is abolished by the removal of NO by the use of an inducible NO synthase (iNOS) inhibitor or iNOS-deficient macrophages.  The exogenous addn. of NO to macrophages results in reduced parasite growth but not the degrdn. of ΔTgPL1 parasites.  These results suggest that NO is necessary but not sufficient for the degrdn. of ΔTgPL1 parasites in activated macrophages.  While some patatin-like proteins have phospholipase A2 (PLA2) activity, recombinant TgPL1 purified from Escherichia coli does not have phospholipase activity.  This result was not surprising, as TgPL1 contains a G-to-S change at the predicted catalytic serine residue.  An epitope-tagged version of TgPL1 partially colocalized with a dense granule protein in the parasitophorous vacuole space.  These results may suggest that TgPL1 moves to the parasitophorous vacuole to protect parasites from nitric oxide by an undetd. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU1uPDCKZvk7Vg90H21EOLACvtfcHk0liLLvIhINxW-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlGitw%253D%253D&md5=4adbe39d3ed61bdd9d57a539cbe58e5f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FIAI.05543-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.05543-11%26sid%3Dliteratum%253Aachs%26aulast%3DTobin%26aufirst%3DC.%2BM.%26aulast%3DKnoll%26aufirst%3DL.%2BJ.%26atitle%3DA%2520patatin-like%2520protein%2520protects%2520Toxoplasma%2520gondii%2520from%2520degradation%2520in%2520a%2520nitric%2520oxide-dependent%2520manner%26jtitle%3DInfect.%2520Immun.%26date%3D2012%26volume%3D80%26issue%3D1%26spage%3D55%26epage%3D61%26doi%3D10.1128%2FIAI.05543-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nawas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title"><i>Toxoplasma gondii</i> strains defective in oral transmission are also defective in developmental stage differentiation</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2580</span>– <span class="NLM_lpage">2590</span>, <span class="refDoi"> DOI: 10.1128/IAI.00085-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FIAI.00085-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=17339346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsV2msbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2007&pages=2580-2590&issue=5&author=B.+Fuxauthor=J.+Nawasauthor=A.+Khanauthor=D.+B.+Gillauthor=C.+Suauthor=L.+D.+Sibley&title=Toxoplasma+gondii+strains+defective+in+oral+transmission+are+also+defective+in+developmental+stage+differentiation&doi=10.1128%2FIAI.00085-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii strains defective in oral transmission are also defective in developmental stage differentiation</span></div><div class="casAuthors">Fux, Blima; Nawas, Julie; Khan, Asis; Gill, Darcy B.; Su, Chunlei; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2580-2590</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toxoplasma gondii undergoes differentiation from rapidly growing tachyzoites to slowly growing bradyzoites during its life cycle in the intermediate host, and conversion can be induced in vitro by stress.  Representative strains of the three clonal lineages showed equal capacity to differentiate into bradyzoites in vitro, as evidenced by induction of bradyzoite antigen 1, staining with Dolichos biflorus lectin (DBL), pepsin resistance, and oral infectivity in mice.  The authors also examd. several recently described exotic strains of T. gondii, which are genetically diverse and have a different ancestry from the clonal lineages.  The exotic strain COUG was essentially like the clonal lineages and showed a high capacity to induce bradyzoites in vitro and in vivo, consistent with its ability to be efficiently transmitted by the oral route.  In contrast, exotic strains MAS and FOU, which are defective in oral transmission, showed a decreased potential to develop into bradyzoites in vitro.  This defect was evident from reduced staining with DBL and the cyst antigen CST1, failure to down-regulate tachyzoite antigens, such as tachyzoite surface antigens 1 and 2A, and decreased resistance to pepsin treatment.  Despite normal in vitro differentiation, the exotic strains CAST and GPHT also showed decreased oral transmission, due to formation of smaller cysts and a lower tissue burden during chronic infection, traits also shared by MAS and FOU.  Collectively, these findings reveal that the limited oral transmission in some strains of T. gondii is due to inefficient differentiation to the bradyzoite form, leading to defects in the formation of tissue cysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobxeb1fjjTGbVg90H21EOLACvtfcHk0ljTtI_cKT7iSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsV2msbg%253D&md5=599861869356140a243b3f20fca000ba</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2FIAI.00085-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00085-07%26sid%3Dliteratum%253Aachs%26aulast%3DFux%26aufirst%3DB.%26aulast%3DNawas%26aufirst%3DJ.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DGill%26aufirst%3DD.%2BB.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DToxoplasma%2520gondii%2520strains%2520defective%2520in%2520oral%2520transmission%2520are%2520also%2520defective%2520in%2520developmental%2520stage%2520differentiation%26jtitle%3DInfect.%2520Immun.%26date%3D2007%26volume%3D75%26issue%3D5%26spage%3D2580%26epage%3D2590%26doi%3D10.1128%2FIAI.00085-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dunay, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Artemisone and artemiside control acute and reactivated toxoplasmosis in the murine model</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4450</span>– <span class="NLM_lpage">4456</span>, <span class="refDoi"> DOI: 10.1128/AAC.00502-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FAAC.00502-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=19635951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KkurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=4450-4456&author=I.+R.+Dunayauthor=W.+C.+Chanauthor=R.+K.+Haynesauthor=L.+D.+Sibley&title=Artemisone+and+artemiside+control+acute+and+reactivated+toxoplasmosis+in+the+murine+model&doi=10.1128%2FAAC.00502-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40aR"><div class="casContent"><span class="casTitleNuber">40a</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model</span></div><div class="casAuthors">Dunay, Ildiko R.; Chan, Wing Chi; Haynes, Richard K.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4450-4456</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Immunocompromised patients are at risk of developing toxoplasmosis, and although chemotherapy is available, std. treatments are often complicated by severe side effects.  Artemisinin is a new highly potent antimalarial drug that has activity against Toxoplasma gondii in vitro.  However, artemisinin derivs. have previously been ineffective in vivo using a rat model of toxoplasmosis.  In the present study, the efficacy of several new artemisinin derivates was investigated for treatment of mice infected with the parasite Toxoplasma gondii.  Artemiside and artemisone displayed better inhibition than either artemisinin or artesunate against the parasite in vitro.  Artemiside and artemisone treatment controlled parasite replication in vivo, and mice survived the acute infection.  In a murine model of reactivated toxoplasmosis, both drugs increased survival, although artemiside was more effective.  These results indicate that these newer derivs. of artemisinin may have potential for treatment of toxoplasmosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2MtmJjyOHtbVg90H21EOLACvtfcHk0ljTtI_cKT7iSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KkurjJ&md5=e86b366adcbd75b40fc3101344613137</span></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1128%2FAAC.00502-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00502-09%26sid%3Dliteratum%253Aachs%26aulast%3DDunay%26aufirst%3DI.%2BR.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DHaynes%26aufirst%3DR.%2BK.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DArtemisone%2520and%2520artemiside%2520control%2520acute%2520and%2520reactivated%2520toxoplasmosis%2520in%2520the%2520murine%2520model%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D4450%26epage%3D4456%26doi%3D10.1128%2FAAC.00502-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dunay, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimesaat, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushrab, F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arasteh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liesenfeld, O.</span></span> <span> </span><span class="NLM_article-title">Atovaquone maintenance therapy prevents reactivation of toxopasmic encepahalitis in the murine model of reactivated toxoplasmosis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4848</span>– <span class="NLM_lpage">4854</span>, <span class="refDoi"> DOI: 10.1128/AAC.48.12.4848-4854.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1128%2FAAC.48.12.4848-4854.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=15561866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKmt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=4848-4854&author=I.+R.+Dunayauthor=M.+M.+Heimesaatauthor=F.+N.+Bushrabauthor=R.+H.+Mullerauthor=H.+Stockerauthor=K.+Arastehauthor=M.+Kurowskiauthor=R.+Fitznerauthor=K.+Bornerauthor=O.+Liesenfeld&title=Atovaquone+maintenance+therapy+prevents+reactivation+of+toxopasmic+encepahalitis+in+the+murine+model+of+reactivated+toxoplasmosis&doi=10.1128%2FAAC.48.12.4848-4854.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40bR"><div class="casContent"><span class="casTitleNuber">40b</span><div class="casTitle"><span class="NLM_cas:atitle">Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis</span></div><div class="casAuthors">Dunay, Ildiko R.; Heimesaat, Markus M.; Bushrab, Faris Nadiem; Mueller, Rainer H.; Stocker, Hartmut; Arasteh, Keikawus; Kurowski, Michael; Fitzner, Rudolf; Borner, Klaus; Liesenfeld, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4848-4854</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Acute therapy with pyrimethamine plus sulfadiazine is the treatment of choice for reactivated toxoplasmic encephalitis (TE).  Acute therapy is followed by lifelong maintenance therapy (secondary prophylaxis) with the same drugs at lower dosages.  The use of pyrimethamine plus sulfadiazine is hampered by severe side effects including allergic reactions and hematotoxicity.  Alternative treatment regimens with pyrimethamine plus clindamycin or other antiparasitic drugs are less efficacious.  Atovaquone nanosuspensions show excellent therapeutic effects for "acute" i.v. treatment of reactivated TE in a murine model.  In the present study, the therapeutic efficacy of atovaquone for oral "maintenance" therapy was investigated.  Mice with a targeted mutation in the interferon regulatory factor 8 gene were latently infected with Toxoplasma gondii, developed reactivated TE, and received acute i.v. therapy with atovaquone nanosuspensions.  Mice were then treated orally with atovaquone suspension or other antiparasitic drugs to prevent relapse of TE.  Maintenance therapy with atovaquone at daily doses of 50 or 100 mg/kg (body wt.) protected mice against reactivated TE and death.  This maintenance treatment was superior to std. therapy with pyrimethamine plus sulfadiazine.  The latter combination was superior to the combination of pyrimethamine plus clindamycin.  Inflammatory changes in the brain parenchyma and meninges, as well as parasite nos., in the brains of mice confirmed the therapeutic efficacy of atovaquone for maintenance therapy.  Atovaquone was detectable in sera, brains, livers, and lungs of infected mice by high-performance liq. chromatog. and/or mass spectrometry.  In conclusion, atovaquone appears to be superior to the std. maintenance therapy regimens in a murine model of reactivated TE.  The therapeutic efficacy of atovaquone for maintenance therapy against TE should be further investigated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKPKQMmt7eL7Vg90H21EOLACvtfcHk0li-tauHHNmpBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKmt7vJ&md5=3a5c765f82509aa8b1121dbb28720c33</span></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.12.4848-4854.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.12.4848-4854.2004%26sid%3Dliteratum%253Aachs%26aulast%3DDunay%26aufirst%3DI.%2BR.%26aulast%3DHeimesaat%26aufirst%3DM.%2BM.%26aulast%3DBushrab%26aufirst%3DF.%2BN.%26aulast%3DMuller%26aufirst%3DR.%2BH.%26aulast%3DStocker%26aufirst%3DH.%26aulast%3DArasteh%26aufirst%3DK.%26aulast%3DKurowski%26aufirst%3DM.%26aulast%3DFitzner%26aufirst%3DR.%26aulast%3DBorner%26aufirst%3DK.%26aulast%3DLiesenfeld%26aufirst%3DO.%26atitle%3DAtovaquone%2520maintenance%2520therapy%2520prevents%2520reactivation%2520of%2520toxopasmic%2520encepahalitis%2520in%2520the%2520murine%2520model%2520of%2520reactivated%2520toxoplasmosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D4848%26epage%3D4854%26doi%3D10.1128%2FAAC.48.12.4848-4854.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darde, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Geographic separation of domestic and wild strains of <i>Toxoplasma gondii</i> in French Guiana correlates with a monomorphic version of chromosome1a</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e3182</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0003182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1371%2Fjournal.pntd.0003182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=25233228" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&author=A.+Khanauthor=D.+Ajzenbergauthor=A.+Mercierauthor=M.+Demarauthor=S.+Simonauthor=M.+L.+Dardeauthor=Q.+Wangauthor=S.+K.+Vermaauthor=B.+M.+Rosenthalauthor=J.+P.+Dubeyauthor=L.+D.+Sibley&title=Geographic+separation+of+domestic+and+wild+strains+of+Toxoplasma+gondii+in+French+Guiana+correlates+with+a+monomorphic+version+of+chromosome1a&doi=10.1371%2Fjournal.pntd.0003182"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0003182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0003182%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DMercier%26aufirst%3DA.%26aulast%3DDemar%26aufirst%3DM.%26aulast%3DSimon%26aufirst%3DS.%26aulast%3DDarde%26aufirst%3DM.%2BL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DRosenthal%26aufirst%3DB.%2BM.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DGeographic%2520separation%2520of%2520domestic%2520and%2520wild%2520strains%2520of%2520Toxoplasma%2520gondii%2520in%2520French%2520Guiana%2520correlates%2520with%2520a%2520monomorphic%2520version%2520of%2520chromosome1a%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26doi%3D10.1371%2Fjournal.pntd.0003182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volkamer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rippmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulle, S.</span></span> <span> </span><span class="NLM_article-title">KinMap: a web-based tool for interactive navigation through human kinome data</span>. <i>BMC Bioinf.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">16</span>, <span class="refDoi"> DOI: 10.1186/s12859-016-1433-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=10.1186%2Fs12859-016-1433-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=28056780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=16&issue=1&author=S.+Eidauthor=S.+Turkauthor=A.+Volkamerauthor=F.+Rippmannauthor=S.+Fulle&title=KinMap%3A+a+web-based+tool+for+interactive+navigation+through+human+kinome+data&doi=10.1186%2Fs12859-016-1433-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">KinMap: a web-based tool for interactive navigation through human kinome data</span></div><div class="casAuthors">Eid, Sameh; Turk, Samo; Volkamer, Andrea; Rippmann, Friedrich; Fulle, Simone</div><div class="citationInfo"><span class="NLM_cas:title">BMC Bioinformatics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16/1-16/6</span>CODEN:
                <span class="NLM_cas:coden">BBMIC4</span>;
        ISSN:<span class="NLM_cas:issn">1471-2105</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Annotations of the phylogenetic tree of the human kinome is an intuitive way to visualize compd. profiling data, structural features of kinases or functional relationships within this important class of proteins.  The increasing vol. and complexity of kinase-related data underlines the need for a tool that enables complex queries pertaining to kinase disease involvement and potential therapeutic uses of kinase inhibitors.  Results: Here, we present KinMap, a user-friendly online tool that facilitates the interactive navigation through kinase knowledge by linking biochem., structural, and disease assocn. data to the human kinome tree.  To this end, preprocessed data from freely-available sources, such as ChEMBL, the Protein Data Bank, and the Center for Therapeutic Target Validation platform are integrated into KinMap and can easily be complemented by proprietary data.  The value of KinMap will be exemplarily demonstrated for uncovering new therapeutic indications of known kinase inhibitors and for prioritizing kinases for drug development efforts.  Conclusions: KinMap represents a new generation of kinome tree viewers which facilitates interactive exploration of the human kinome.  KinMap enables generation of high-quality annotated images of the human kinome tree as well as exchange of kinome-related data in scientific communications.  Furthermore, KinMap supports multiple input and output formats and recognizes alternative kinase names and links them to a unified naming scheme, which makes it a useful tool across different disciplines and applications.  A web-service of KinMap is freely available at http://www.kinhub.org/kinmap/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1M2aa8fuKALVg90H21EOLACvtfcHk0li-tauHHNmpBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCjtLc%253D&md5=29737c7cda8d9caf75018e0d29e9a459</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1186%2Fs12859-016-1433-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12859-016-1433-7%26sid%3Dliteratum%253Aachs%26aulast%3DEid%26aufirst%3DS.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DVolkamer%26aufirst%3DA.%26aulast%3DRippmann%26aufirst%3DF.%26aulast%3DFulle%26aufirst%3DS.%26atitle%3DKinMap%253A%2520a%2520web-based%2520tool%2520for%2520interactive%2520navigation%2520through%2520human%2520kinome%2520data%26jtitle%3DBMC%2520Bioinf.%26date%3D2017%26volume%3D18%26issue%3D1%26spage%3D16%26doi%3D10.1186%2Fs12859-016-1433-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IHP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IHP','PDB','4IHP'); return false;">PDB: 4IHP</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i68"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00419">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_85424"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00419?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00419</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Supplementary figures and tables and detailed chemical synthesis; chemistry spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formulas strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_001.pdf">jm0c00419_si_001.pdf (9.36 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00419/suppl_file/jm0c00419_si_002.csv">jm0c00419_si_002.csv (13.0 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00419&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00419%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00419" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                10MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b9e66f3d2332","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
